BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Canto MI, Harinck F, Hruban RH, Offerhaus GJ, Poley JW, Kamel I, Nio Y, Schulick RS, Bassi C, Kluijt I, Levy MJ, Chak A, Fockens P, Goggins M, Bruno M; International Cancer of Pancreas Screening (CAPS) Consortium. International Cancer of the Pancreas Screening (CAPS) Consortium summit on the management of patients with increased risk for familial pancreatic cancer. Gut 2013;62:339-47. [PMID: 23135763 DOI: 10.1136/gutjnl-2012-303108] [Cited by in Crossref: 535] [Cited by in F6Publishing: 493] [Article Influence: 53.5] [Reference Citation Analysis]
Number Citing Articles
1 Ha CSR, Müller-Nurasyid M, Petrera A, Hauck SM, Marini F, Bartsch DK, Slater EP, Strauch K. Proteomics biomarker discovery for individualized prevention of familial pancreatic cancer using statistical learning. PLoS One 2023;18:e0280399. [PMID: 36701413 DOI: 10.1371/journal.pone.0280399] [Reference Citation Analysis]
2 Nero LD, Dabizzi E, Ceglie A, Ziola S, Zerbi A, Baron TH, Conio M. FAMILIAL PANCREATIC CANCER. Clin Res Hepatol Gastroenterol 2023;:102079. [PMID: 36681116 DOI: 10.1016/j.clinre.2023.102079] [Reference Citation Analysis]
3 Granata V, Fusco R, Setola SV, Galdiero R, Maggialetti N, Silvestro L, De Bellis M, Di Girolamo E, Grazzini G, Chiti G, Brunese MC, Belli A, Patrone R, Palaia R, Avallone A, Petrillo A, Izzo F. Risk Assessment and Pancreatic Cancer: Diagnostic Management and Artificial Intelligence. Cancers (Basel) 2023;15. [PMID: 36672301 DOI: 10.3390/cancers15020351] [Reference Citation Analysis]
4 Huang X, Chi H, Gou S, Guo X, Li L, Peng G, Zhang J, Xu J, Nian S, Yuan Q. An Aggrephagy-Related LncRNA Signature for the Prognosis of Pancreatic Adenocarcinoma. Genes (Basel) 2023;14. [PMID: 36672865 DOI: 10.3390/genes14010124] [Reference Citation Analysis]
5 Santos R, Coleman HG, Cairnduff V, Kunzmann AT. Clinical Prediction Models for Pancreatic Cancer in General and At-Risk Populations: A Systematic Review. Am J Gastroenterol 2023;118:26-40. [PMID: 36148840 DOI: 10.14309/ajg.0000000000002022] [Reference Citation Analysis]
6 Papadopoulos PC, Roarty EB, Bello RS, Fokom Domgue J, Shete S, Maitra A. The MD Anderson Cancer Center Moon Shots Program®: A Global Priority. Perioperative Care of the Cancer Patient 2023. [DOI: 10.1016/b978-0-323-69584-8.00062-1] [Reference Citation Analysis]
7 Zannini G, Facchini G, De Sio M, De Vita F, Ronchi A, Orditura M, Vietri MT, Ciardiello F, Franco R, Accardo M, Marino FZ. Implementation of BRCA mutations testing in formalin-fixed paraffin-embedded (FFPE) samples of different cancer types. Pathology - Research and Practice 2023. [DOI: 10.1016/j.prp.2023.154336] [Reference Citation Analysis]
8 Li J, Li Y, Chen C, Guo J, Qiao M, Lyu J. Recent estimates and predictions of 5-year survival rate in patients with pancreatic cancer: A model-based period analysis. Front Med (Lausanne) 2022;9:1049136. [PMID: 36569146 DOI: 10.3389/fmed.2022.1049136] [Reference Citation Analysis]
9 Greco L, Rubbino F, Laghi L. Epithelial to Mesenchymal Transition as Mechanism of Progression of Pancreatic Cancer: From Mice to Men. Cancers (Basel) 2022;14. [PMID: 36497278 DOI: 10.3390/cancers14235797] [Reference Citation Analysis]
10 Sirtl S, Vornhülz M, Hofmann FO, Mayerle J, Beyer G. Pankreaskarzinom – Screening oder Surveillance: Was ergibt Sinn? Gastroenterologie 2022. [DOI: 10.1007/s11377-022-00652-5] [Reference Citation Analysis]
11 Badheeb M, Abdelrahim A, Esmail A, Umoru G, Abboud K, Al-Najjar E, Rasheed G, Alkhulaifawi M, Abudayyeh A, Abdelrahim M. Pancreatic Tumorigenesis: Precursors, Genetic Risk Factors and Screening. Curr Oncol 2022;29:8693-719. [PMID: 36421339 DOI: 10.3390/curroncol29110686] [Reference Citation Analysis]
12 Sharma N, Arora V. Strategies for drug targeting in pancreatic cancer. Pancreatology 2022;22:937-50. [PMID: 36055937 DOI: 10.1016/j.pan.2022.08.001] [Reference Citation Analysis]
13 Visser IJ, Levink IJM, Peppelenbosch MP, Fuhler GM, Bruno MJ, Cahen DL. Systematic review and meta-analysis: Diagnostic performance of DNA alterations in pancreatic juice for the detection of pancreatic cancer. Pancreatology 2022;22:973-86. [PMID: 35864067 DOI: 10.1016/j.pan.2022.06.260] [Reference Citation Analysis]
14 Seufferlein T, Mayerle J, Böck S, Brunner T, Ettrich TJ, Grenacher L, Gress TM, Hackert T, Heinemann V, Kestler A, Sinn M, Tannapfel A, Wedding U, Uhl W. S3-Leitlinie zum exokrinen Pankreaskarzinom – Langversion 2.0 – Dezember 2021 – AWMF-Registernummer: 032/010OL. Z Gastroenterol 2022;60:e812-909. [PMID: 36368658 DOI: 10.1055/a-1856-7346] [Reference Citation Analysis]
15 Siegel A, Friedman M, Feldman D, Krishnan K, Casey B, Pisuchpen N, Kambadakone A, Chung DC. Concordance of EUS and MRI/MRCP findings among high-risk individuals undergoing pancreatic cancer screening. Pancreatology 2022;22:951-8. [PMID: 35995658 DOI: 10.1016/j.pan.2022.07.015] [Reference Citation Analysis]
16 Paramythiotis D, Kyriakidis F, Karlafti E, Didangelos T, Oikonomou I, Karakatsanis A, Poulios C, Chamalidou E, Vagionas A, Michalopoulos A. Adenosquamous carcinoma of the pancreas: two case reports and review of the literature. J Med Case Reports 2022;16:395. [DOI: 10.1186/s13256-022-03610-5] [Reference Citation Analysis]
17 Bluebond R, Bannon SA, Hyde SM, Woodson AH, You NY, Lu KH, Arun B. Hereditary Cancer Syndromes: Risk Assessment and Genetic Counseling. Holland‐Frei Cancer Medicine 2022. [DOI: 10.1002/9781119000822.hfcm143.pub2] [Reference Citation Analysis]
18 Clarysse K, Lacy K. Why, Who and How We Should Screen for Melanoma. Curr Genet Med Rep. [DOI: 10.1007/s40142-022-00204-x] [Reference Citation Analysis]
19 Dbouk M, Katona BW, Brand RE, Chak A, Syngal S, Farrell JJ, Kastrinos F, Stoffel EM, Blackford AL, Rustgi AK, Dudley B, Lee LS, Chhoda A, Kwon R, Ginsberg GG, Klein AP, Kamel I, Hruban RH, He J, Shin EJ, Lennon AM, Canto MI, Goggins M. The Multicenter Cancer of Pancreas Screening Study: Impact on Stage and Survival. J Clin Oncol 2022;40:3257-66. [PMID: 35704792 DOI: 10.1200/JCO.22.00298] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 11.0] [Reference Citation Analysis]
20 Barnes CA, Tsai S. Novel Considerations in Surgical Management of Individuals with Pancreatic Adenocarcinoma. Hematology/Oncology Clinics of North America 2022;36:979-994. [DOI: 10.1016/j.hoc.2022.07.004] [Reference Citation Analysis]
21 Labiner AJ, Aronson A, Lucas AL. Screening and Surveillance for Pancreatic Adenocarcinoma in High-Risk Individuals. Hematology/Oncology Clinics of North America 2022;36:929-942. [DOI: 10.1016/j.hoc.2022.06.004] [Reference Citation Analysis]
22 Bernstein-molho R, Friedman E, Evron E. Controversies and Open Questions in Management of Cancer-Free Carriers of Germline Pathogenic Variants in BRCA1/BRCA2. Cancers 2022;14:4592. [DOI: 10.3390/cancers14194592] [Reference Citation Analysis]
23 Peters MLB, Eckel A, Lietz A, Seguin C, Mueller P, Hur C, Pandharipande PV. Genetic testing to guide screening for pancreatic ductal adenocarcinoma: Results of a microsimulation model. Pancreatology 2022;22:760-9. [PMID: 35752568 DOI: 10.1016/j.pan.2022.05.003] [Reference Citation Analysis]
24 Vanek P, Urban O, Zoundjiekpon V, Falt P. Current Screening Strategies for Pancreatic Cancer. Biomedicines 2022;10:2056. [DOI: 10.3390/biomedicines10092056] [Reference Citation Analysis]
25 Moutinho-Ribeiro P, Batista IA, Quintas ST, Adem B, Silva M, Morais R, Peixoto A, Coelho R, Costa-Moreira P, Medas R, Lopes S, Vilas-Boas F, Baptista M, Dias-Silva D, Esteves AL, Martins F, Lopes J, Barroca H, Carneiro F, Macedo G, Melo SA. Exosomal glypican-1 is elevated in pancreatic cancer precursors and can signal genetic predisposition in the absence of endoscopic ultrasound abnormalities. World J Gastroenterol 2022; 28(31): 4310-4327 [DOI: 10.3748/wjg.v28.i31.4310] [Reference Citation Analysis]
26 Xia C, Yin H, Zhang K, Wang Z, Yang X, Huang H. The global research status and trends of the application of endoscopic ultrasonography in pancreatic tumors over the last decades: A bibliometric study. Front Oncol 2022;12:980415. [DOI: 10.3389/fonc.2022.980415] [Reference Citation Analysis]
27 Cai J, Chen H, Lu M, Zhang Y, Lu B, Luo C, Feng X, You L, Dai M, Zhao Y. Association between Temporal Glycemic Change and Risk of Pancreatic Cancer in Men: A Prospective Cohort Study. Cancers 2022;14:3403. [DOI: 10.3390/cancers14143403] [Reference Citation Analysis]
28 Akushevich I, Yashkin A, Kovtun M, Yashin AI, Kravchenko J. Underlying mechanisms of change in cancer prevalence in older U.S. adults: contributions of incidence, survival, and ascertainment at early stages. Cancer Causes Control 2022. [PMID: 35799033 DOI: 10.1007/s10552-022-01595-6] [Reference Citation Analysis]
29 Korenevskiy NA, Okhotnikov OI, Belozerov VA, Rodionova SN. Fuzzy Models of the Differential Diagnosis of Pancreatic Cancer and Chronic Pancreatitis Using Endoscopic Ultrasonography Data. Biomed Eng 2022;56:132-136. [DOI: 10.1007/s10527-022-10183-6] [Reference Citation Analysis]
30 Fukushima G, Abe K, Kitago M, Iwasaki E, Hirata A, Takemura R, Ishii R, Yagi H, Abe Y, Hasegawa Y, Fukuhara S, Hori S, Tanaka M, Nakano Y, Yokose T, Shimane G, Kitagawa Y. Association Between Clinical Backgrounds and Malignant Progression of Suspected Intraductal Papillary Mucinous Neoplasm. Pancreas 2022;51:617-23. [PMID: 36099509 DOI: 10.1097/MPA.0000000000002064] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
31 Beyer G, Hoffmeister A, Lorenz P, Lynen P, Lerch MM, Mayerle J. Clinical Practice Guideline—Acute and Chronic Pancreatitis. Dtsch Arztebl Int 2022;119:495-501. [PMID: 35945698 DOI: 10.3238/arztebl.m2022.0223] [Reference Citation Analysis]
32 Casolino R, Corbo V, Beer P, Hwang C, Paiella S, Silvestri V, Ottini L, Biankin AV. Germline Aberrations in Pancreatic Cancer: Implications for Clinical Care. Cancers 2022;14:3239. [DOI: 10.3390/cancers14133239] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
33 Ashida R, Ioka T, Takada R, Fukutake N, Ikezawa K, Ohkawa K, Nagata S, Takahashi H. New Screening System Using Forward-Viewing Radial Endoscopic Ultrasound and Magnetic Resonance Imaging for High-Risk Individuals With Familial History of Pancreatic Cancer. Front Med 2022;9:928182. [DOI: 10.3389/fmed.2022.928182] [Reference Citation Analysis]
34 Bagias G, Kanavidis P, Vailas M, Despotidis M, Sotiropoulou M, Katsaros I, Maroulis I, Filippou D, Schizas D. Surgical management of familial pancreatic cancer: a systematic review of the literature. ANZ J Surg 2022. [PMID: 35758214 DOI: 10.1111/ans.17834] [Reference Citation Analysis]
35 Ardeshna DR, Rangwani S, Cao T, Pawlik TM, Stanich PP, Krishna SG. Intraductal Papillary Mucinous Neoplasms in Hereditary Cancer Syndromes. Biomedicines 2022;10:1475. [DOI: 10.3390/biomedicines10071475] [Reference Citation Analysis]
36 Ulanja MB, Moody AE, Beutler BD, Antwi-Amoabeng D, Rahman GA, Alese OB. Early-onset pancreatic cancer: a review of molecular mechanisms, management, and survival. Oncotarget 2022;13:828-41. [PMID: 35720978 DOI: 10.18632/oncotarget.28242] [Reference Citation Analysis]
37 Nesteruk K, Levink IJM, de Vries E, Visser IJ, Peppelenbosch MP, Cahen DL, Fuhler GM, Bruno MJ. Extracellular vesicle-derived microRNAs in pancreatic juice as biomarkers for detection of pancreatic ductal adenocarcinoma. Pancreatology 2022;22:626-35. [PMID: 35613957 DOI: 10.1016/j.pan.2022.04.010] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
38 Potjer TP. Pancreatic cancer surveillance and its ongoing challenges: is it time to refine our eligibility criteria? Gut 2022;71:1047-9. [PMID: 34145046 DOI: 10.1136/gutjnl-2021-324739] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
39 Boland CR, Idos GE, Durno C, Giardiello FM, Anderson JC, Burke CA, Dominitz JA, Gross S, Gupta S, Jacobson BC, Patel SG, Shaukat A, Syngal S, Robertson DJ. Diagnosis and Management of Cancer Risk in the Gastrointestinal Hamartomatous Polyposis Syndromes: Recommendations From the US Multi-Society Task Force on Colorectal Cancer. Gastroenterology 2022;162:2063-85. [PMID: 35487791 DOI: 10.1053/j.gastro.2022.02.021] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
40 Boland CR, Idos GE, Durno C, Giardiello FM, Anderson JC, Burke CA, Dominitz JA, Gross S, Gupta S, Jacobson BC, Patel SG, Shaukat A, Syngal S, Robertson DJ. Diagnosis and management of cancer risk in the gastrointestinal hamartomatous polyposis syndromes: recommendations from the U.S. Multi-Society Task Force on Colorectal Cancer. Gastrointest Endosc 2022;95:1025-47. [PMID: 35487765 DOI: 10.1016/j.gie.2022.02.044] [Reference Citation Analysis]
41 Wang Y, Cuggia A, Chen YI, Parent J, Stanek A, Denroche RE, Zhang A, Grant RC, Domecq C, Golesworthy B, Shwaartz C, Borgida A, Holter S, Wilson JM, Chong G, O'Kane GM, Knox JJ, Fischer SE, Gallinger S, Gao ZH, Foulkes WD, Waschke KA, Zogopoulos G. Is Biannual Surveillance for Pancreatic Cancer Sufficient in Individuals With Genetic Syndromes or Familial Pancreatic Cancer? J Natl Compr Canc Netw 2022;20:663-673.e12. [PMID: 35714671 DOI: 10.6004/jnccn.2021.7107] [Reference Citation Analysis]
42 Boland CR, Idos GE, Durno C, Giardiello FM, Anderson JC, Burke CA, Dominitz JA, Gross S, Gupta S, Jacobson BC, Patel SG, Shaukat A, Syngal S, Robertson DJ. Diagnosis and Management of Cancer Risk in the Gastrointestinal Hamartomatous Polyposis Syndromes: Recommendations From the US Multi-Society Task Force on Colorectal Cancer. Am J Gastroenterol 2022;117:846-64. [PMID: 35471415 DOI: 10.14309/ajg.0000000000001755] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
43 Raoof S, Lee RJ, Jajoo K, Mancias JD, Rebbeck TR, Skates SJ. Multicancer Early Detection Technologies: A Review Informed by Past Cancer Screening Studies. Cancer Epidemiol Biomarkers Prev 2022;31:1139-45. [PMID: 35320352 DOI: 10.1158/1055-9965.EPI-21-1443] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
44 Farr KP, Moses D, Haghighi KS, Phillips PA, Hillenbrand CM, Chua BH. Imaging Modalities for Early Detection of Pancreatic Cancer: Current State and Future Research Opportunities. Cancers 2022;14:2539. [DOI: 10.3390/cancers14102539] [Reference Citation Analysis]
45 Calderwood AH, Sawhney MS, Thosani NC, Rebbeck TR, Wani S, Canto MI, Fishman DS, Golan T, Hidalgo M, Kwon RS, Riegert-Johnson DL, Sahani DV, Stoffel EM, Vollmer CM Jr, Al-Haddad MA, Amateau SK, Buxbaum JL, DiMaio CJ, Fujii-Lau LL, Jamil LH, Jue TL, Law JK, Lee JK, Naveed M, Pawa S, Storm AC, Qumseya BJ. American Society for Gastrointestinal Endoscopy guideline on screening for pancreatic cancer in individuals with genetic susceptibility: methodology and review of evidence. Gastrointest Endosc 2022;95:827-854.e3. [PMID: 35183359 DOI: 10.1016/j.gie.2021.12.002] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
46 Sawhney MS, Calderwood AH, Thosani NC, Rebbeck TR, Wani S, Canto MI, Fishman DS, Golan T, Hidalgo M, Kwon RS, Riegert-Johnson DL, Sahani DV, Stoffel EM, Vollmer CM Jr, Qumseya BJ; Prepared by: ASGE STANDARDS OF PRACTICE COMMITTEE. ASGE guideline on screening for pancreatic cancer in individuals with genetic susceptibility: summary and recommendations. Gastrointest Endosc 2022;95:817-26. [PMID: 35183358 DOI: 10.1016/j.gie.2021.12.001] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 6.0] [Reference Citation Analysis]
47 Hijioka S, Morizane C, Takaori K, Okusaka T. Study protocol for a multi-institutional prospective surveillance study among kindreds with familial pancreatic cancer and individuals with hereditary pancreatic cancer syndrome: The Diamond Study. Pancreatology 2022;22:534-8. [PMID: 35443912 DOI: 10.1016/j.pan.2022.04.006] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
48 Honda K, Honda K. Risk stratification of pancreatic cancer by a blood test for apolipoprotein A2-isoforms. CBM 2022;33:503-12. [DOI: 10.3233/cbm-210198] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
49 Pauley K, Khan A, Kohlmann W, Jeter J. Considerations for Germline Testing in Melanoma: Updates in Behavioral Change and Pancreatic Surveillance for Carriers of CDKN2A Pathogenic Variants. Front Oncol 2022;12:837057. [PMID: 35372037 DOI: 10.3389/fonc.2022.837057] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
50 Molero X, Ayuso JR, Balsells J, Boadas J, Busquets J, Casteràs A, Concepción M, Cuatrecasas M, Fernàndez Esparrach G, Fort E, Garcia Borobia F, Ginès À, Ilzarbe L, Loras C, Masachs M, Merino X, Olsina JJ, Puig-diví V, Salord S, Serrano T, Vaquero EC. Chronic pancreatitis for the clinician. Part 2: Treatment and follow-up. Interdisciplinary position paper of the Societat Catalana de Digestologia and the Societat Catalana de Pàncrees. Gastroenterología y Hepatología (English Edition) 2022;45:304-314. [DOI: 10.1016/j.gastre.2021.05.003] [Reference Citation Analysis]
51 Beyer G, Hoffmeister A, Michl P, Gress TM, Huber W, Algül H, Neesse A, Meining A, Seufferlein TW, Rosendahl J, Kahl S, Keller J, Werner J, Friess H, Bufler P, Löhr MJ, Schneider A, Lynen Jansen P, Esposito I, Grenacher L, Mössner J, Lerch MM, Mayerle J; Collaborators:. S3-Leitlinie Pankreatitis – Leitlinie der Deutschen Gesellschaft für Gastroenterologie, Verdauungs- und Stoffwechselkrankheiten (DGVS) – September 2021 – AWMF Registernummer 021-003. Z Gastroenterol 2022;60:419-521. [PMID: 35263785 DOI: 10.1055/a-1735-3864] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
52 Firpo MA, Boucher KM, Bleicher J, Khanderao GD, Rosati A, Poruk KE, Kamal S, Marzullo L, De Marco M, Falco A, Genovese A, Adler JM, De Laurenzi V, Adler DG, Affolter KE, Garrido-laguna I, Scaife CL, Turco MC, Mulvihill SJ. A multi-analyte serum biomarker panel for early detection of pancreatic adenocarcinoma.. [DOI: 10.1101/2022.03.03.22271867] [Reference Citation Analysis]
53 Menko FH, Monkhorst K, Hogervorst FB, Rosenberg EH, Adank M, Ruijs MW, Bleiker EM, Sonke GS, Russell NS, Oldenburg HS, van der Kolk LE. Challenges in breast cancer genetic testing. A call for novel forms of multidisciplinary care and long-term evaluation. Critical Reviews in Oncology/Hematology 2022. [DOI: 10.1016/j.critrevonc.2022.103642] [Reference Citation Analysis]
54 Overbeek KA, Goggins MG, Dbouk M, Levink IJM, Koopmann BDM, Chuidian M, Konings ICAW, Paiella S, Earl J, Fockens P, Gress TM, Ausems MGEM, Poley JW, Thosani NC, Half E, Lachter J, Stoffel EM, Kwon RS, Stoita A, Kastrinos F, Lucas AL, Syngal S, Brand RE, Chak A, Carrato A, Vleggaar FP, Bartsch DK, van Hooft JE, Cahen DL, Canto MI, Bruno MJ; International Cancer of the Pancreas Screening Consortium. Timeline of Development of Pancreatic Cancer and Implications for Successful Early Detection in High-Risk Individuals. Gastroenterology 2022;162:772-785.e4. [PMID: 34678218 DOI: 10.1053/j.gastro.2021.10.014] [Cited by in Crossref: 20] [Cited by in F6Publishing: 19] [Article Influence: 20.0] [Reference Citation Analysis]
55 Morizane C. Germline pathogenic variants in patients with pancreatic cancer. Journal of the Japan Pancreas Society 2022;37:22-28. [DOI: 10.2958/suizo.37.22] [Reference Citation Analysis]
56 Lee HA, Chen KW, Hsu CY. Prediction Model for Pancreatic Cancer-A Population-Based Study from NHIRD. Cancers (Basel) 2022;14:882. [PMID: 35205630 DOI: 10.3390/cancers14040882] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
57 Vietri MT, D’elia G, Caliendo G, Albanese L, Signoriello G, Napoli C, Molinari AM. Pancreatic Cancer with Mutation in BRCA1/2, MLH1, and APC Genes: Phenotype Correlation and Detection of a Novel Germline BRCA2 Mutation. Genes 2022;13:321. [DOI: 10.3390/genes13020321] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
58 Kimura H, Paranal RM, Nanda N, Wood LD, Eshleman JR, Hruban RH, Goggins MG, Klein AP, Roberts NJ; Familial Pancreatic Cancer Genome Sequencing Project. Functional CDKN2A assay identifies frequent deleterious alleles misclassified as variants of uncertain significance. Elife 2022;11:e71137. [PMID: 35001868 DOI: 10.7554/eLife.71137] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
59 Schwartz I, Sharma P, Vankawala P, Cruz N, Abraham RR, Sussman DA, Girotra M. High Rate of Pancreatic Structural Changes Among Tobacco-Using Individuals at High Risk for Pancreatic Ductal Adenocarcinoma Undergoing Endoscopic Ultrasound. Pancreas 2022;51:e1-3. [PMID: 35195604 DOI: 10.1097/MPA.0000000000001969] [Reference Citation Analysis]
60 Kothari S, Kaul V, Kothari TH. Reducing the Risk of and Screening for Pancreatic Cancer. Hepato-Pancreato-Biliary Malignancies 2022. [DOI: 10.1007/978-3-030-41683-6_35] [Reference Citation Analysis]
61 Chandan S, Deliwala SS, Facciorusso A, Mohan BP, Ramai D, Kochhar GS. Association of BRCA Mutations and Pancreatic Cancer: Review of Literature and Meta-analysis. Pancreas 2022;51:e8-e10. [PMID: 35195609 DOI: 10.1097/MPA.0000000000001956] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
62 Lew D, Kwok K. Diagnosis and Evaluation of Pancreatic and Periampullary Adenocarcinoma. Hepato-Pancreato-Biliary Malignancies 2022. [DOI: 10.1007/978-3-030-41683-6_29] [Reference Citation Analysis]
63 Kana MA, Khanijahani A, Raji IA, Adamu A, Linkov F. Data Use in Public Health. Health Informatics 2022. [DOI: 10.1007/978-3-031-07912-2_12] [Reference Citation Analysis]
64 王 登. Research Progress in Pancreatic Cancer. ACM 2022;12:5181-5188. [DOI: 10.12677/acm.2022.126751] [Reference Citation Analysis]
65 Haan D, Bergamaschi A, Guler GD, Friedl V, Ning Y, Reggiardo R, Kesling M, Collins M, Gibb B, Pitea A, Hazen K, Bates S, Antoine M, Fraire C, Lopez V, Malta R, Nabiyouni M, Nguyen A, Phillips T, Riviere M, Scott A, Nilson E, Sheard J, Peters M, Chowdhury S, Volkmuth W, Levy S. Validation of a Pancreatic Cancer Detection Test in New-Onset Diabetes Using Cell-Free DNA 5-Hydroxymethylation Signatures.. [DOI: 10.1101/2021.12.27.21268450] [Reference Citation Analysis]
66 Yamamoto H, Hirasawa A. Homologous Recombination Deficiencies and Hereditary Tumors. Int J Mol Sci 2021;23:348. [PMID: 35008774 DOI: 10.3390/ijms23010348] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
67 Gonda TA, Everett JN, Wallace M, Simeone DM; PRECEDE Consortium. Recommendations for a More Organized and Effective Approach to the Early Detection of Pancreatic Cancer From the PRECEDE (Pancreatic Cancer Early Detection) Consortium. Gastroenterology 2021;161:1751-7. [PMID: 34454916 DOI: 10.1053/j.gastro.2021.08.036] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
68 Dayem Ullah AZM, Stasinos K, Chelala C, Kocher HM. Temporality of clinical factors associated with pancreatic cancer: a case-control study using linked electronic health records. BMC Cancer 2021;21:1279. [PMID: 34837975 DOI: 10.1186/s12885-021-09014-w] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
69 Smith JP, Cao H, Edmondson EF, Dasa SSK, Stern ST. Cholecystokinin-B Receptor-Targeted Nanoparticle for Imaging and Detection of Precancerous Lesions in the Pancreas. Biomolecules 2021;11:1766. [DOI: 10.3390/biom11121766] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
70 Rustgi SD, Hilfrank KJ, Kastrinos F. Familial Predisposition and Genetic Risk Factors Associated with Pancreatic Cancer. Gastrointest Endosc Clin N Am 2022;32:1-12. [PMID: 34798979 DOI: 10.1016/j.giec.2021.09.001] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
71 Ren H, Mori N, Hirasawa M, Hamada S, Mugikura S, Masamune A, Takase K. Abnormal Findings on "T1WI or DWI or MRCP:" An Effective Boolean Interpretation Model in Discriminating Small Pancreatic Ductal Adenocarcinoma from Control Group. J Clin Imaging Sci 2021;11:54. [PMID: 34754594 DOI: 10.25259/JCIS_158_2021] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
72 本田 一. がん早期診断・リスク層別化,精密医療に資するバイオマーカー探索と社会実装を目指して. Nihon Ika Daigaku Igakkai Zasshi 2021;17:146-157. [DOI: 10.1272/manms.17.146] [Reference Citation Analysis]
73 Chen X, Yu Z, Wang J, Cui W, Cui C, Wang Y, Liu Y, Zhou H, Wang C, Wang Z, Chen X. Opportunistic Detection for Pancreatic Cystic Lesions During Chest Multidetector CT Scans for Lung Cancer Screening. Cancer Manag Res 2021;13:7559-68. [PMID: 34629902 DOI: 10.2147/CMAR.S327022] [Reference Citation Analysis]
74 Belozerov VA, Ohotnikov OI, Korenevskij NA, Grigorev SN. Differential Diagnostics Focal Pancreatics Masses Based on the Analysis of the Echographic Texture of Endosonograms Using Fuzzy Mathematical Models. jour 2021;4:64-73. [DOI: 10.37174/2587-7593-2021-4-3-64-73] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
75 Kurita A, Mori Y, Someya Y, Kubo S, Azuma S, Iwano K, Ikeda S, Okumura R, Yazumi S. High signal intensity on diffusion-weighted magnetic resonance images is a useful finding for detecting early-stage pancreatic cancer. Abdom Radiol (NY) 2021;46:4817-27. [PMID: 34223962 DOI: 10.1007/s00261-021-03199-1] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
76 Rahmanuddin S, Korn R, Cridebring D, Borazanci E, Brase J, Boswell W, Jamil A, Cai W, Sabir A, Motarjem P, Koay E, Mitra A, Goel A, Ho J, Chung V, Von Hoff DD. Role of 3D Volumetric and Perfusion Imaging for Detecting Early Changes in Pancreatic Adenocarcinoma. Front Oncol 2021;11:678617. [PMID: 34568010 DOI: 10.3389/fonc.2021.678617] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
77 Teufel A, Quante M, Kandulski A, Hirth M, Zhan T, Eckardt M, Thieme R, Kusnik A, Yesmembetov K, Wiest I, Riemann JF, Schlitt HJ, Gockel I, Malfertheiner P, Ebert MP. [Prevention of gastrointestinal cancer]. Z Gastroenterol 2021;59:964-82. [PMID: 34507375 DOI: 10.1055/a-1540-7539] [Reference Citation Analysis]
78 Chen X, Liu F, Xue Q, Weng X, Xu F. Metastatic pancreatic cancer: Mechanisms and detection (Review). Oncol Rep 2021;46:231. [PMID: 34498718 DOI: 10.3892/or.2021.8182] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
79 Kimura H, Klein AP, Hruban RH, Roberts NJ. The Role of Inherited Pathogenic CDKN2A Variants in Susceptibility to Pancreatic Cancer. Pancreas 2021;50:1123-30. [PMID: 34714275 DOI: 10.1097/MPA.0000000000001888] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 4.0] [Reference Citation Analysis]
80 Tewari M, Swain JR, Mahendran R. Update on Management Periampullary/Pancreatic Head Cancer. Indian J Surg 2021;83:654-664. [DOI: 10.1007/s12262-019-02053-5] [Reference Citation Analysis]
81 Yousaf MN, Chaudhary FS, Ehsan A, Suarez AL, Muniraj T, Jamidar P, Aslanian HR, Farrell JJ. Endoscopic ultrasound (EUS) and the management of pancreatic cancer. BMJ Open Gastroenterol 2020;7:e000408. [PMID: 32414753 DOI: 10.1136/bmjgast-2020-000408] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 4.5] [Reference Citation Analysis]
82 Olivier R, Randrian V, Tougeron D, Saurin JC. Endoscopy to Diagnose and Prevent Digestive Cancers in Lynch Syndrome. Cancers (Basel) 2021;13:3505. [PMID: 34298719 DOI: 10.3390/cancers13143505] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
83 Schorr F, Essig MW. [Early detection of pancreatic cancer - The role of endoscopic and transabdominal ultrasound]. Z Gastroenterol 2021. [PMID: 34243212 DOI: 10.1055/a-1515-3123] [Reference Citation Analysis]
84 Ribeiro Moura Brasil Arnaut J, Dos Santos Guimarães I, Evangelista Dos Santos AC, de Moraes Lino da Silva F, Machado JR, de Melo AC. Molecular landscape of Hereditary Melanoma. Crit Rev Oncol Hematol 2021;164:103425. [PMID: 34245855 DOI: 10.1016/j.critrevonc.2021.103425] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
85 Slater EP, Wilke LM, Böhm LB, Strauch K, Lutz M, Gercke N, Matthäi E, Hemminki K, Försti A, Schlesner M, Paramasivam N, Bartsch DK. Combinations of Low-Frequency Genetic Variants Might Predispose to Familial Pancreatic Cancer. J Pers Med 2021;11:631. [PMID: 34357098 DOI: 10.3390/jpm11070631] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
86 Klein AP. Pancreatic cancer epidemiology: understanding the role of lifestyle and inherited risk factors. Nat Rev Gastroenterol Hepatol 2021;18:493-502. [PMID: 34002083 DOI: 10.1038/s41575-021-00457-x] [Cited by in Crossref: 95] [Cited by in F6Publishing: 89] [Article Influence: 47.5] [Reference Citation Analysis]
87 Kumar S, Saumoy M, Oh A, Schneider Y, Brand RE, Chak A, Ginsberg GG, Kochman ML, Canto MI, Goggins MG, Hur C, Kastrinos F, Katona BW, Rustgi AK. Threshold Analysis of the Cost-effectiveness of Endoscopic Ultrasound in Patients at High Risk for Pancreatic Ductal Adenocarcinoma. Pancreas 2021;50:807-14. [PMID: 34149034 DOI: 10.1097/MPA.0000000000001835] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
88 Maisonneuve P. Epidemiological Impact of Pancreatic Cancer. Clinical Pancreatology for Practising Gastroenterologists and Surgeons 2021. [DOI: 10.1002/9781119570097.ch49] [Reference Citation Analysis]
89 Cai J, Chen H, Lu M, Zhang Y, Lu B, You L, Zhang T, Dai M, Zhao Y. Advances in the epidemiology of pancreatic cancer: Trends, risk factors, screening, and prognosis. Cancer Lett 2021;520:1-11. [PMID: 34216688 DOI: 10.1016/j.canlet.2021.06.027] [Cited by in Crossref: 15] [Cited by in F6Publishing: 10] [Article Influence: 7.5] [Reference Citation Analysis]
90 Kichler A, Jang S. Chronic Pancreatitis: Epidemiology, Diagnosis, and Management Updates. Drugs 2020;80:1155-68. [PMID: 32647920 DOI: 10.1007/s40265-020-01360-6] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 7.0] [Reference Citation Analysis]
91 Molero X, Ayuso JR, Balsells J, Boadas J, Busquets J, Casteràs A, Concepción M, Cuatrecasas M, Fernàndez Esparrach G, Fort E, Garcia Borobia F, Ginès À, Ilzarbe L, Loras C, Masachs M, Merino X, Olsina JJ, Puig-Diví V, Salord S, Serrano T, Vaquero EC. Chronic pancreatitis for the clinician. Part 2: Treatment and follow-up. Interdisciplinary Position Paper of the Societat Catalana de Digestologia and the Societat Catalana de Pàncrees. Gastroenterol Hepatol 2021:S0210-5705(21)00205-3. [PMID: 34171422 DOI: 10.1016/j.gastrohep.2021.05.016] [Reference Citation Analysis]
92 Wiest NE, Moktan VP, Oman SP, Chirilă RM. Screening for pancreatic cancer: a review for general clinicians. Rom J Intern Med 2020;58:119-28. [PMID: 32364522 DOI: 10.2478/rjim-2020-0009] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
93 Kurlinkus B, Ger M, Kaupinis A, Jasiunas E, Valius M, Sileikis A. CEACAM6's Role as a Chemoresistance and Prognostic Biomarker for Pancreatic Cancer: A Comparison of CEACAM6's Diagnostic and Prognostic Capabilities with Those of CA19-9 and CEA. Life (Basel) 2021;11:542. [PMID: 34207784 DOI: 10.3390/life11060542] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
94 Grapa CM, Mocan L, Crisan D, Florea M, Mocan T. Biomarkers in Pancreatic Cancer as Analytic Targets for Nanomediated Imaging and Therapy. Materials (Basel) 2021;14:3083. [PMID: 34199998 DOI: 10.3390/ma14113083] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
95 Assarzadegan N, Thompson E, Salimian K, Gaida MM, Brosens LAA, Wood L, Ali SZ, Hruban RH. Pathology of intraductal papillary mucinous neoplasms. Langenbecks Arch Surg 2021. [PMID: 34047827 DOI: 10.1007/s00423-021-02201-0] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
96 Gallo M, Adinolfi V, Morviducci L, Acquati S, Tuveri E, Ferrari P, Zatelli MC, Faggiano A, Argentiero A, Natalicchio A, D'Oronzo S, Danesi R, Gori S, Russo A, Montagnani M, Beretta GD, Di Bartolo P, Silvestris N, Giorgino F. Early prediction of pancreatic cancer from new-onset diabetes: an Associazione Italiana Oncologia Medica (AIOM)/Associazione Medici Diabetologi (AMD)/Società Italiana Endocrinologia (SIE)/Società Italiana Farmacologia (SIF) multidisciplinary consensus position paper. ESMO Open 2021;6:100155. [PMID: 34020401 DOI: 10.1016/j.esmoop.2021.100155] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
97 Jacobson S, Dahlqvist P, Johansson M, Svensson J, Billing O, Sund M, Franklin O. Hyperglycemia as a risk factor in pancreatic cancer: A nested case-control study using prediagnostic blood glucose levels. Pancreatology 2021:S1424-3903(21)00159-9. [PMID: 34049822 DOI: 10.1016/j.pan.2021.05.008] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
98 Blackford AL, Canto MI, Klein AP, Hruban RH, Goggins M. Recent Trends in the Incidence and Survival of Stage 1A Pancreatic Cancer: A Surveillance, Epidemiology, and End Results Analysis. J Natl Cancer Inst 2020;112:1162-9. [PMID: 31958122 DOI: 10.1093/jnci/djaa004] [Cited by in Crossref: 60] [Cited by in F6Publishing: 66] [Article Influence: 30.0] [Reference Citation Analysis]
99 Khalaf N, El-Serag HB, Abrams HR, Thrift AP. Burden of Pancreatic Cancer: From Epidemiology to Practice. Clin Gastroenterol Hepatol 2021;19:876-84. [PMID: 32147593 DOI: 10.1016/j.cgh.2020.02.054] [Cited by in Crossref: 73] [Cited by in F6Publishing: 68] [Article Influence: 36.5] [Reference Citation Analysis]
100 Wang CC, Tseng MH, Wu SW, Yang TW, Chen HY, Sung WW, Su CC, Wang YT, Chen WL, Lai HC, Lin CC, Tsai MC. Symptomatic cholelithiasis patients have an increased risk of pancreatic cancer: A population-based study. J Gastroenterol Hepatol 2021;36:1187-96. [PMID: 32881083 DOI: 10.1111/jgh.15234] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
101 Hintzen KFH, Grote J, Wintjens AGWE, Lubbers T, Eussen MMM, van Schooten FJ, Bouvy ND, Peeters A. Breath analysis for the detection of digestive tract malignancies: systematic review. BJS Open 2021;5:zrab013. [PMID: 33855362 DOI: 10.1093/bjsopen/zrab013] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
102 Kim SH, Hwang HK, Lee WJ, Kang CM. Biologic behavior of resected BRCA-mutated pancreatic cancer: Comparison with sporadic pancreatic cancer and other BRCA-related cancers. Pancreatology 2021;21:544-9. [PMID: 33612442 DOI: 10.1016/j.pan.2021.02.007] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
103 Dbouk M, Brewer Gutierrez OI, Lennon AM, Chuidian M, Shin EJ, Kamel IR, Fishman EK, He J, Burkhart RA, Wolfgang CL, Hruban RH, Goggins MG, Canto MI. Guidelines on management of pancreatic cysts detected in high-risk individuals: An evaluation of the 2017 Fukuoka guidelines and the 2020 International Cancer of the Pancreas Screening (CAPS) consortium statements. Pancreatology 2021;21:613-21. [PMID: 33593706 DOI: 10.1016/j.pan.2021.01.017] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 5.0] [Reference Citation Analysis]
104 Kartal K, Guan Z, Tang R, Griffin M, Wang Y, Braun D, Klein AP, Hughes KS. Familial pancreatic cancer: who should be considered for genetic testing? Ir J Med Sci 2021. [PMID: 33733397 DOI: 10.1007/s11845-021-02572-9] [Reference Citation Analysis]
105 Hilfrank KJ, Rustgi SD, Kastrinos F. Inherited predisposition to pancreatic cancer. Semin Oncol 2021:S0093-7754(21)00011-7. [PMID: 33773812 DOI: 10.1053/j.seminoncol.2021.02.006] [Reference Citation Analysis]
106 González-Gómez R, Pazo-Cid RA, Sarría L, Morcillo MÁ, Schuhmacher AJ. Diagnosis of Pancreatic Ductal Adenocarcinoma by Immuno-Positron Emission Tomography. J Clin Med 2021;10:1151. [PMID: 33801810 DOI: 10.3390/jcm10061151] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
107 Hanna-Sawires RG, Schiphuis JH, Wuhrer M, Vasen HFA, van Leerdam ME, Bonsing BA, Mesker WE, van der Burgt YEM, Tollenaar RAEM. Clinical Perspective on Proteomic and Glycomic Biomarkers for Diagnosis, Prognosis, and Prediction of Pancreatic Cancer. Int J Mol Sci 2021;22:2655. [PMID: 33800786 DOI: 10.3390/ijms22052655] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 3.5] [Reference Citation Analysis]
108 Bartsch DK, Matthäi E, Mintziras I, Bauer C, Figiel J, Sina-Boemers M, Gress TM, Langer P, Slater EP. The German National Case Collection for Familial Pancreatic Carcinoma (FaPaCa)—Knowledge Gained in 20 Years. Dtsch Arztebl Int 2021;118:arztebl. [PMID: 33531114 DOI: 10.3238/arztebl.m2021.0004] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
109 Hallenstein LG, Sorensen C, Hodgson L, Wen S, Westhuyzen J, Hansen C, Last ATJ, Amalaseelan JV, Salindera S, Ross W, Spigelman AD, Shakespeare TP, Aherne NJ. Assessment of genetic referrals and outcomes for women with triple negative breast cancer in regional cancer centres in Australia. Hered Cancer Clin Pract 2021;19:19. [PMID: 33637119 DOI: 10.1186/s13053-021-00176-z] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
110 Oman SP, Corral JE, Stauffer J, Raimondo M, Mody K, Wallace M. The Increasing Proportion of Early-Stage Pancreatic Cancer between 2004-2013: A SEER Analysis. Cancer Invest 2021;39:229-34. [PMID: 33571039 DOI: 10.1080/07357907.2021.1888386] [Reference Citation Analysis]
111 O'Neill RS, Meiser B, Emmanuel S, Williams DB, Stoita A. Long-term positive psychological outcomes in an Australian pancreatic cancer screening program. Fam Cancer 2020;19:23-35. [PMID: 31625003 DOI: 10.1007/s10689-019-00147-3] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 4.0] [Reference Citation Analysis]
112 Ishii Y, Serikawa M, Tsuboi T, Kawamura R, Tsushima K, Nakamura S, Hirano T, Fukiage A, Mori T, Ikemoto J, Kiyoshita Y, Saeki S, Tamura Y, Miyamoto S, Chayama K. Role of Endoscopic Ultrasonography and Endoscopic Retrograde Cholangiopancreatography in the Diagnosis of Pancreatic Cancer. Diagnostics (Basel) 2021;11:238. [PMID: 33557084 DOI: 10.3390/diagnostics11020238] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
113 Wagner A, Aretz S, Auranen A, Bruno MJ, Cavestro GM, Crosbie EJ, Goverde A, Jelsig AM, Latchford A, Leerdam MEV, Lepisto A, Puzzono M, Winship I, Zuber V, Möslein G. The Management of Peutz-Jeghers Syndrome: European Hereditary Tumour Group (EHTG) Guideline. J Clin Med 2021;10:473. [PMID: 33513864 DOI: 10.3390/jcm10030473] [Cited by in Crossref: 21] [Cited by in F6Publishing: 25] [Article Influence: 10.5] [Reference Citation Analysis]
114 Agostini A, Borgheresi A, Bruno F, Natella R, Floridi C, Carotti M, Giovagnoni A. New advances in CT imaging of pancreas diseases: a narrative review. Gland Surg 2020;9:2283-94. [PMID: 33447580 DOI: 10.21037/gs-20-551] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
115 Abe K, Ueki A, Urakawa Y, Kitago M, Yoshihama T, Nanki Y, Kitagawa Y, Aoki D, Kosaki K, Hirasawa A. Familial pancreatic cancer with PALB2 and NBN pathogenic variants: a case report. Hered Cancer Clin Pract 2021;19:5. [PMID: 33413558 DOI: 10.1186/s13053-020-00160-z] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
116 Berliner JL, Cummings SA, Boldt Burnett B, Ricker CN. Risk assessment and genetic counseling for hereditary breast and ovarian cancer syndromes-Practice resource of the National Society of Genetic Counselors. J Genet Couns 2021;30:342-60. [PMID: 33410258 DOI: 10.1002/jgc4.1374] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
117 Peretti U, Cavaliere A, Niger M, Tortora G, Di Marco MC, Rodriquenz MG, Centonze F, Rapposelli IG, Giordano G, De Vita F, Stuppia L, Avallone A, Ratti M, Paratore C, Forti LG, Orsi G, Valente MM, Gaule M, Macchini M, Carrera P, Calzavara S, Simbolo M, Melisi D, De Braud F, Salvatore L, De Lorenzo S, Chiarazzo C, Falconi M, Cascinu S, Milella M, Reni M. Germinal BRCA1-2 pathogenic variants (gBRCA1-2pv) and pancreatic cancer: epidemiology of an Italian patient cohort. ESMO Open 2021;6:100032. [PMID: 33399070 DOI: 10.1016/j.esmoop.2020.100032] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 5.5] [Reference Citation Analysis]
118 Buscail L, Bournet B, Carrère N, Muscari F, Otal P. Cancer du pancréas. Traité de Pancréatologie 2021. [DOI: 10.1016/b978-2-294-77623-6.00006-7] [Reference Citation Analysis]
119 Viswanath P. Integration into cancer studies. Advances in Magnetic Resonance Technology and Applications 2021. [DOI: 10.1016/b978-0-12-822269-0.00010-5] [Reference Citation Analysis]
120 Chalhoub JM, Andrawes S. Pancreatic Cancer Screening. Clinical Gastroenterology 2021. [DOI: 10.1007/978-3-030-69940-6_8] [Reference Citation Analysis]
121 Kothari S, Kaul V, Kothari TH. Reducing the Risk of and Screening for Pancreatic Cancer. Hepato-Pancreato-Biliary Malignancies 2021. [DOI: 10.1007/978-3-030-37482-2_35-1] [Reference Citation Analysis]
122 Lew D, Kwok K. Diagnosis and Evaluation of Pancreatic and Periampullary Adenocarcinoma. Hepato-Pancreato-Biliary Malignancies 2021. [DOI: 10.1007/978-3-030-37482-2_29-1] [Reference Citation Analysis]
123 Cannizzaro R, Magris R, Maiero S, Guarnieri G, Fornasarig M, Canzonieri V. Role of Endoscopic Ultrasound in Pancreatic Cancer Screening. Endoscopic Ultrasound Management of Pancreatic Lesions 2021. [DOI: 10.1007/978-3-030-71937-1_11] [Reference Citation Analysis]
124 Del Chiaro M, Beckman R, Ateeb Z, Orsini N, Rezaee N, Manos L, Valente R, Yuan C, Ding D, Margonis GA, Yin L, Cameron JL, Makary MA, Burkhart RA, Weiss MJ, He J, Arnelo U, Yu J, Wolfgang CL. Main Duct Dilatation Is the Best Predictor of High-grade Dysplasia or Invasion in Intraductal Papillary Mucinous Neoplasms of the Pancreas. Ann Surg. 2019;. [PMID: 30672797 DOI: 10.1097/sla.0000000000003174] [Cited by in Crossref: 36] [Cited by in F6Publishing: 40] [Article Influence: 12.0] [Reference Citation Analysis]
125 Appelbaum L, Cambronero JP, Stevens JP, Horng S, Pollick K, Silva G, Haneuse S, Piatkowski G, Benhaga N, Duey S, Stevenson MA, Mamon H, Kaplan ID, Rinard MC. Development and validation of a pancreatic cancer risk model for the general population using electronic health records: An observational study. Eur J Cancer 2021;143:19-30. [PMID: 33278770 DOI: 10.1016/j.ejca.2020.10.019] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 3.3] [Reference Citation Analysis]
126 Bar-mashiah A, Aronson A, Naparst M, Dimaio CJ, Lucas AL. Elevated hemoglobin A1c is associated with the presence of pancreatic cysts in a high-risk pancreatic surveillance program. BMC Gastroenterol 2020;20:161. [DOI: 10.1186/s12876-020-01308-w] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
127 Kogekar N, Diaz KE, Weinberg AD, Lucas AL. Surveillance of high-risk individuals for pancreatic cancer with EUS and MRI: A meta-analysis. Pancreatology 2020;20:1739-46. [PMID: 33077384 DOI: 10.1016/j.pan.2020.10.025] [Cited by in Crossref: 12] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
128 Matsubayashi H, Ishiwatari H, Sasaki K, Uesaka K, Ono H. Detecting Early Pancreatic Cancer: Current Problems and Future Prospects. Gut Liver. 2020;14:30-36. [PMID: 31009958 DOI: 10.5009/gnl18491] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
129 Kassem N, Stout LA, Hunter C, Schneider B, Radovich M. Precision Prevention: The Current State and Future of Genomically Guided Cancer Prevention. JCO Precis Oncol 2020;4:96-108. [PMID: 35050732 DOI: 10.1200/PO.19.00278] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
130 García-Costela M, Escudero-Feliú J, Puentes-Pardo JD, San Juán SM, Morales-Santana S, Ríos-Arrabal S, Carazo Á, León J. Circadian Genes as Therapeutic Targets in Pancreatic Cancer. Front Endocrinol (Lausanne) 2020;11:638. [PMID: 33042011 DOI: 10.3389/fendo.2020.00638] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 2.3] [Reference Citation Analysis]
131 Sharma GG, Okada Y, Von Hoff D, Goel A. Non-coding RNA biomarkers in pancreatic ductal adenocarcinoma. Semin Cancer Biol 2020:S1044-579X(20)30204-2. [PMID: 33049362 DOI: 10.1016/j.semcancer.2020.10.001] [Cited by in Crossref: 15] [Cited by in F6Publishing: 19] [Article Influence: 5.0] [Reference Citation Analysis]
132 Yuan C, Babic A, Khalaf N, Nowak JA, Brais LK, Rubinson DA, Ng K, Aguirre AJ, Pandharipande PV, Fuchs CS, Giovannucci EL, Stampfer MJ, Rosenthal MH, Sander C, Kraft P, Wolpin BM. Diabetes, Weight Change, and Pancreatic Cancer Risk. JAMA Oncol. 2020;6:e202948. [PMID: 32789511 DOI: 10.1001/jamaoncol.2020.2948] [Cited by in Crossref: 42] [Cited by in F6Publishing: 42] [Article Influence: 14.0] [Reference Citation Analysis]
133 Haeri HH, Tomaszewski J, Phytides B, Schimm H, Möslein G, Niedergethmann M, Hinderberger D, Gelos M. Identification of Patients with Pancreatic Cancer by Electron Paramagnetic Resonance Spectroscopy of Fatty Acid Binding to Human Serum Albumin. ACS Pharmacol Transl Sci 2020;3:1188-98. [PMID: 33344896 DOI: 10.1021/acsptsci.0c00116] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
134 Fukuba N, Ishitobi H, Takahashi Y, Nagaoka M, Fukuhara H, Yuki M, Komazawa Y, Kuroda H, Sato S, Shizuku T. Real-world Evidence of Diffusion-weighted Imaging Combined With Magnetic Resonance Cholangiopancreatography for Pancreatic Tumor Screening: A Cross-Sectional Diagnostic Accuracy Study. Pancreas 2020;49:1182-6. [PMID: 32898002 DOI: 10.1097/MPA.0000000000001653] [Reference Citation Analysis]
135 Capurso G, Paiella S, Carrara S, Butturini G, Secchettin E, Frulloni L, Zerbi A, Falconi M. Italian registry of families at risk of pancreatic cancer: AISP Familial Pancreatic Cancer Study Group. Dig Liver Dis 2020;52:1126-30. [PMID: 32819857 DOI: 10.1016/j.dld.2020.07.027] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
136 Sato Y, Kobayashi T, Nishiumi S, Okada A, Fujita T, Sanuki T, Kobayashi M, Asahara M, Adachi M, Sakai A, Shiomi H, Masuda A, Yoshida M, Takeuchi K, Kodama Y, Kutsumi H, Nagashima K, Honda K. Prospective Study Using Plasma Apolipoprotein A2-Isoforms to Screen for High-Risk Status of Pancreatic Cancer. Cancers (Basel). 2020;12. [PMID: 32937962 DOI: 10.3390/cancers12092625] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
137 Kowada A. Cost-effectiveness of Abdominal Ultrasound Versus Magnetic Resonance Imaging for Pancreatic Cancer Screening in Familial High-Risk Individuals in Japan. Pancreas 2020;49:1052-6. [PMID: 32769852 DOI: 10.1097/MPA.0000000000001614] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
138 Kitano M, Morizane C, Hijioka S, Matsubayashi H, Ashida R, Ikeura T, Ito T, Kamisawa T, Kawaguchi T, Kawabe K, Kosugi S, Kodama Y, Shimizu K, Takahashi H, Yachida S, Terashima T, Torishima M, Hanada K, Furukawa T, Furukawa M, Furuse J, Maguchi H, Majima Y, Mizuno N, Mizuma M, Mizumoto M, Yoshida T, Wada K, Takaori K. Surveillance for the early diagnosis of familial pancreatic cancer (Expert consensus). Journal of the Japan Pancreas Society 2020;35:322-330. [DOI: 10.2958/suizo.35.322] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
139 Patel N, Petrinic T, Silva M, Soonawalla Z, Reddy S, Gordon-Weeks A. The Diagnostic Accuracy of Mutant KRAS Detection from Pancreatic Secretions for the Diagnosis of Pancreatic Cancer: A Meta-Analysis. Cancers (Basel). 2020;12. [PMID: 32825312 DOI: 10.3390/cancers12092353] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
140 Stjepanovic N, Moreira L, Carneiro F, Balaguer F, Cervantes A, Balmaña J, Martinelli E; ESMO Guidelines Committee. Electronic address: clinicalguidelines@esmo.org. Hereditary gastrointestinal cancers: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up†. Ann Oncol 2019;30:1558-71. [PMID: 31378807 DOI: 10.1093/annonc/mdz233] [Cited by in Crossref: 73] [Cited by in F6Publishing: 58] [Article Influence: 24.3] [Reference Citation Analysis]
141 Sin ZW, Bhardwaj V, Pandey AK, Garg M. A brief overview of antitumoral actions of bruceine D. Exploration of Targeted Anti-tumor Therapy 2020;1:200-17. [DOI: 10.37349/etat.2020.00013] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
142 Kato S, Honda K. Use of Biomarkers and Imaging for Early Detection of Pancreatic Cancer. Cancers (Basel) 2020;12:E1965. [PMID: 32707720 DOI: 10.3390/cancers12071965] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 6.0] [Reference Citation Analysis]
143 Piombino C, Cortesi L, Lambertini M, Punie K, Grandi G, Toss A. Secondary Prevention in Hereditary Breast and/or Ovarian Cancer Syndromes Other Than BRCA. J Oncol 2020;2020:6384190. [PMID: 32733558 DOI: 10.1155/2020/6384190] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 5.0] [Reference Citation Analysis]
144 Collins JM, Isaacs C. Management of breast cancer risk in BRCA1/2 mutation carriers who are unaffected with cancer. Breast J 2020;26:1520-7. [PMID: 32652823 DOI: 10.1111/tbj.13970] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
145 Greenhalf W, Lévy P, Gress T, Rebours V, Brand RE, Pandol S, Chari S, Jørgensen MT, Mayerle J, Lerch MM, Hegyi P, Kleeff J, Castillo CF, Isaji S, Shimosegawa T, Sheel A, Halloran CM, Garg P, Takaori K, Besselink MG, Forsmark CE, Wilcox CM, Maisonneuve P, Yadav D, Whitcomb D, Neoptolemos J; Working group for the International (IAP – APA – JPS – EPC) Consensus Guidelines for Chronic Pancreatitis. International consensus guidelines on surveillance for pancreatic cancer in chronic pancreatitis. Recommendations from the working group for the international consensus guidelines for chronic pancreatitis in collaboration with the International Association of Pancreatology, the American Pancreatic Association, the Japan Pancreas Society, and European Pancreatic Club. Pancreatology 2020;20:910-8. [PMID: 32624419 DOI: 10.1016/j.pan.2020.05.011] [Cited by in Crossref: 23] [Cited by in F6Publishing: 24] [Article Influence: 7.7] [Reference Citation Analysis]
146 Aslanian HR, Lee JH, Canto MI. AGA Clinical Practice Update on Pancreas Cancer Screening in High-Risk Individuals: Expert Review. Gastroenterology 2020;159:358-62. [PMID: 32416142 DOI: 10.1053/j.gastro.2020.03.088] [Cited by in Crossref: 85] [Cited by in F6Publishing: 83] [Article Influence: 28.3] [Reference Citation Analysis]
147 Galeotti AA, Gentiluomo M, Rizzato C, Obazee O, Neoptolemos JP, Pasquali C, Nentwich M, Cavestro GM, Pezzilli R, Greenhalf W, Holleczek B, Schroeder C, Schöttker B, Ivanauskas A, Ginocchi L, Key TJ, Hegyi P, Archibugi L, Darvasi E, Basso D, Sperti C, Bijlsma MF, Palmieri O, Hlavac V, Talar-Wojnarowska R, Mohelnikova-Duchonova B, Hackert T, Vashist Y, Strouhal O, van Laarhoven H, Tavano F, Lovecek M, Dervenis C, Izbéki F, Padoan A, Małecka-Panas E, Maiello E, Vanella G, Capurso G, Izbicki JR, Theodoropoulos GE, Jamroziak K, Katzke V, Kaaks R, Mambrini A, Papanikolaou IS, Szmola R, Szentesi A, Kupcinskas J, Bursi S, Costello E, Boggi U, Milanetto AC, Landi S, Gazouli M, Vodickova L, Soucek P, Gioffreda D, Gemignani F, Brenner H, Strobel O, Büchler M, Vodicka P, Paiella S, Canzian F, Campa D. Polygenic and multifactorial scores for pancreatic ductal adenocarcinoma risk prediction. J Med Genet 2021;58:369-77. [PMID: 32591343 DOI: 10.1136/jmedgenet-2020-106961] [Cited by in Crossref: 15] [Cited by in F6Publishing: 17] [Article Influence: 5.0] [Reference Citation Analysis]
148 Dumonceau JM, Delhaye M, Charette N, Farina A. Challenging biliary strictures: pathophysiological features, differential diagnosis, diagnostic algorithms, and new clinically relevant biomarkers - part 1.Therap Adv Gastroenterol. 2020;13:1756284820927292. [PMID: 32595761 DOI: 10.1177/1756284820927292] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 4.0] [Reference Citation Analysis]
149 Mizrahi JD, Surana R, Valle JW, Shroff RT. Pancreatic cancer. The Lancet 2020;395:2008-20. [DOI: 10.1016/s0140-6736(20)30974-0] [Cited by in Crossref: 612] [Cited by in F6Publishing: 696] [Article Influence: 204.0] [Reference Citation Analysis]
150 Kumar S, Metz DC, Kaplan DE, Goldberg DS. The association of Helicobacter pylori with pancreatic cancer. GastroHep 2020;2:157-64. [PMID: 33692655 DOI: 10.1002/ygh2.398] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
151 Geurts JL, Strong EA, Wang TS, Evans DB, Clarke CN. Screening guidelines and recommendations for patients at high risk of developing endocrine cancers. J Surg Oncol 2020;121:975-83. [DOI: 10.1002/jso.25869] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
152 Canto MI, Kerdsirichairat T, Yeo CJ, Hruban RH, Shin EJ, Almario JA, Blackford A, Ford M, Klein AP, Javed AA, Lennon AM, Zaheer A, Kamel IR, Fishman EK, Burkhart R, He J, Makary M, Weiss MJ, Schulick RD, Goggins MG, Wolfgang CL. Surgical Outcomes After Pancreatic Resection of Screening-Detected Lesions in Individuals at High Risk for Developing Pancreatic Cancer. J Gastrointest Surg 2020;24:1101-10. [PMID: 31197699 DOI: 10.1007/s11605-019-04230-z] [Reference Citation Analysis]
153 Canto MI, Kerdsirichairat T, Yeo CJ, Hruban RH, Shin EJ, Almario JA, Blackford A, Ford M, Klein AP, Javed AA, Lennon AM, Zaheer A, Kamel IR, Fishman EK, Burkhart R, He J, Makary M, Weiss MJ, Schulick RD, Goggins MG, Wolfgang CL. Surgical Outcomes After Pancreatic Resection of Screening-Detected Lesions in Individuals at High Risk for Developing Pancreatic Cancer. J Gastrointest Surg 2020;24:1101-10. [PMID: 31197699 DOI: 10.1007/s11605-019-04230-z] [Cited by in Crossref: 41] [Cited by in F6Publishing: 39] [Article Influence: 13.7] [Reference Citation Analysis]
154 Fried L, Tan A, Bajaj S, Liebman TN, Polsky D, Stein JA. Technological advances for the detection of melanoma: Advances in molecular techniques. J Am Acad Dermatol 2020;83:996-1004. [PMID: 32360759 DOI: 10.1016/j.jaad.2020.03.122] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 3.3] [Reference Citation Analysis]
155 Wong W, Raufi AG, Safyan RA, Bates SE, Manji GA. BRCA Mutations in Pancreas Cancer: Spectrum, Current Management, Challenges and Future Prospects. Cancer Manag Res. 2020;12:2731-2742. [PMID: 32368150 DOI: 10.2147/cmar.s211151] [Cited by in Crossref: 41] [Cited by in F6Publishing: 43] [Article Influence: 13.7] [Reference Citation Analysis]
156 Kim J, Yuan C, Babic A, Bao Y, Clish CB, Pollak MN, Amundadottir LT, Klein AP, Stolzenberg-Solomon RZ, Pandharipande PV, Brais LK, Welch MW, Ng K, Giovannucci EL, Sesso HD, Manson JE, Stampfer MJ, Fuchs CS, Wolpin BM, Kraft P. Genetic and Circulating Biomarker Data Improve Risk Prediction for Pancreatic Cancer in the General Population. Cancer Epidemiol Biomarkers Prev 2020;29:999-1008. [PMID: 32321713 DOI: 10.1158/1055-9965.EPI-19-1389] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 4.0] [Reference Citation Analysis]
157 Harrington KA, Shukla-Dave A, Paudyal R, Do RKG. MRI of the Pancreas. J Magn Reson Imaging 2021;53:347-59. [PMID: 32302044 DOI: 10.1002/jmri.27148] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 3.3] [Reference Citation Analysis]
158 Younan G. Pancreas Solid Tumors. Surg Clin North Am 2020;100:565-80. [PMID: 32402301 DOI: 10.1016/j.suc.2020.02.008] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
159 Cremin C, Lee MK, Hong Q, Hoeschen C, Mackenzie A, Dixon K, McCullum M, Nuk J, Kalloger S, Karasinska J, Scudamore C, Kim PTW, Donnellan F, Lam ECS, Lim HJ, Neben CL, Stedden W, Zhou AY, Schaeffer DF, Sun S, Renouf DJ, Schrader KA. Burden of hereditary cancer susceptibility in unselected patients with pancreatic ductal adenocarcinoma referred for germline screening. Cancer Med 2020;9:4004-13. [PMID: 32255556 DOI: 10.1002/cam4.2973] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 5.7] [Reference Citation Analysis]
160 Macgregor-Das A, Yu J, Tamura K, Abe T, Suenaga M, Shindo K, Borges M, Koi C, Kohi S, Sadakari Y, Dal Molin M, Almario JA, Ford M, Chuidian M, Burkhart R, He J, Hruban RH, Eshleman JR, Klein AP, Wolfgang CL, Canto MI, Goggins M. Detection of Circulating Tumor DNA in Patients with Pancreatic Cancer Using Digital Next-Generation Sequencing. J Mol Diagn 2020;22:748-56. [PMID: 32205290 DOI: 10.1016/j.jmoldx.2020.02.010] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
161 Tanaka Y, Kumagi T, Terao T, Kuroda T, Yokota T, Azemoto N, Imamura Y, Uesugi K, Kisaka Y, Shibata N, Koizumi M, Ohno Y, Kanemitsu K, Yukimoto A, Tange K, Nishiyama M, Miyake T, Miyata H, Ishii H, Abe M, Hiasa Y; Ehime Pancreato-Cholangiology (EPOCH) Study Group. ABO Blood Type and the Long-term Outcomes of Pancreatic Cancer. Intern Med 2020;59:761-8. [PMID: 32173688 DOI: 10.2169/internalmedicine.3748-19] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
162 Morani AC, Hanafy AK, Ramani NS, Katabathina VS, Yedururi S, Dasyam AK, Prasad SR. Hereditary and Sporadic Pancreatic Ductal Adenocarcinoma: Current Update on Genetics and Imaging. Radiol Imaging Cancer 2020;2:e190020. [PMID: 33778702 DOI: 10.1148/rycan.2020190020] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
163 Paiella S, Marinelli V, Secchettin E, Mazzi MA, Ferretto F, Casolino R, Bassi C, Salvia R. The emotional impact of surveillance programs for pancreatic cancer on high-risk individuals: A prospective analysis. Psychooncology 2020;29:1004-11. [PMID: 32108397 DOI: 10.1002/pon.5370] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
164 Pereira SP, Oldfield L, Ney A, Hart PA, Keane MG, Pandol SJ, Li D, Greenhalf W, Jeon CY, Koay EJ, Almario CV, Halloran C, Lennon AM, Costello E. Early detection of pancreatic cancer. Lancet Gastroenterol Hepatol. 2020;5:698-710. [PMID: 32135127 DOI: 10.1016/s2468-1253(19)30416-9] [Cited by in Crossref: 127] [Cited by in F6Publishing: 137] [Article Influence: 42.3] [Reference Citation Analysis]
165 Skipworth JR, Pereira SP. Tumours of the pancreas. Oxford Textbook of Medicine 2020. [DOI: 10.1093/med/9780198746690.003.0337] [Reference Citation Analysis]
166 Kempeneers MA, Issa Y, Ali UA, Baron RD, Besselink MG, Büchler M, Erkan M, Fernandez-Del Castillo C, Isaji S, Izbicki J, Kleeff J, Laukkarinen J, Sheel ARG, Shimosegawa T, Whitcomb DC, Windsor J, Miao Y, Neoptolemos J, Boermeester MA; Working group for the International (IAP – APA – JPS – EPC) Consensus Guidelines for Chronic Pancreatitis. International consensus guidelines for surgery and the timing of intervention in chronic pancreatitis. Pancreatology 2020;20:149-57. [PMID: 31870802 DOI: 10.1016/j.pan.2019.12.005] [Cited by in Crossref: 41] [Cited by in F6Publishing: 36] [Article Influence: 13.7] [Reference Citation Analysis]
167 Kulkarni NM, Mannelli L, Zins M, Bhosale PR, Arif-Tiwari H, Brook OR, Hecht EM, Kastrinos F, Wang ZJ, Soloff EV, Tolat PP, Sangster G, Fleming J, Tamm EP, Kambadakone AR. White paper on pancreatic ductal adenocarcinoma from society of abdominal radiology's disease-focused panel for pancreatic ductal adenocarcinoma: Part II, update on imaging techniques and screening of pancreatic cancer in high-risk individuals. Abdom Radiol (NY) 2020;45:729-42. [PMID: 31768594 DOI: 10.1007/s00261-019-02290-y] [Cited by in Crossref: 11] [Cited by in F6Publishing: 13] [Article Influence: 3.7] [Reference Citation Analysis]
168 Monahan KJ, Bradshaw N, Dolwani S, Desouza B, Dunlop MG, East JE, Ilyas M, Kaur A, Lalloo F, Latchford A, Rutter MD, Tomlinson I, Thomas HJW, Hill J; Hereditary CRC guidelines eDelphi consensus group. Guidelines for the management of hereditary colorectal cancer from the British Society of Gastroenterology (BSG)/Association of Coloproctology of Great Britain and Ireland (ACPGBI)/United Kingdom Cancer Genetics Group (UKCGG). Gut 2020;69:411-44. [PMID: 31780574 DOI: 10.1136/gutjnl-2019-319915] [Cited by in Crossref: 143] [Cited by in F6Publishing: 117] [Article Influence: 47.7] [Reference Citation Analysis]
169 Matsubayashi H, Takaori K, Morizane C, Kiyozumi Y. Familial Pancreatic Cancer and Surveillance of High-Risk Individuals. Gut Liver 2019;13:498-505. [PMID: 30917631 DOI: 10.5009/gnl18449] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 4.3] [Reference Citation Analysis]
170 Llach J, Carballal S, Moreira L. Familial Pancreatic Cancer: Current Perspectives. Cancer Manag Res 2020;12:743-58. [PMID: 32099470 DOI: 10.2147/CMAR.S172421] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 5.7] [Reference Citation Analysis]
171 Matsubayashi H, Notohara K, Hruban RH, Satoh T, Kaneko J, Sato J, Ishiwatari H, Ashida R, Uesaka K, Kiyozumi Y, Ono H. Multiple Carcinomas and Intraepithelial Neoplasms in a Case of Familial Pancreatic Cancer: Rapid Morphological Changes in the Pancreatic Cyst and Pathological Lesions Undetected by Clinical Images. Intern Med 2020;59:1041-6. [DOI: 10.2169/internalmedicine.3882-19] [Reference Citation Analysis]
172 De Jesus-acosta A, Narang A, Mauro L, Herman J, Jaffee EM, Laheru DA. Carcinoma of the Pancreas. Abeloff's Clinical Oncology 2020. [DOI: 10.1016/b978-0-323-47674-4.00078-5] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
173 Li M, Nie X, Reheman Y, Huang P, Zhang S, Yuan Y, Chen C, Yan Z, Chen C, Lv X, Han W. Computer-Aided Diagnosis and Staging of Pancreatic Cancer Based on CT Images. IEEE Access 2020;8:141705-18. [DOI: 10.1109/access.2020.3012967] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
174 Sharman R, Shroff RT, University of Arizona Cancer Center, Tucson, AZ, USA, University of Arizona Cancer Center, Tucson, AZ, USA. Improving Outcomes in Pancreatic Cancer. Oncology & Hematology Review (US) 2020;16:59. [DOI: 10.17925/ohr.2020.16.1.59] [Reference Citation Analysis]
175 Zou J, Chen S, Li Y, Zeng L, Lian G, Li J, Chen S, Huang K, Chen Y. Nanoparticles modified by triple single chain antibodies for MRI examination and targeted therapy in pancreatic cancer. Nanoscale 2020;12:4473-90. [DOI: 10.1039/c9nr04976b] [Cited by in Crossref: 14] [Cited by in F6Publishing: 16] [Article Influence: 4.7] [Reference Citation Analysis]
176 Sancio JB, Campanati R, Lima LDP, Rubião F, de-Freitas JC, de-Melo FHC, Machado CJ, Sanches MD, Resende V. Fatores prognósticos pré-operatórios em pacientes com adenocarcinoma ductal da cabeça do pâncreas. Rev Col Bras Cir 2020;47. [DOI: 10.1590/0100-6991e-20202363] [Reference Citation Analysis]
177 Rädle J. Hereditäre Tumorerkrankungen – Diagnostik und Überwachungsstrategien. Prävention gastroenterologischer Tumorerkrankungen 2020. [DOI: 10.1007/978-3-662-58879-6_9] [Reference Citation Analysis]
178 Weiss J, Zakas A, Hause J. Gastrointestinal disorders. Handbook of Clinical Adult Genetics and Genomics 2020. [DOI: 10.1016/b978-0-12-817344-2.00013-7] [Reference Citation Analysis]
179 Cazacu IM, Luzuriaga Chavez AA, Mendoza TR, Qiao W, Singh BS, Bokhari RH, Saftoiu A, Lee JH, Weston B, Stroehlein JR, Kim MP, G Katz MH, Maitra A, McAllister F, Bhutani MS. Quality of life impact of EUS in patients at risk for developing pancreatic cancer. Endosc Ultrasound 2020;9:53-8. [PMID: 31552914 DOI: 10.4103/eus.eus_56_19] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
180 Uchida D, Kato H, Matsumoto K, Ishihara Y, Matsumi A, Saragai Y, Takada S, Yabe S, Muro S, Tomoda T, Horiguchi S, Okada H. Single-session esophagogastroduodenoscopy and endoscopic ultrasound using a forward-viewing radial scan ultrasonic endoscope. BMC Gastroenterol 2019;19:220. [PMID: 31852458 DOI: 10.1186/s12876-019-1141-7] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
181 Webster R, Bannon SA, Hyde SM, Woodson AH, You NY, Lu KH, Arun B. Hereditary Cancer Syndromes: Risk Assessment and Genetic Counseling. Holland‐Frei Cancer Medicine 2019. [DOI: 10.1002/9781119000822.hfcm143] [Reference Citation Analysis]
182 Bruno MJ. Pancreatic cancer screening - is it prime time yet? Nat Rev Gastroenterol Hepatol 2019;16:709-10. [PMID: 31591511 DOI: 10.1038/s41575-019-0221-z] [Reference Citation Analysis]
183 Dudley B, Brand RE. Pancreatic Cancer Surveillance: Who, When, and How. Curr Treat Options Gastroenterol 2019;17:681-91. [PMID: 31761968 DOI: 10.1007/s11938-019-00247-0] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
184 Wood ME, Bedrosian I. Hot Topic: Should all Women with Breast Cancer Undergo Genetic Testing? Curr Breast Cancer Rep 2019;11:381-4. [DOI: 10.1007/s12609-019-00343-1] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
185 Hank T, Strobel O. Conversion Surgery for Advanced Pancreatic Cancer. J Clin Med 2019;8:E1945. [PMID: 31718103 DOI: 10.3390/jcm8111945] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 3.5] [Reference Citation Analysis]
186 Kidambi TD, Kohli DR, Samadder NJ, Singh A. Hereditary Polyposis Syndromes. Curr Treat Options Gastroenterol 2019;17:650-65. [PMID: 31705372 DOI: 10.1007/s11938-019-00251-4] [Cited by in Crossref: 13] [Cited by in F6Publishing: 9] [Article Influence: 3.3] [Reference Citation Analysis]
187 Cao CX, Sharib JM, Blanco AM, Goldberg D, Bracci P, Mukhtar RA, Esserman LJ, Kirkwood KS. Abdominal Imaging of Pancreatic Cysts and Cyst-Associated Pancreatic Cancer in BRCA1/2 Mutation Carriers: A Retrospective Cross-Sectional Study. J Am Coll Surg 2020;230:53-63.e1. [PMID: 31672679 DOI: 10.1016/j.jamcollsurg.2019.09.019] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
188 Matsubayashi H, Kiyozumi Y, Ishiwatari H, Uesaka K, Kikuyama M, Ono H. Surveillance of Individuals with a Family History of Pancreatic Cancer and Inherited Cancer Syndromes: A Strategy for Detecting Early Pancreatic Cancers. Diagnostics (Basel) 2019;9:E169. [PMID: 31683730 DOI: 10.3390/diagnostics9040169] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
189 Dwarte T, McKay S, Johns A, Tucker K, Spigelman AD, Williams D, Stoita A. Genetic counselling and personalised risk assessment in the Australian pancreatic cancer screening program. Hered Cancer Clin Pract 2019;17:30. [PMID: 31666883 DOI: 10.1186/s13053-019-0129-1] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
190 Diaz KE, Lucas AL. Familial Pancreatic Ductal Adenocarcinoma. Am J Pathol 2019;189:36-43. [PMID: 30558720 DOI: 10.1016/j.ajpath.2018.06.026] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 2.3] [Reference Citation Analysis]
191 Chhoda A, Lu L, Clerkin BM, Risch H, Farrell JJ. Current approaches to pancreatic cancer screening. Am J Pathol. 2019;189:22-35. [PMID: 30558719 DOI: 10.1016/j.ajpath.2018.09.013] [Cited by in Crossref: 26] [Cited by in F6Publishing: 28] [Article Influence: 6.5] [Reference Citation Analysis]
192 Muller N, Sarantitis I, Rouanet M, de Mestier L, Halloran C, Greenhalf W, Férec C, Masson E, Ruszniewski P, Lévy P, Neoptolemos J, Buscail L, Rebours V. Natural history of SPINK1 germline mutation related-pancreatitis. EBioMedicine 2019;48:581-91. [PMID: 31628023 DOI: 10.1016/j.ebiom.2019.09.032] [Cited by in Crossref: 25] [Cited by in F6Publishing: 18] [Article Influence: 6.3] [Reference Citation Analysis]
193 Vasen HFA, Boekestijn B, Ibrahim IS, Inderson A, Bonsing BA, de Vos Tot Nederveen Cappel WH, Feshtali S, Wasser MN. Dilatation of the main pancreatic duct as first manifestation of small pancreatic ductal adenocarcinomas detected in a hereditary pancreatic cancer surveillance program. HPB (Oxford) 2019;21:1371-5. [PMID: 30910317 DOI: 10.1016/j.hpb.2019.02.013] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
194 Kim JY, Byeon JS. Genetic Counseling and Surveillance Focused on Lynch Syndrome. J Anus Rectum Colon 2019;3:60-8. [PMID: 31559369 DOI: 10.23922/jarc.2019-002] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
195 Shishin KV, Bystrovskaya EV, Nedoluzhko IY, Kovalenko DD, Pronina GG, Orlova MV. Endoscopy and endosonography in the diagnostics of pancreatic cancer. Ann hir gepatol 2019;24:36-44. [DOI: 10.16931/1995-5464.2019336-44] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
196 Lorenzo D, Rebours V, Maire F, Palazzo M, Gonzalez JM, Vullierme MP, Aubert A, Hammel P, Lévy P, Mestier L. Role of endoscopic ultrasound in the screening and follow-up of high-risk individuals for familial pancreatic cancer. World J Gastroenterol 2019; 25(34): 5082-5096 [PMID: 31558858 DOI: 10.3748/wjg.v25.i34.5082] [Cited by in CrossRef: 10] [Cited by in F6Publishing: 10] [Article Influence: 2.5] [Reference Citation Analysis]
197 Liang J, Suprapto J, Crawford S, Tong WG. Sensitive multi-photon nonlinear laser wave-mixing detection of cancer and heart failure biomarkers. Novel Optical Systems, Methods, and Applications XXII 2019. [DOI: 10.1117/12.2529899] [Reference Citation Analysis]
198 Schwartz M, Korenbaum C, Benfoda M, Mary M, Colas C, Coulet F, Parrin M, Jonveaux P, Ingster O, Granier S, De Mestier L, Cros J, Riffault A, Muller M, Levy P, Rebours V, Greenhalf W, Soufir N, Hammel P. Familial pancreatic adenocarcinoma: A retrospective analysis of germline genetic testing in a French multicentre cohort. Clin Genet 2019;96:579-84. [DOI: 10.1111/cge.13629] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
199 Katabathina VS, Menias CO, Khanna L, Murphy L, Dasyam AK, Lubner MG, Prasad SR. Hereditary Gastrointestinal Cancer Syndromes: Role of Imaging in Screening, Diagnosis, and Management. RadioGraphics 2019;39:1280-301. [DOI: 10.1148/rg.2019180185] [Cited by in Crossref: 14] [Cited by in F6Publishing: 17] [Article Influence: 3.5] [Reference Citation Analysis]
200 Lucas AL, Kastrinos F. Screening for Pancreatic Cancer. JAMA 2019;322:407-8. [PMID: 31386115 DOI: 10.1001/jama.2019.9690] [Cited by in Crossref: 18] [Cited by in F6Publishing: 20] [Article Influence: 4.5] [Reference Citation Analysis]
201 Ko SW, Hwang JS, Song TJ. The Role of Endoscopic Ultrasound in Early Detection of Pancreatic Cancer. Korean J Pancreas Biliary Tract 2019;24:102-110. [DOI: 10.15279/kpba.2019.24.3.102] [Reference Citation Analysis]
202 Yoshida T, Yamashita Y, Kitano M. Endoscopic Ultrasound for Early Diagnosis of Pancreatic Cancer. Diagnostics (Basel) 2019;9:E81. [PMID: 31344904 DOI: 10.3390/diagnostics9030081] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 3.5] [Reference Citation Analysis]
203 Saldia A, Olson SH, Nunes P, Liang X, Samson ML, Salo-Mullen E, Marcell V, Stadler ZK, Allen PJ, Offit K, Kurtz RC. Outcome of Pancreatic Cancer Surveillance Among High-Risk Individuals Tested for Germline Mutations in BRCA1 and BRCA2. Cancer Prev Res (Phila) 2019;12:599-608. [PMID: 31337648 DOI: 10.1158/1940-6207.CAPR-18-0272] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
204 Kobayashi T, Honda K. Trends in biomarker discoveries for the early detection and risk stratification of pancreatic cancer using omics studies. Expert Rev Mol Diagn 2019;19:651-4. [PMID: 31298060 DOI: 10.1080/14737159.2019.1643718] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
205 Lo W, Morris MC, Ahmad SA, Patel SH. Screening patients at high risk for pancreatic cancer—Is it time for a paradigm shift? J Surg Oncol 2019;120:851-7. [DOI: 10.1002/jso.25616] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
206 Srivastava S, Koay EJ, Borowsky AD, De Marzo AM, Ghosh S, Wagner PD, Kramer BS. Cancer overdiagnosis: a biological challenge and clinical dilemma. Nat Rev Cancer 2019;19:349-58. [PMID: 31024081 DOI: 10.1038/s41568-019-0142-8] [Cited by in Crossref: 126] [Cited by in F6Publishing: 134] [Article Influence: 31.5] [Reference Citation Analysis]
207 Noë M, Hackeng WM, de Leng WWJ, Vergeer M, Vleggaar FP, Morsink FHM, Wood LD, Hruban RH, Offerhaus GJA, Brosens LAA. Well-differentiated Pancreatic Neuroendocrine Tumor in a Patient With Familial Atypical Multiple Mole Melanoma Syndrome (FAMMM). Am J Surg Pathol 2019;43:1297-302. [PMID: 31261289 DOI: 10.1097/PAS.0000000000001314] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
208 Konings ICAW, Canto MI, Almario JA, Harinck F, Saxena P, Lucas AL, Kastrinos F, Whitcomb DC, Brand RE, Lachter J, Malleo G, Paiella S, Syngal S, Saltzman JR, Stoffel EM, van Hooft JE, Hruban RH, Poley JW, Fockens P, Goggins MG, Bruno MJ; International CAncer of the Pancreas Screening (CAPS) Consortium. Surveillance for pancreatic cancer in high-risk individuals. BJS Open 2019;3:656-65. [PMID: 31592073 DOI: 10.1002/bjs5.50180] [Cited by in Crossref: 17] [Cited by in F6Publishing: 19] [Article Influence: 4.3] [Reference Citation Analysis]
209 Mizuno S, Isayama H, Nakai Y, Ishigaki K, Saito K, Sato T, Takeda T, Hakuta R, Saito T, Takahara N, Kogure H, Ijichi H, Tateishi K, Tada M, Shikata N, Tagami T, Kikuchi S, Yamamoto H, Yamakado M, Koike K. Diagnostic yield of the plasma free amino acid index for pancreatic cancer in patients with diabetes mellitus. Pancreatology 2019;19:695-8. [PMID: 31320196 DOI: 10.1016/j.pan.2019.07.002] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
210 Korn RL, Rahmanuddin S, Borazanci E. Use of Precision Imaging in the Evaluation of Pancreas Cancer. Cancer Treat Res 2019;178:209-36. [PMID: 31209847 DOI: 10.1007/978-3-030-16391-4_8] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
211 Kohli DR, Smith KR, Wong J, Yu Z, Boucher K, Faigel DO, Pannala R, Burt RW, Curtin K, Samadder NJ. Familial pancreatic cancer risk: a population-based study in Utah. J Gastroenterol 2019;54:1106-12. [DOI: 10.1007/s00535-019-01597-3] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 1.5] [Reference Citation Analysis]
212 Hand F, Conlon KC. Pancreatic cancer. Surgery (Oxford) 2019;37:319-26. [DOI: 10.1016/j.mpsur.2019.03.005] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
213 Pilarski R. The Role of BRCA Testing in Hereditary Pancreatic and Prostate Cancer Families. Am Soc Clin Oncol Educ Book. 2019;39:79-86. [PMID: 31099688 DOI: 10.1200/edbk_238977] [Cited by in Crossref: 50] [Cited by in F6Publishing: 52] [Article Influence: 12.5] [Reference Citation Analysis]
214 Yu A, Romero TA, Genkinger JM. Primary and Secondary Prevention of Pancreatic Cancer. Curr Epidemiol Rep 2019;6:119-37. [DOI: 10.1007/s40471-019-00189-2] [Reference Citation Analysis]
215 Wood LD, Yurgelun MB, Goggins MG. Genetics of Familial and Sporadic Pancreatic Cancer. Gastroenterology 2019;156:2041-55. [PMID: 30660730 DOI: 10.1053/j.gastro.2018.12.039] [Cited by in Crossref: 39] [Cited by in F6Publishing: 40] [Article Influence: 9.8] [Reference Citation Analysis]
216 Holtzman NA, Probst-Hensch N. Editorial Commentary on "Psychological Impact of Learning CDKN2A Variant Status as a Genetic Research Result" by Zhu et al. Public Health Genomics 2018;21:164-8. [PMID: 30999315 DOI: 10.1159/000499051] [Reference Citation Analysis]
217 Zhu X, Leof ER, Rabe KG, McCormick JB, Petersen GM, Radecki Breitkopf C. Psychological Impact of Learning CDKN2A Variant Status as a Genetic Research Result. Public Health Genomics 2018;21:154-63. [PMID: 30999302 DOI: 10.1159/000496556] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
218 Leof ER, Zhu X, Rabe KG, McCormick JB, Petersen GM, Radecki Breitkopf C. Pancreatic cancer and melanoma related perceptions and behaviors following disclosure of CDKN2A variant status as a research result. Genet Med 2019;21:2468-77. [PMID: 30992552 DOI: 10.1038/s41436-019-0517-y] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
219 Vullierme MP, Menassa L, Couvelard A, Rebours V, Maire F, Ibrahim T, Cros J, Ruszniewski P, Sauvanet A, Levy P, Soyer P, Vilgrain V. Non-branched microcysts of the pancreas on MR imaging of patients with pancreatic tumors who had pancreatectomy may predict the presence of pancreatic intraepithelial neoplasia (PanIN): a preliminary study. Eur Radiol. 2019;. [PMID: 30972547 DOI: 10.1007/s00330-019-06154-3] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
220 Eissa MAL, Lerner L, Abdelfatah E, Shankar N, Canner JK, Hasan NM, Yaghoobi V, Huang B, Kerner Z, Takaesu F, Wolfgang C, Kwak R, Ruiz M, Tam M, Pisanic TR 2nd, Iacobuzio-Donahue CA, Hruban RH, He J, Wang TH, Wood LD, Sharma A, Ahuja N. Promoter methylation of ADAMTS1 and BNC1 as potential biomarkers for early detection of pancreatic cancer in blood. Clin Epigenetics. 2019;11:59. [PMID: 30953539 DOI: 10.1186/s13148-019-0650-0] [Cited by in Crossref: 66] [Cited by in F6Publishing: 71] [Article Influence: 16.5] [Reference Citation Analysis]
221 Paiella S, Capurso G, Cavestro GM, Butturini G, Pezzilli R, Salvia R, Signoretti M, Crippa S, Carrara S, Frigerio I, Bassi C, Falconi M, Iannicelli E, Giardino A, Mannucci A, Laghi A, Laghi L, Frulloni L, Zerbi A. Results of First-Round of Surveillance in Individuals at High-Risk of Pancreatic Cancer from the AISP (Italian Association for the Study of the Pancreas) Registry. Am J Gastroenterol 2019;114:665-70. [PMID: 30538291 DOI: 10.1038/s41395-018-0414-z] [Cited by in Crossref: 24] [Cited by in F6Publishing: 22] [Article Influence: 6.0] [Reference Citation Analysis]
222 Thiruvengadam SS, Chuang J, Huang R, Girotra M, Park WG. Chronic pancreatitis changes in high-risk individuals for pancreatic ductal adenocarcinoma. Gastrointest Endosc 2019;89:842-851.e1. [PMID: 30145314 DOI: 10.1016/j.gie.2018.08.029] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 2.8] [Reference Citation Analysis]
223 Brewer Gutierrez OI, Lennon AM. Chronic pancreatitis-like changes in individuals at high risk for the development of pancreatic cancer: What is the significance? Gastrointest Endosc 2019;89:852-4. [PMID: 30902206 DOI: 10.1016/j.gie.2019.01.023] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
224 Collisson EA, Bailey P, Chang DK, Biankin AV. Molecular subtypes of pancreatic cancer. Nat Rev Gastroenterol Hepatol 2019;16:207-20. [PMID: 30718832 DOI: 10.1038/s41575-019-0109-y] [Cited by in Crossref: 367] [Cited by in F6Publishing: 355] [Article Influence: 91.8] [Reference Citation Analysis]
225 Hart PA. Early Detection of Pancreatic Cancer in High-Risk Individuals: Where Do We Go From Here? Am J Gastroenterol 2019;114:560-1. [PMID: 30908300 DOI: 10.14309/ajg.0000000000000192] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
226 Corral JE, Das A, Bruno MJ, Wallace MB. Cost-effectiveness of Pancreatic Cancer Surveillance in High-Risk Individuals: An Economic Analysis. Pancreas 2019;48:526-36. [PMID: 30946242 DOI: 10.1097/MPA.0000000000001268] [Cited by in Crossref: 30] [Cited by in F6Publishing: 27] [Article Influence: 7.5] [Reference Citation Analysis]
227 Abe T, Blackford AL, Tamura K, Ford M, McCormick P, Chuidian M, Almario JA, Borges M, Lennon AM, Shin EJ, Klein AP, Hruban RH, Canto MI, Goggins M. Deleterious Germline Mutations Are a Risk Factor for Neoplastic Progression Among High-Risk Individuals Undergoing Pancreatic Surveillance. J Clin Oncol 2019;37:1070-80. [PMID: 30883245 DOI: 10.1200/JCO.18.01512] [Cited by in Crossref: 43] [Cited by in F6Publishing: 46] [Article Influence: 10.8] [Reference Citation Analysis]
228 Maisonneuve P. Epidemiology and burden of pancreatic cancer. Presse Med. 2019;48:e113-e123. [PMID: 30878335 DOI: 10.1016/j.lpm.2019.02.030] [Cited by in Crossref: 63] [Cited by in F6Publishing: 59] [Article Influence: 15.8] [Reference Citation Analysis]
229 West AH, Blazer KR, Stoll J, Jones M, Weipert CM, Nielsen SM, Kupfer SS, Weitzel JN, Olopade OI. Clinical interpretation of pathogenic ATM and CHEK2 variants on multigene panel tests: navigating moderate risk. Fam Cancer 2018;17:495-505. [PMID: 29445900 DOI: 10.1007/s10689-018-0070-x] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 3.3] [Reference Citation Analysis]
230 McNamara GPJ, Ali KN, Vyas S, Huynh T, Nyland M, Almanza D, Laronga C, Klapman J, Permuth JB. Characteristics and Clinical Outcomes of Individuals at High Risk for Pancreatic Cancer: A Descriptive Analysis from a Comprehensive Cancer Center. Gastrointest Disord (Basel) 2019;1:106-19. [PMID: 32601617 DOI: 10.3390/gidisord1010008] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
231 Ahn HS, Kang TU, Swan H, Kang MJ, Kim N, Kim HJ, Park SM. Incidence and Mortality Rates of Second Pancreatic Cancer Among Survivors of Digestive Cancers: A Nationwide Population-Based Study. Pancreas 2019;48:412-9. [PMID: 30768577 DOI: 10.1097/MPA.0000000000001254] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
232 Mintziras I, Bartsch DK. Progress report: familial pancreatic cancer. Familial Cancer 2019;18:359-62. [DOI: 10.1007/s10689-019-00125-9] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
233 Idachaba S, Dada O, Abimbola O, Olayinka O, Uma A, Olunu E, Fakoya AOJ. A Review of Pancreatic Cancer: Epidemiology, Genetics, Screening, and Management. Open Access Maced J Med Sci 2019;7:663-71. [PMID: 30894932 DOI: 10.3889/oamjms.2019.104] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 3.8] [Reference Citation Analysis]
234 Pang Y, Holmes MV, Chen Z, Kartsonaki C. A review of lifestyle, metabolic risk factors, and blood-based biomarkers for early diagnosis of pancreatic ductal adenocarcinoma. J Gastroenterol Hepatol 2019;34:330-45. [PMID: 30550622 DOI: 10.1111/jgh.14576] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 2.8] [Reference Citation Analysis]
235 Rossi M, Pellegrini C, Cardelli L, Ciciarelli V, Di Nardo L, Fargnoli MC. Familial Melanoma: Diagnostic and Management Implications. Dermatol Pract Concept 2019;9:10-6. [PMID: 30775140 DOI: 10.5826/dpc.0901a03] [Cited by in Crossref: 33] [Cited by in F6Publishing: 34] [Article Influence: 8.3] [Reference Citation Analysis]
236 Ohmoto A, Yachida S, Morizane C. Genomic Features and Clinical Management of Patients with Hereditary Pancreatic Cancer Syndromes and Familial Pancreatic Cancer. Int J Mol Sci. 2019;20. [PMID: 30699894 DOI: 10.3390/ijms20030561] [Cited by in Crossref: 23] [Cited by in F6Publishing: 27] [Article Influence: 5.8] [Reference Citation Analysis]
237 Slavin TP, Neuhausen SL, Nehoray B, Niell-Swiller M, Solomon I, Rybak C, Blazer K, Adamson A, Yang K, Sand S, Guerrero-Llamas N, Castillo D, Herzog J, Wu X, Tao S, Raja S, Chung V, Singh G, Nadesan S, Brown S, Cruz-Correa M, Petersen GM, Weitzel J; Clinical Cancer Genomics Community Research Network (CCGCRN). The spectrum of genetic variants in hereditary pancreatic cancer includes Fanconi anemia genes. Fam Cancer 2018;17:235-45. [PMID: 28687971 DOI: 10.1007/s10689-017-0019-5] [Cited by in Crossref: 21] [Cited by in F6Publishing: 20] [Article Influence: 5.3] [Reference Citation Analysis]
238 Corrias G, Raeside MC, Agostini A, Huicochea-Castellanos S, Aramburu-Nunez D, Paudyal R, Shukla-Dave A, Smelianskaia O, Capanu M, Zheng J, Fung M, Kelsen DP, Mangino DA, Robson ME, Goldfrank DJ, Carter J, Allen PJ, Conti B, Monti S, Do RKG, Mannelli L. Pilot study of rapid MR pancreas screening for patients with BRCA mutation. Eur Radiol 2019;29:3976-85. [PMID: 30689033 DOI: 10.1007/s00330-018-5975-0] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 1.8] [Reference Citation Analysis]
239 Yeo TP, Lavu H, Nevler A, Brumbaugh J, Vicchairelli D, Winter JM, Brody JR, Yeo CJ. Precious Data: Interim Report from the Jefferson Pancreas Tumor Registry. J Pancreat Cancer 2018;4:17-24. [PMID: 30631853 DOI: 10.1089/pancan.2018.0004] [Reference Citation Analysis]
240 de Mestier L, Muller M, Cros J, Vullierme MP, Vernerey D, Maire F, Dokmak S, Rebours V, Sauvanet A, Lévy P, Hammel P. Appropriateness of pancreatic resection in high-risk individuals for familial pancreatic ductal adenocarcinoma: a patient-level meta-analysis and proposition of the Beaujon score. United European Gastroenterol J 2019;7:358-68. [PMID: 31019704 DOI: 10.1177/2050640618824910] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
241 Roch AM, Schneider J, Carr RA, Lancaster WP, House MG, Zyromski NJ, Nakeeb A, Schmidt CM, Ceppa EP. Are BRCA1 and BRCA2 gene mutation patients underscreened for pancreatic adenocarcinoma? J Surg Oncol. 2019;119:777-783. [PMID: 30636051 DOI: 10.1002/jso.25376] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 3.3] [Reference Citation Analysis]
242 Nellen JR, Strickland AG, Yeo CJ. Completion Pancreaticoduodenectomy for Hereditary Pancreatitis After Prior Puestow Procedure: A Case Report. J Pancreat Cancer 2018;4:60-3. [PMID: 30631860 DOI: 10.1089/pancan.2018.0012] [Reference Citation Analysis]
243 Stoffel EM, Mckernin SE, Brand R, Canto M, Goggins M, Moravek C, Nagarajan A, Petersen GM, Simeone DM, Yurgelun M, Khorana AA. Evaluating Susceptibility to Pancreatic Cancer: ASCO Provisional Clinical Opinion. JCO 2019;37:153-64. [DOI: 10.1200/jco.18.01489] [Cited by in Crossref: 89] [Cited by in F6Publishing: 99] [Article Influence: 22.3] [Reference Citation Analysis]
244 Moutinho-Ribeiro P, Macedo G, Melo SA. Pancreatic Cancer Diagnosis and Management: Has the Time Come to Prick the Bubble? Front Endocrinol (Lausanne) 2018;9:779. [PMID: 30671023 DOI: 10.3389/fendo.2018.00779] [Cited by in Crossref: 23] [Cited by in F6Publishing: 28] [Article Influence: 5.8] [Reference Citation Analysis]
245 Barnes CA, Krzywda E, Lahiff S, McDowell D, Christians KK, Knechtges P, Tolat P, Hohenwalter M, Dua K, Khan AH, Evans DB, Geurts J, Tsai S. Development of a high risk pancreatic screening clinic using 3.0 T MRI. Fam Cancer 2018;17:101-11. [PMID: 29101607 DOI: 10.1007/s10689-017-0057-z] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 4.0] [Reference Citation Analysis]
246 Hasan A, Moscoso DI, Kastrinos F. The Role of Genetics in Pancreatitis. Gastrointest Endosc Clin N Am 2018;28:587-603. [PMID: 30241646 DOI: 10.1016/j.giec.2018.06.001] [Cited by in Crossref: 26] [Cited by in F6Publishing: 29] [Article Influence: 6.5] [Reference Citation Analysis]
247 Barbara M, Tsen A, Tenner L, Rosenkranz L. Talking Genes in Breast and Pancreatic Malignancies. Mater Sociomed 2019;31:146-9. [PMID: 31452642 DOI: 10.5455/msm.2019.31.146-149] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
248 Tekkesin N, Tetik S. Therapeutic vaccines for pancreatic cancer. Theranostic Approach for Pancreatic Cancer 2019. [DOI: 10.1016/b978-0-12-819457-7.00014-1] [Reference Citation Analysis]
249 Hamman KJ, Kohlmann W, Leachman S. Genetic Counseling. Melanoma 2019. [DOI: 10.1007/978-1-4614-7147-9_8] [Reference Citation Analysis]
250 Hruban RH. Is the Early Detection of Pancreatic Cancer Possible? It Is Good News, Bad News. Pancreas 2019;48:591-3. [PMID: 31090658 DOI: 10.1097/MPA.0000000000001299] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
251 Moutinho-Ribeiro P, Iglesias-Garcia J, Gaspar R, Macedo G. Early pancreatic cancer - The role of endoscopic ultrasound with or without tissue acquisition in diagnosis and staging. Dig Liver Dis 2019;51:4-9. [PMID: 30337098 DOI: 10.1016/j.dld.2018.09.027] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 3.0] [Reference Citation Analysis]
252 Cazacu IM, Luzuriaga Chavez AA, Saftoiu A, Bhutani MS. Psychological impact of pancreatic cancer screening by EUS or magnetic resonance imaging in high-risk individuals: A systematic review. Endosc Ultrasound. 2019;8:17-24. [PMID: 30246710 DOI: 10.4103/eus.eus_25_18] [Cited by in Crossref: 12] [Cited by in F6Publishing: 16] [Article Influence: 3.0] [Reference Citation Analysis]
253 Geurts JL. Genetic Counseling for Pancreatic Cancer. Management of Localized Pancreatic Cancer 2019. [DOI: 10.1007/978-3-319-98944-0_13] [Reference Citation Analysis]
254 Patel V, Willingham F. The Management of Chronic Pancreatitis. Medical Clinics of North America 2019;103:153-62. [DOI: 10.1016/j.mcna.2018.08.012] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 1.8] [Reference Citation Analysis]
255 Mai C, Lutz M. Pankreaskarzinom: Klinik, Labordiagnostik und bildgebende Diagnostik. DGIM Innere Medizin 2019. [DOI: 10.1007/978-3-642-54676-1_123-2] [Reference Citation Analysis]
256 Sheel ARG, Harrison S, Sarantitis I, Nicholson JA, Hanna T, Grocock C, Raraty M, Ramesh J, Farooq A, Costello E, Jackson R, Chapman M, Smith A, Carter R, Mckay C, Hamady Z, Aithal GP, Mountford R, Ghaneh P, Hammel P, Lerch MM, Halloran C, Pereira SP, Greenhalf W. Identification of Cystic Lesions by Secondary Screening of Familial Pancreatic Cancer (FPC) Kindreds Is Not Associated with the Stratified Risk of Cancer. Am J Gastroenterol 2019;114:155-64. [PMID: 30353057 DOI: 10.1038/s41395-018-0395-y] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 2.8] [Reference Citation Analysis]
257 Shane-carson K, Jeter JM. Hereditary Risk for Cancer. Fundamentals of Cancer Prevention 2019. [DOI: 10.1007/978-3-030-15935-1_6] [Reference Citation Analysis]
258 Thirumurthi S, Vilar E, Lynch PJ. Hereditary Gastrointestinal Cancers. Textbook of Gastrointestinal Oncology 2019. [DOI: 10.1007/978-3-030-18890-0_33] [Reference Citation Analysis]
259 Huang L, Jansen L, Balavarca Y, Molina-Montes E, Babaei M, van der Geest L, Lemmens V, Van Eycken L, De Schutter H, Johannesen TB, Fristrup CW, Mortensen MB, Primic-Žakelj M, Zadnik V, Becker N, Hackert T, Mägi M, Cassetti T, Sassatelli R, Grützmann R, Merkel S, Gonçalves AF, Bento MJ, Hegyi P, Lakatos G, Szentesi A, Moreau M, van de Velde T, Broeks A, Sant M, Minicozzi P, Mazzaferro V, Real FX, Carrato A, Molero X, Besselink MG, Malats N, Büchler MW, Schrotz-King P, Brenner H. Resection of pancreatic cancer in Europe and USA: an international large-scale study highlighting large variations. Gut 2019;68:130-9. [PMID: 29158237 DOI: 10.1136/gutjnl-2017-314828] [Cited by in Crossref: 99] [Cited by in F6Publishing: 97] [Article Influence: 24.8] [Reference Citation Analysis]
260 Corral JE, Mareth KF, Riegert-Johnson DL, Das A, Wallace MB. Diagnostic Yield From Screening Asymptomatic Individuals at High Risk for Pancreatic Cancer: A Meta-analysis of Cohort Studies. Clin Gastroenterol Hepatol 2019;17:41-53. [PMID: 29775792 DOI: 10.1016/j.cgh.2018.04.065] [Cited by in Crossref: 51] [Cited by in F6Publishing: 37] [Article Influence: 12.8] [Reference Citation Analysis]
261 Levy M, Al-haddad M. Evaluation and Staging of Pancreaticobiliary Malignancy. Clinical Gastrointestinal Endoscopy 2019. [DOI: 10.1016/b978-0-323-41509-5.00062-1] [Reference Citation Analysis]
262 Hart PA, Chari ST. Is Screening for Pancreatic Cancer in High-Risk Individuals One Step Closer or a Fool's Errand? Clin Gastroenterol Hepatol 2019;17:36-8. [PMID: 30268560 DOI: 10.1016/j.cgh.2018.09.024] [Cited by in Crossref: 17] [Cited by in F6Publishing: 13] [Article Influence: 4.3] [Reference Citation Analysis]
263 Stoffel EM, McKernin SE, Khorana AA. Evaluating Susceptibility to Pancreatic Cancer: ASCO Clinical Practice Provisional Clinical Opinion Summary. J Oncol Pract. 2019;15:108-111. [PMID: 30589608 DOI: 10.1200/jop.18.00629] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 2.8] [Reference Citation Analysis]
264 Neuzillet C, Gaujoux S, Williet N, Bachet JB, Bauguion L, Colson Durand L, Conroy T, Dahan L, Gilabert M, Huguet F, Marthey L, Meilleroux J, de Mestier L, Napoléon B, Portales F, Sa Cunha A, Schwarz L, Taieb J, Chibaudel B, Bouché O, Hammel P; Thésaurus National de Cancérologie Digestive (TNCD), Société Nationale Française de Gastroentérologie (SNFGE), Fédération Francophone de Cancérologie Digestive (FFCD), Groupe Coopérateur multidisciplinaire en Oncologie (GERCOR), Fédération Nationale des Centres de Lutte Contre le Cancer (UNICANCER), Société Française de Chirurgie Digestive (SFCD), Société Française d’Endoscopie Digestive (SFED), Société Française de Radiothérapie Oncologique (SFRO), Association de Chirurgie Hépato-Bilio-Pancréatique et Transplantation (ACHBT), Association Française de Chirurgie (AFC). Pancreatic cancer: French clinical practice guidelines for diagnosis, treatment and follow-up (SNFGE, FFCD, GERCOR, UNICANCER, SFCD, SFED, SFRO, ACHBT, AFC). Dig Liver Dis 2018;50:1257-71. [PMID: 30219670 DOI: 10.1016/j.dld.2018.08.008] [Cited by in Crossref: 71] [Cited by in F6Publishing: 71] [Article Influence: 14.2] [Reference Citation Analysis]
265 O'Reilly D, Fou L, Hasler E, Hawkins J, O'Connell S, Pelone F, Callaway M, Campbell F, Capel M, Charnley R, Corrie P, Elliot D, Goodburn L, Jewell A, Joharchi S, McGeeney L, Mukherjee S, Oppong K, Whelan P, Primrose J, Neoptolemos J. Diagnosis and management of pancreatic cancer in adults: A summary of guidelines from the UK National Institute for Health and Care Excellence. Pancreatology 2018;18:962-70. [PMID: 30292643 DOI: 10.1016/j.pan.2018.09.012] [Cited by in Crossref: 56] [Cited by in F6Publishing: 55] [Article Influence: 11.2] [Reference Citation Analysis]
266 Franke FS, Matthäi E, Slater EP, Schicker C, Kruse J, Bartsch DK. German National Case Collection for familial pancreatic Cancer (FaPaCa) - acceptance and psychological aspects of a pancreatic cancer screening program. Hered Cancer Clin Pract 2018;16:17. [PMID: 30519369 DOI: 10.1186/s13053-018-0100-6] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.4] [Reference Citation Analysis]
267 Aspinwall LG, Stump TK, Taber JM, Drummond DM, Kohlmann W, Champine M, Leachman SA. Genetic test reporting of CDKN2A provides informational and motivational benefits for managing melanoma risk. Transl Behav Med 2018;8:29-43. [PMID: 29385581 DOI: 10.1093/tbm/ibx011] [Cited by in Crossref: 13] [Cited by in F6Publishing: 16] [Article Influence: 2.6] [Reference Citation Analysis]
268 McGuigan A, Kelly P, Turkington RC, Jones C, Coleman HG, McCain RS. Pancreatic cancer: A review of clinical diagnosis, epidemiology, treatment and outcomes. World J Gastroenterol 2018; 24(43): 4846-4861 [PMID: 30487695 DOI: 10.3748/wjg.v24.i43.4846] [Cited by in CrossRef: 766] [Cited by in F6Publishing: 786] [Article Influence: 153.2] [Reference Citation Analysis]
269 Vangala DB, Cauchin E, Balmaña J, Wyrwicz L, van Cutsem E, Güller U, Castells A, Carneiro F, Hammel P, Ducreux M, van Laethem JL, Matysiak-Budnik T, Schmiegel W. Screening and surveillance in hereditary gastrointestinal cancers: Recommendations from the European Society of Digestive Oncology (ESDO) expert discussion at the 20th European Society for Medical Oncology (ESMO)/World Congress on Gastrointestinal Cancer, Barcelona, June 2018. Eur J Cancer 2018;104:91-103. [PMID: 30342310 DOI: 10.1016/j.ejca.2018.09.004] [Cited by in Crossref: 38] [Cited by in F6Publishing: 41] [Article Influence: 7.6] [Reference Citation Analysis]
270 Vasen HFA. The importance of a well-structured pancreatic screening program for familial and hereditary pancreatic cancer. Fam Cancer 2018;17:1-3. [PMID: 29204967 DOI: 10.1007/s10689-017-0066-y] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.4] [Reference Citation Analysis]
271 Lachter J, Rosenberg C, Hananiya T, Khamaysi I, Klein A, Yassin K, Half E. Screening to Detect Precursor Lesions of Pancreatic Adenocarcinoma in High-risk Individuals: A Single-center Experience. Rambam Maimonides Med J 2018;9. [PMID: 30309438 DOI: 10.5041/RMMJ.10353] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
272 Lo TW. Screening for Pancreatic Cancer in Individuals With New-onset Diabetes Mellitus. The Journal for Nurse Practitioners 2018;14:657-62. [DOI: 10.1016/j.nurpra.2018.07.010] [Reference Citation Analysis]
273 Bannon SA, Montiel MF, Goldstein JB, Dong W, Mork ME, Borras E, Hasanov M, Varadhachary GR, Maitra A, Katz MH, Feng L, Futreal A, Fogelman DR, Vilar E, McAllister F. High Prevalence of Hereditary Cancer Syndromes and Outcomes in Adults with Early-Onset Pancreatic Cancer. Cancer Prev Res (Phila) 2018;11:679-86. [PMID: 30274973 DOI: 10.1158/1940-6207.CAPR-18-0014] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 3.2] [Reference Citation Analysis]
274 Benzel J, Fendrich V. Familial Pancreatic Cancer. Oncol Res Treat. 2018;41:611-618. [PMID: 30269130 DOI: 10.1159/000493473] [Cited by in Crossref: 27] [Cited by in F6Publishing: 28] [Article Influence: 5.4] [Reference Citation Analysis]
275 Bartsch DK, Gercke N, Strauch K, Wieboldt R, Matthäi E, Wagner V, Rospleszcz S, Schäfer A, Franke FS, Mintziras I, Bauer C, Grote T, Figiel J, Di Fazio P, Burchert A, Reinartz S, Pogge von Strandmann E, Klöppel G, Slater EP. The Combination of MiRNA-196b, LCN2, and TIMP1 is a Potential Set of Circulating Biomarkers for Screening Individuals at Risk for Familial Pancreatic Cancer. J Clin Med 2018;7:E295. [PMID: 30241369 DOI: 10.3390/jcm7100295] [Cited by in Crossref: 21] [Cited by in F6Publishing: 26] [Article Influence: 4.2] [Reference Citation Analysis]
276 Macklin SK, Kasi PM, Jackson JL, Hines SL. Incidence of Pathogenic Variants in Those With a Family History of Pancreatic Cancer. Front Oncol 2018;8:330. [PMID: 30186770 DOI: 10.3389/fonc.2018.00330] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
277 Canto MI, Almario JA, Schulick RD, Yeo CJ, Klein A, Blackford A, Shin EJ, Sanyal A, Yenokyan G, Lennon AM, Kamel IR, Fishman EK, Wolfgang C, Weiss M, Hruban RH, Goggins M. Risk of Neoplastic Progression in Individuals at High Risk for Pancreatic Cancer Undergoing Long-term Surveillance. Gastroenterology 2018;155:740-751.e2. [PMID: 29803839 DOI: 10.1053/j.gastro.2018.05.035] [Cited by in Crossref: 205] [Cited by in F6Publishing: 209] [Article Influence: 41.0] [Reference Citation Analysis]
278 Chen F, Roberts NJ, Klein AP. Inherited pancreatic cancer. Chin Clin Oncol. 2017;6:58. [PMID: 29307198 DOI: 10.21037/cco.2017.12.04] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 3.2] [Reference Citation Analysis]
279 Long NP, Yoon SJ, Anh NH, Nghi TD, Lim DK, Hong YJ, Hong SS, Kwon SW. A systematic review on metabolomics-based diagnostic biomarker discovery and validation in pancreatic cancer. Metabolomics 2018;14:109. [PMID: 30830397 DOI: 10.1007/s11306-018-1404-2] [Cited by in Crossref: 36] [Cited by in F6Publishing: 36] [Article Influence: 7.2] [Reference Citation Analysis]
280 Brand R, Borazanci E, Speare V, Dudley B, Karloski E, Peters MLB, Stobie L, Bahary N, Zeh H, Zureikat A, Hogg M, Lee K, Tsung A, Rhee J, Ohr J, Sun W, Lee J, Moser AJ, DeLeonardis K, Krejdovsky J, Dalton E, LaDuca H, Dolinsky J, Colvin A, Lim C, Black MH, Tung N. Prospective study of germline genetic testing in incident cases of pancreatic adenocarcinoma. Cancer 2018;124:3520-7. [PMID: 30067863 DOI: 10.1002/cncr.31628] [Cited by in Crossref: 52] [Cited by in F6Publishing: 54] [Article Influence: 10.4] [Reference Citation Analysis]
281 Burk KS, Knipp D, Sahani DV. Cystic Pancreatic Tumors. Magnetic Resonance Imaging Clinics of North America 2018;26:405-20. [DOI: 10.1016/j.mric.2018.03.006] [Cited by in Crossref: 20] [Cited by in F6Publishing: 12] [Article Influence: 4.0] [Reference Citation Analysis]
282 Yoshikawa T, Abe T, Amano H, Hanada K, Minami T, Kobayashi T, Yonehara S, Nakahara M, Ohdan H, Noriyuki T. Metachronous triple cancer associated with Peutz-Jeghers syndrome treated with curative surgery: a case report. Surg Case Rep 2018;4:84. [PMID: 30069736 DOI: 10.1186/s40792-018-0492-6] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
283 Hu C, LaDuca H, Shimelis H, Polley EC, Lilyquist J, Hart SN, Na J, Thomas A, Lee KY, Davis BT, Black MH, Pesaran T, Goldgar DE, Dolinsky JS, Couch FJ. Multigene Hereditary Cancer Panels Reveal High-Risk Pancreatic Cancer Susceptibility Genes. JCO Precis Oncol 2018;2. [PMID: 31497750 DOI: 10.1200/PO.17.00291] [Cited by in Crossref: 8] [Cited by in F6Publishing: 15] [Article Influence: 1.6] [Reference Citation Analysis]
284 Paluch-Shimon S, Cardoso F, Sessa C, Balmana J, Cardoso MJ, Gilbert F, Senkus E; ESMO Guidelines Committee. Prevention and screening in BRCA mutation carriers and other breast/ovarian hereditary cancer syndromes: ESMO Clinical Practice Guidelines for cancer prevention and screening. Ann Oncol 2016;27:v103-10. [PMID: 27664246 DOI: 10.1093/annonc/mdw327] [Cited by in Crossref: 223] [Cited by in F6Publishing: 240] [Article Influence: 44.6] [Reference Citation Analysis]
285 Chu LC, Goggins MG, Fishman EK. Diagnosis and Detection of Pancreatic Cancer. Cancer J. 2017;23:333-342. [PMID: 29189329 DOI: 10.1097/ppo.0000000000000290] [Cited by in Crossref: 136] [Cited by in F6Publishing: 160] [Article Influence: 27.2] [Reference Citation Analysis]
286 Welinsky S, Lucas AL. Familial Pancreatic Cancer and the Future of Directed Screening. Gut Liver 2017;11:761-70. [PMID: 28609837 DOI: 10.5009/gnl16414] [Cited by in Crossref: 20] [Cited by in F6Publishing: 21] [Article Influence: 4.0] [Reference Citation Analysis]
287 Hu C, Hart SN, Polley EC, Gnanaolivu R, Shimelis H, Lee KY, Lilyquist J, Na J, Moore R, Antwi SO, Bamlet WR, Chaffee KG, DiCarlo J, Wu Z, Samara R, Kasi PM, McWilliams RR, Petersen GM, Couch FJ. Association Between Inherited Germline Mutations in Cancer Predisposition Genes and Risk of Pancreatic Cancer. JAMA 2018;319:2401-9. [PMID: 29922827 DOI: 10.1001/jama.2018.6228] [Cited by in Crossref: 265] [Cited by in F6Publishing: 284] [Article Influence: 53.0] [Reference Citation Analysis]
288 Syngal S, Furniss CS. Germline Genetic Testing for Pancreatic Ductal Adenocarcinoma at Time of Diagnosis. JAMA 2018;319:2383-5. [PMID: 29922810 DOI: 10.1001/jama.2018.6227] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.4] [Reference Citation Analysis]
289 Katabathina VS, Rikhtehgar OY, Dasyam AK, Manickam R, Prasad SR. Genetics of Pancreatic Neoplasms and Role of Screening. Magn Reson Imaging Clin N Am. 2018;26:375-389. [PMID: 30376976 DOI: 10.1016/j.mric.2018.03.005] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 1.4] [Reference Citation Analysis]
290 Chao DT, Shah NH, Zeh HJ 3rd, Singhi AD, Bahary N, McGrath KM, Fasanella KE, Zureikat AH, Whitcomb DC, Brand RE. Overweight or Obese Individuals at Eighteen Years of Age Develop Pancreatic Adenocarcinoma at a Significantly Earlier Age. Gastroenterol Res Pract 2018;2018:2380596. [PMID: 29967636 DOI: 10.1155/2018/2380596] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
291 Paiella S, Salvia R, De Pastena M, Pollini T, Casetti L, Landoni L, Esposito A, Marchegiani G, Malleo G, De Marchi G, Scarpa A, D'Onofrio M, De Robertis R, Pan TL, Maggino L, Andrianello S, Secchettin E, Bonamini D, Melisi D, Tuveri M, Bassi C. Screening/surveillance programs for pancreatic cancer in familial high-risk individuals: A systematic review and proportion meta-analysis of screening results. Pancreatology 2018;18:420-8. [PMID: 29709409 DOI: 10.1016/j.pan.2018.04.002] [Cited by in Crossref: 30] [Cited by in F6Publishing: 30] [Article Influence: 6.0] [Reference Citation Analysis]
292 Bruno MJ. Pancreatic cancer screening in high-risk individuals: Ready for prime time? Gastrointest Endosc 2018;87:1451-3. [PMID: 29759159 DOI: 10.1016/j.gie.2018.02.011] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
293 DaVee T, Coronel E, Papafragkakis C, Thaiudom S, Lanke G, Chakinala RC, Nogueras González GM, Bhutani MS, Ross WA, Weston BR, Lee JH. Pancreatic cancer screening in high-risk individuals with germline genetic mutations. Gastrointest Endosc 2018;87:1443-50. [PMID: 29309780 DOI: 10.1016/j.gie.2017.12.019] [Cited by in Crossref: 39] [Cited by in F6Publishing: 35] [Article Influence: 7.8] [Reference Citation Analysis]
294 Zhang L, Sanagapalli S, Stoita A. Challenges in diagnosis of pancreatic cancer. World J Gastroenterol 2018; 24(19): 2047-2060 [PMID: 29785074 DOI: 10.3748/wjg.v24.i19.2047] [Cited by in CrossRef: 224] [Cited by in F6Publishing: 225] [Article Influence: 44.8] [Reference Citation Analysis]
295 Gangi A, Malafa M, Klapman J. Endoscopic Ultrasound-Based Pancreatic Cancer Screening of High-Risk Individuals: A Prospective Observational Trial. Pancreas 2018;47:586-91. [PMID: 29683970 DOI: 10.1097/MPA.0000000000001038] [Cited by in Crossref: 20] [Cited by in F6Publishing: 14] [Article Influence: 4.0] [Reference Citation Analysis]
296 Unger K, Mehta KY, Kaur P, Wang Y, Menon SS, Jain SK, Moonjelly RA, Suman S, Datta K, Singh R, Fogel P, Cheema AK. Metabolomics based predictive classifier for early detection of pancreatic ductal adenocarcinoma. Oncotarget. 2018;9:23078-23090. [PMID: 29796173 DOI: 10.18632/oncotarget.25212] [Cited by in Crossref: 22] [Cited by in F6Publishing: 23] [Article Influence: 4.4] [Reference Citation Analysis]
297 European Study Group on Cystic Tumours of the Pancreas. European evidence-based guidelines on pancreatic cystic neoplasms. Gut 2018;67:789-804. [PMID: 29574408 DOI: 10.1136/gutjnl-2018-316027] [Cited by in Crossref: 589] [Cited by in F6Publishing: 513] [Article Influence: 117.8] [Reference Citation Analysis]
298 He X, Li Y, Su T, Lai S, Wu W, Chen L, Si J, Sun L. The impact of a history of cancer on pancreatic ductal adenocarcinoma survival. United European Gastroenterol J 2018;6:888-94. [PMID: 30023066 DOI: 10.1177/2050640618765505] [Cited by in Crossref: 12] [Cited by in F6Publishing: 17] [Article Influence: 2.4] [Reference Citation Analysis]
299 Konings ICAW, Cahen DL, Harinck F, Fockens P, van Hooft JE, Poley JW, Bruno MJ. Evolution of features of chronic pancreatitis during endoscopic ultrasound-based surveillance of individuals at high risk for pancreatic cancer. Endosc Int Open. 2018;6:E541-E548. [PMID: 29713680 DOI: 10.1055/a-0574-2396] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.2] [Reference Citation Analysis]
300 Tezuka K, Ishiyama T, Takeshita A, Matsumoto H, Jingu A, Kikuchi J, Yamaya H, Ohe R, Ishizawa T. Poorly differentiated ductal adenocarcinoma of the pancreas with rapid progression in a young man. Clin J Gastroenterol 2018;11:417-23. [PMID: 29663140 DOI: 10.1007/s12328-018-0859-z] [Reference Citation Analysis]
301 Tamura K, Yu J, Hata T, Suenaga M, Shindo K, Abe T, MacGregor-Das A, Borges M, Wolfgang CL, Weiss MJ, He J, Canto MI, Petersen GM, Gallinger S, Syngal S, Brand RE, Rustgi A, Olson SH, Stoffel E, Cote ML, Zogopoulos G, Potash JB, Goes FS, McCombie RW, Zandi PP, Pirooznia M, Kramer M, Parla J, Eshleman JR, Roberts NJ, Hruban RH, Klein AP, Goggins M. Mutations in the pancreatic secretory enzymes CPA1 and CPB1 are associated with pancreatic cancer. Proc Natl Acad Sci U S A 2018;115:4767-72. [PMID: 29669919 DOI: 10.1073/pnas.1720588115] [Cited by in Crossref: 43] [Cited by in F6Publishing: 45] [Article Influence: 8.6] [Reference Citation Analysis]
302 Almeida RR, Lo GC, Patino M, Bizzo B, Canellas R, Sahani DV. Advances in Pancreatic CT Imaging. AJR Am J Roentgenol. 2018;211:52-66. [PMID: 29629796 DOI: 10.2214/ajr.17.18665] [Cited by in Crossref: 35] [Cited by in F6Publishing: 39] [Article Influence: 7.0] [Reference Citation Analysis]
303 Lipner MB, Yeh JJ. Sequencing Pancreatic Juice: Squeezing the Most Out of Surveillance. Clin Cancer Res 2018;24:2713-5. [PMID: 29500277 DOI: 10.1158/1078-0432.CCR-18-0215] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
304 Felsenstein M, Hruban RH, Wood LD. New Developments in the Molecular Mechanisms of Pancreatic Tumorigenesis. Adv Anat Pathol 2018;25:131-42. [PMID: 28914620 DOI: 10.1097/PAP.0000000000000172] [Cited by in Crossref: 28] [Cited by in F6Publishing: 30] [Article Influence: 5.6] [Reference Citation Analysis]
305 Lee HS, Jang CY, Kim SA, Park SB, Jung DE, Kim BO, Kim HY, Chung MJ, Park JY, Bang S, Park SW, Song SY. Combined use of CEMIP and CA 19-9 enhances diagnostic accuracy for pancreatic cancer. Sci Rep 2018;8:3383. [PMID: 29467409 DOI: 10.1038/s41598-018-21823-x] [Cited by in Crossref: 19] [Cited by in F6Publishing: 22] [Article Influence: 3.8] [Reference Citation Analysis]
306 Kandel P, Wallace MB. Advanced EUS Guided Tissue Acquisition Methods for Pancreatic Cancer. Cancers (Basel) 2018;10:E54. [PMID: 29463004 DOI: 10.3390/cancers10020054] [Cited by in Crossref: 5] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
307 Chu QD, Borazanci E, Kim RH, Sangster G. Adenocarcinoma of the Pancreas. The American Cancer Society's Oncology in Practice 2018. [DOI: 10.1002/9781118592168.ch6] [Reference Citation Analysis]
308 Sereti E, Karagianellou T, Kotsoni I, Magouliotis D, Kamposioras K, Ulukaya E, Sakellaridis N, Zacharoulis D, Dimas K. Patient Derived Xenografts (PDX) for personalized treatment of pancreatic cancer: emerging allies in the war on a devastating cancer? J Proteomics 2018;188:107-18. [PMID: 29398619 DOI: 10.1016/j.jprot.2018.01.012] [Cited by in Crossref: 11] [Cited by in F6Publishing: 13] [Article Influence: 2.2] [Reference Citation Analysis]
309 Papadopoulos N, Hruban RH. Molecular Mechanisms of Cystic Neoplasia. The Pancreas 2018. [DOI: 10.1002/9781119188421.ch75] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
310 Klein AP. Familial Pancreatic Cancer. The Pancreas 2018. [DOI: 10.1002/9781119188421.ch91] [Reference Citation Analysis]
311 Goggins M. Screening of Patients with Hereditary Pancreatic Cancer. The Pancreas 2018. [DOI: 10.1002/9781119188421.ch98] [Reference Citation Analysis]
312 Lindquist CM, Miller FH, Hammond NA, Nikolaidis P. Pancreatic cancer screening. Abdom Radiol (NY) 2018;43:264-72. [PMID: 28840303 DOI: 10.1007/s00261-017-1308-z] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 3.6] [Reference Citation Analysis]
313 Bhattacharya A, Gandhi NS, Baker ME, Chahal P. Gastroenterology and pancreatic adenocarcinoma: what the radiologist needs to know. Abdom Radiol (NY) 2018;43:364-73. [PMID: 29116342 DOI: 10.1007/s00261-017-1347-5] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.6] [Reference Citation Analysis]
314 Torphy RJ, Schulick RD. Screening of Patients at Risk for Familial Pancreatic Cancer. Surgical Clinics of North America 2018;98:25-35. [DOI: 10.1016/j.suc.2017.09.003] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 2.2] [Reference Citation Analysis]
315 Bhosale P, Cox V, Faria S, Javadi S, Viswanathan C, Koay E, Tamm E. Genetics of pancreatic cancer and implications for therapy. Abdom Radiol (NY) 2018;43:404-14. [PMID: 29177925 DOI: 10.1007/s00261-017-1394-y] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.4] [Reference Citation Analysis]
316 Signoretti M, Bruno MJ, Zerboni G, Poley JW, Delle Fave G, Capurso G. Results of surveillance in individuals at high-risk of pancreatic cancer: A systematic review and meta-analysis. United European Gastroenterol J. 2018;6:489-499. [PMID: 29881603 DOI: 10.1177/2050640617752182] [Cited by in Crossref: 29] [Cited by in F6Publishing: 31] [Article Influence: 5.8] [Reference Citation Analysis]
317 Suenaga M, Yu J, Shindo K, Tamura K, Almario JA, Zaykoski C, Witmer PD, Fesharakizadeh S, Borges M, Lennon AM, Shin EJ, Canto MI, Goggins M. Pancreatic Juice Mutation Concentrations Can Help Predict the Grade of Dysplasia in Patients Undergoing Pancreatic Surveillance. Clin Cancer Res. 2018;24:2963-2974. [PMID: 29301828 DOI: 10.1158/1078-0432.ccr-17-2463] [Cited by in Crossref: 48] [Cited by in F6Publishing: 50] [Article Influence: 9.6] [Reference Citation Analysis]
318 Roberts NJ, Klein AP. Familial Pancreatic Cancer. Pancreatic Cancer 2018. [DOI: 10.1007/978-1-4939-7193-0_78] [Cited by in Crossref: 1] [Article Influence: 0.2] [Reference Citation Analysis]
319 Kim SB. Model to Stratify Risk of Pancreatic Cancer in Patients Diagnosed as New-onset Diabetes. Korean J Gastroenterol 2018;72:159. [DOI: 10.4166/kjg.2018.72.3.159] [Reference Citation Analysis]
320 Hart PA, Stanich PP, Hampel H. Screening for Pancreatic Cancer: Who to Screen and How to Follow-Up? Current and Emerging Therapies in Pancreatic Cancer 2018. [DOI: 10.1007/978-3-319-58256-6_4] [Reference Citation Analysis]
321 Stoffel EM, Yurgelun MB, Boland CR. Lynch Syndrome. Hereditary Colorectal Cancer 2018. [DOI: 10.1007/978-3-319-74259-5_1] [Reference Citation Analysis]
322 Miyabayashi K, Tuveson DA, Yu KH. Multiparameter Modalities for the Study of Patients in the Setting of Individualized Medicine. Pancreatic Cancer 2018. [DOI: 10.1007/978-1-4939-7193-0_65] [Reference Citation Analysis]
323 Mayerle J, Kalthoff H, Reszka R, Kamlage B, Peter E, Schniewind B, González Maldonado S, Pilarsky C, Heidecke CD, Schatz P, Distler M, Scheiber JA, Mahajan UM, Weiss FU, Grützmann R, Lerch MM. Metabolic biomarker signature to differentiate pancreatic ductal adenocarcinoma from chronic pancreatitis. Gut 2018;67:128-37. [PMID: 28108468 DOI: 10.1136/gutjnl-2016-312432] [Cited by in Crossref: 148] [Cited by in F6Publishing: 153] [Article Influence: 29.6] [Reference Citation Analysis]
324 Farrell JJ. Advanced Endoscopic Procedures. Current and Emerging Therapies in Pancreatic Cancer 2018. [DOI: 10.1007/978-3-319-58256-6_8] [Reference Citation Analysis]
325 Macgregor-das A, Goggins M. Diagnostic Biomarkers. Pancreatic Cancer 2018. [DOI: 10.1007/978-1-4939-7193-0_56] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
326 Hamman KJ, Kohlmann W, Leachman S. Genetic Counseling. Melanoma 2018. [DOI: 10.1007/978-1-4614-7322-0_8-1] [Reference Citation Analysis]
327 Sheel A, Nicholson J, Sarantitis I, Neoptolemos JP, Greenhalf W. Secondary Screening for Inherited Pancreatic Ductal Adenocarcinoma. Pancreatic Cancer 2018. [DOI: 10.1007/978-1-4939-7193-0_63] [Reference Citation Analysis]
328 Farrell JJ. Intraductal papillary mucinous neoplasm to pancreas ductal adenocarcinoma sequence and pancreas cancer screening. Endosc Ultrasound 2018;7:314-8. [PMID: 30323160 DOI: 10.4103/eus.eus_49_18] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
329 Stjepanovic N, Moreira L, Balmaña J, Brunet J. Surveillance Guidelines for Hereditary Colorectal Cancer Syndromes. Hereditary Colorectal Cancer 2018. [DOI: 10.1007/978-3-319-74259-5_20] [Reference Citation Analysis]
330 Grote T, Gress TM. EUS and Its Role in Pancreatic Cancer. Pancreatic Cancer 2018. [DOI: 10.1007/978-1-4939-7193-0_79] [Reference Citation Analysis]
331 Kahlert C, Distler M, Aust D, Gieldon L, Weitz J, Welsch T. Pankreasfrühkarzinom. Chirurg 2018;89:257-65. [DOI: 10.1007/s00104-017-0569-y] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
332 Drouillard A, Manfredi S, Lepage C, Bouvier AM. [Epidemiology of pancreatic cancer]. Bull Cancer 2018;105:63-9. [PMID: 29273548 DOI: 10.1016/j.bulcan.2017.11.004] [Cited by in Crossref: 21] [Cited by in F6Publishing: 23] [Article Influence: 3.5] [Reference Citation Analysis]
333 Kyrochristos ID, Ziogas DE, Glantzounis GK, Roukos DH. Prediction of pancreatic cancer risk and therapeutic response with next-generation sequencing. Biomark Med 2018;12:5-8. [PMID: 29235881 DOI: 10.2217/bmm-2017-0315] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
334 Giri VN, Knudsen KE, Kelly WK, Abida W, Andriole GL, Bangma CH, Bekelman JE, Benson MC, Blanco A, Burnett A, Catalona WJ, Cooney KA, Cooperberg M, Crawford DE, Den RB, Dicker AP, Eggener S, Fleshner N, Freedman ML, Hamdy FC, Hoffman-Censits J, Hurwitz MD, Hyatt C, Isaacs WB, Kane CJ, Kantoff P, Karnes RJ, Karsh LI, Klein EA, Lin DW, Loughlin KR, Lu-Yao G, Malkowicz SB, Mann MJ, Mark JR, McCue PA, Miner MM, Morgan T, Moul JW, Myers RE, Nielsen SM, Obeid E, Pavlovich CP, Peiper SC, Penson DF, Petrylak D, Pettaway CA, Pilarski R, Pinto PA, Poage W, Raj GV, Rebbeck TR, Robson ME, Rosenberg MT, Sandler H, Sartor O, Schaeffer E, Schwartz GF, Shahin MS, Shore ND, Shuch B, Soule HR, Tomlins SA, Trabulsi EJ, Uzzo R, Vander Griend DJ, Walsh PC, Weil CJ, Wender R, Gomella LG. Role of Genetic Testing for Inherited Prostate Cancer Risk: Philadelphia Prostate Cancer Consensus Conference 2017. J Clin Oncol 2018;36:414-24. [PMID: 29236593 DOI: 10.1200/JCO.2017.74.1173] [Cited by in Crossref: 121] [Cited by in F6Publishing: 129] [Article Influence: 20.2] [Reference Citation Analysis]
335 Hata T, Dal Molin M, McGregor-Das A, Song TJ, Wolfgang C, Eshleman JR, Hruban RH, Goggins M. Simple Detection of Telomere Fusions in Pancreatic Cancer, Intraductal Papillary Mucinous Neoplasm, and Pancreatic Cyst Fluid. J Mol Diagn 2018;20:46-55. [PMID: 29229290 DOI: 10.1016/j.jmoldx.2017.09.006] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 1.8] [Reference Citation Analysis]
336 Dumstrei K, Chen H, Brenner H. A systematic review of serum autoantibodies as biomarkers for pancreatic cancer detection. Oncotarget. 2016;7:11151-11164. [PMID: 26840568 DOI: 10.18632/oncotarget.7098] [Cited by in Crossref: 29] [Cited by in F6Publishing: 30] [Article Influence: 4.8] [Reference Citation Analysis]
337 Park H, Jang K, Song K, Kim S, Kim Y, Cha M, Choi S, Min K. Value of unenhanced MRI with diffusion-weighted imaging for detection of primary small (≤20 mm) solid pancreatic tumours and prediction of pancreatic ductal adenocarcinoma. Clinical Radiology 2017;72:1076-84. [DOI: 10.1016/j.crad.2017.07.009] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.3] [Reference Citation Analysis]
338 Suenaga M, Sadakari Y, Almario JA, Borges M, Lennon AM, Shin EJ, Canto MI, Goggins M. Using an endoscopic distal cap to collect pancreatic fluid from the ampulla (with video). Gastrointest Endosc 2017;86:1152-1156.e2. [PMID: 28259593 DOI: 10.1016/j.gie.2017.02.026] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
339 Walling A, Freelove R. Pancreatitis and Pancreatic Cancer. Primary Care: Clinics in Office Practice 2017;44:609-20. [DOI: 10.1016/j.pop.2017.07.004] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 2.5] [Reference Citation Analysis]
340 Burk KS, Lo GC, Gee MS, Sahani DV. Imaging and Screening of Pancreatic Cancer. Radiol Clin North Am 2017;55:1223-34. [PMID: 28991562 DOI: 10.1016/j.rcl.2017.06.006] [Cited by in Crossref: 12] [Cited by in F6Publishing: 14] [Article Influence: 2.0] [Reference Citation Analysis]
341 Jawad ZAR, Theodorou IG, Jiao LR, Xie F. Highly Sensitive Plasmonic Detection of the Pancreatic Cancer Biomarker CA 19-9. Sci Rep 2017;7:14309. [PMID: 29085011 DOI: 10.1038/s41598-017-14688-z] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 2.8] [Reference Citation Analysis]
342 Kumar S, Inigo JR, Kumar R, Chaudhary AK, O'Malley J, Balachandar S, Wang J, Attwood K, Yadav N, Hochwald S, Wang X, Chandra D. Nimbolide reduces CD44 positive cell population and induces mitochondrial apoptosis in pancreatic cancer cells. Cancer Lett 2018;413:82-93. [PMID: 29107110 DOI: 10.1016/j.canlet.2017.10.029] [Cited by in Crossref: 19] [Cited by in F6Publishing: 17] [Article Influence: 3.2] [Reference Citation Analysis]
343 Bujanda L, Herreros-Villanueva M. Pancreatic Cancer in Lynch Syndrome Patients. J Cancer 2017;8:3667-74. [PMID: 29151953 DOI: 10.7150/jca.20750] [Cited by in Crossref: 23] [Cited by in F6Publishing: 25] [Article Influence: 3.8] [Reference Citation Analysis]
344 Leachman SA, Lucero OM, Sampson JE, Cassidy P, Bruno W, Queirolo P, Ghiorzo P. Identification, genetic testing, and management of hereditary melanoma. Cancer Metastasis Rev 2017;36:77-90. [PMID: 28283772 DOI: 10.1007/s10555-017-9661-5] [Cited by in Crossref: 67] [Cited by in F6Publishing: 73] [Article Influence: 11.2] [Reference Citation Analysis]
345 Carreras-Torres R, Johansson M, Gaborieau V, Haycock PC, Wade KH, Relton CL, Martin RM, Davey Smith G, Brennan P. The Role of Obesity, Type 2 Diabetes, and Metabolic Factors in Pancreatic Cancer: A Mendelian Randomization Study.J Natl Cancer Inst. 2017;109. [PMID: 28954281 DOI: 10.1093/jnci/djx012] [Cited by in Crossref: 133] [Cited by in F6Publishing: 144] [Article Influence: 22.2] [Reference Citation Analysis]
346 Kanth P, Grimmett J, Champine M, Burt R, Samadder NJ. Hereditary Colorectal Polyposis and Cancer Syndromes: A Primer on Diagnosis and Management. Am J Gastroenterol 2017;112:1509-25. [PMID: 28786406 DOI: 10.1038/ajg.2017.212] [Cited by in Crossref: 92] [Cited by in F6Publishing: 93] [Article Influence: 15.3] [Reference Citation Analysis]
347 Martínez de Juan F, Reolid Escribano M, Martínez Lapiedra C, Maia de Alcantara F, Caballero Soto M, Calatrava Fons A, Machado I. Pancreatic adenosquamous carcinoma and intraductal papillary mucinous neoplasm in a CDKN2A germline mutation carrier. World J Gastrointest Oncol 2017; 9(9): 390-396 [PMID: 28979722 DOI: 10.4251/wjgo.v9.i9.390] [Cited by in CrossRef: 9] [Cited by in F6Publishing: 10] [Article Influence: 1.5] [Reference Citation Analysis]
348 Das KK, Early D. Pancreatic cancer screening. Curr Treat Options Gastroenterol. 2017;15:562-575. [PMID: 28879469 DOI: 10.1007/s11938-017-0149-8] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.7] [Reference Citation Analysis]
349 Yu J, Sadakari Y, Shindo K, Suenaga M, Brant A, Almario JAN, Borges M, Barkley T, Fesharakizadeh S, Ford M, Hruban RH, Shin EJ, Lennon AM, Canto MI, Goggins M. Digital next-generation sequencing identifies low-abundance mutations in pancreatic juice samples collected from the duodenum of patients with pancreatic cancer and intraductal papillary mucinous neoplasms. Gut 2017;66:1677-87. [PMID: 27432539 DOI: 10.1136/gutjnl-2015-311166] [Cited by in Crossref: 107] [Cited by in F6Publishing: 96] [Article Influence: 17.8] [Reference Citation Analysis]
350 Frič P, Šedo A, Škrha J, Bušek P, Laclav M, Škrha P, Zavoral M. Early detection of sporadic pancreatic cancer: time for change. Eur J Gastroenterol Hepatol 2017;29:885-91. [PMID: 28471824 DOI: 10.1097/MEG.0000000000000904] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.3] [Reference Citation Analysis]
351 Maire F, Cibot JO, Compagne C, Hentic O, Hammel P, Muller N, Ponsot P, Levy P, Ruszniewski P. Epidemiology of pancreatic cancer in France: descriptive study from the French national hospital database. Eur J Gastroenterol Hepatol 2017;29:904-8. [PMID: 28471829 DOI: 10.1097/MEG.0000000000000901] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 1.5] [Reference Citation Analysis]
352 Takeda Y, Saiura A, Takahashi Y, Inoue Y, Ishizawa T, Mise Y, Matsumura M, Ichida H, Matsuki R, Tanaka M, Ito H. Asymptomatic Pancreatic Cancer: Does Incidental Detection Impact Long-Term Outcomes? J Gastrointest Surg 2017;21:1287-95. [PMID: 28397027 DOI: 10.1007/s11605-017-3421-2] [Cited by in Crossref: 14] [Cited by in F6Publishing: 16] [Article Influence: 2.3] [Reference Citation Analysis]
353 Moutinho-Ribeiro P, Coelho R, Giovannini M, Macedo G. Pancreatic cancer screening: Still a delusion? Pancreatology 2017;17:754-65. [PMID: 28739291 DOI: 10.1016/j.pan.2017.07.001] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 2.5] [Reference Citation Analysis]
354 Jo JH, Cho IR, Jung JH, Lee HS, Chung MJ, Bang S, Park SW, Chung JB, Song SY, Park JY. Clinical characteristics of second primary pancreatic cancer. PLoS One 2017;12:e0179784. [PMID: 28650984 DOI: 10.1371/journal.pone.0179784] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.2] [Reference Citation Analysis]
355 Nakamura M, Miyasaka Y, Sadakari Y, Date K, Ohtsuka T. Comparison of guidelines for intraductal papillary mucinous neoplasm: What is the next step beyond the current guidelines? Ann Gastroenterol Surg. 2017;1:90-98. [PMID: 29863135 DOI: 10.1002/ags3.12012] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.7] [Reference Citation Analysis]
356 Guillén-ponce C, Blázquez J, González I, de-Madaria E, Montáns J, Carrato A. Diagnosis and staging of pancreatic ductal adenocarcinoma. Clin Transl Oncol 2017;19:1205-16. [DOI: 10.1007/s12094-017-1681-7] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.3] [Reference Citation Analysis]
357 Razvi MA, Giardiello FM, Law JK. DNA Mismatch Repair and Lynch Syndrome. Curr Colorectal Cancer Rep 2017;13:212-219. [DOI: 10.1007/s11888-017-0366-5] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
358 Connor AA, Gallinger S. Next generation sequencing of pancreatic ductal adenocarcinoma: right or wrong? Expert Rev Gastroenterol Hepatol 2017;11:683-94. [PMID: 28460572 DOI: 10.1080/17474124.2017.1324296] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
359 Sohal DPS, Willingham FF, Falconi M, Raphael KL, Crippa S. Pancreatic Adenocarcinoma: Improving Prevention and Survivorship. American Society of Clinical Oncology Educational Book 2017. [DOI: 10.1200/edbk_175222] [Cited by in Crossref: 8] [Cited by in F6Publishing: 11] [Article Influence: 1.3] [Reference Citation Analysis]
360 Borazanci E, Haag S. Hereditary Pancreatic Cancer. Challenges in Pancreatic Pathology 2017. [DOI: 10.5772/65067] [Reference Citation Analysis]
361 Pihlak R, Valle JW, McNamara MG. Germline mutations in pancreatic cancer and potential new therapeutic options. Oncotarget. 2017;8:73240-73257. [PMID: 29069866 DOI: 10.18632/oncotarget.17291] [Cited by in Crossref: 34] [Cited by in F6Publishing: 35] [Article Influence: 5.7] [Reference Citation Analysis]
362 Fogel EL, Shahda S, Sandrasegaran K, DeWitt J, Easler JJ, Agarwal DM, Eagleson M, Zyromski NJ, House MG, Ellsworth S, El Hajj I, O'Neil BH, Nakeeb A, Sherman S. A Multidisciplinary Approach to Pancreas Cancer in 2016: A Review. Am J Gastroenterol 2017;112:537-54. [PMID: 28139655 DOI: 10.1038/ajg.2016.610] [Cited by in Crossref: 80] [Cited by in F6Publishing: 78] [Article Influence: 13.3] [Reference Citation Analysis]
363 Soldan M. Pancreatic cancer screening. Rev Col Bras Cir 2017;44:109-11. [DOI: 10.1590/0100-69912017002015] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
364 Romero-Laorden N, Castro E. Inherited mutations in DNA repair genes and cancer risk. Curr Probl Cancer 2017;41:251-64. [PMID: 28454847 DOI: 10.1016/j.currproblcancer.2017.02.009] [Cited by in Crossref: 22] [Cited by in F6Publishing: 20] [Article Influence: 3.7] [Reference Citation Analysis]
365 Matsubayashi H, Takaori K, Morizane C, Maguchi H, Mizuma M, Takahashi H, Wada K, Hosoi H, Yachida S, Suzuki M, Usui R, Furukawa T, Furuse J, Sato T, Ueno M, Kiyozumi Y, Hijioka S, Mizuno N, Terashima T, Mizumoto M, Kodama Y, Torishima M, Kawaguchi T, Ashida R, Kitano M, Hanada K, Furukawa M, Kawabe K, Majima Y, Shimosegawa T. Familial pancreatic cancer: Concept, management and issues. World J Gastroenterol 2017; 23(6): 935-948 [PMID: 28246467 DOI: 10.3748/wjg.v23.i6.935] [Cited by in CrossRef: 60] [Cited by in F6Publishing: 72] [Article Influence: 10.0] [Reference Citation Analysis]
366 Serrao EM, Brindle KM. Dynamic nuclear polarisation: The future of imaging in oncology? Porto Biomed J 2017;2:71-5. [PMID: 32258590 DOI: 10.1016/j.pbj.2017.01.002] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
367 Kamps R, Brandão RD, Bosch BJ, Paulussen AD, Xanthoulea S, Blok MJ, Romano A. Next-Generation Sequencing in Oncology: Genetic Diagnosis, Risk Prediction and Cancer Classification. Int J Mol Sci 2017;18:E308. [PMID: 28146134 DOI: 10.3390/ijms18020308] [Cited by in Crossref: 251] [Cited by in F6Publishing: 264] [Article Influence: 41.8] [Reference Citation Analysis]
368 Ngamruengphong S, Canto MI. Screening for Pancreatic Cancer. Surg Clin North Am 2016;96:1223-33. [PMID: 27865274 DOI: 10.1016/j.suc.2016.07.016] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 2.7] [Reference Citation Analysis]
369 Lucas AL, Tarlecki A, Van Beck K, Lipton C, RoyChoudhury A, Levinson E, Kumar S, Chung WK, Frucht H, Genkinger JM. Self-Reported Questionnaire Detects Family History of Cancer in a Pancreatic Cancer Screening Program. J Genet Couns 2017;26:806-13. [PMID: 28039657 DOI: 10.1007/s10897-016-0057-4] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
370 Miyabayashi K, Tuveson DA, Yu KH. Multiparameter Modalities for the Study of Patients in the Setting of Individualized Medicine. Pancreatic Cancer 2017. [DOI: 10.1007/978-1-4939-6631-8_65-1] [Reference Citation Analysis]
371 Bekkali NLH, Oppong KW. Pancreatic ductal adenocarcinoma epidemiology and risk assessment: Could we prevent? Possibility for an early diagnosis. Endosc Ultrasound 2017;6:S58-61. [PMID: 29387690 DOI: 10.4103/eus.eus_60_17] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 0.8] [Reference Citation Analysis]
372 Caputo D, Papi M, Coppola R, Palchetti S, Digiacomo L, Caracciolo G, Pozzi D. A protein corona-enabled blood test for early cancer detection. Nanoscale 2017;9:349-54. [DOI: 10.1039/c6nr05609a] [Cited by in Crossref: 64] [Cited by in F6Publishing: 66] [Article Influence: 10.7] [Reference Citation Analysis]
373 Foo WC, Wang H. Pathology and Molecular Pathology of Pancreatic Cancer. Pathology and Epidemiology of Cancer 2017. [DOI: 10.1007/978-3-319-35153-7_26] [Reference Citation Analysis]
374 Morizane C, Kitano M, Hijioka S, Ito T, Kamisawa T, Kosugi S, Furukawa T, Furuse J, Majima Y, Matsubayashi H, Mizuma M, Mizumoto M, Wada K, Takaori K. Japanese Familial Pancreatic Cancer Registry with the aim to early detection of pancreatic cancer. Journal of the Japan Pancreas Society 2017;32:23-29. [DOI: 10.2958/suizo.32.23] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
375 Martinelli P, Lonardo E. Metastatic Pancreatic Cancer. Introduction to Cancer Metastasis 2017. [DOI: 10.1016/b978-0-12-804003-4.00007-4] [Reference Citation Analysis]
376 Sheth SG, Conwell DL, Whitcomb DC, Alsante M, Anderson MA, Barkin J, Brand R, Cote GA, Freedman SD, Gelrud A, Gorelick F, Lee LS, Morgan K, Pandol S, Singh VK, Yadav D, Wilcox CM, Hart PA. Academic Pancreas Centers of Excellence: Guidance from a multidisciplinary chronic pancreatitis working group at PancreasFest. Pancreatology 2017;17:419-30. [PMID: 28268158 DOI: 10.1016/j.pan.2017.02.015] [Cited by in Crossref: 21] [Cited by in F6Publishing: 20] [Article Influence: 3.5] [Reference Citation Analysis]
377 Sheel A, Nicholson J, Sarantitis I, Neoptolemos J, Greenhalf W. Secondary Screening for Inherited Pancreatic Ductal Adenocarcinoma. Pancreatic Cancer 2017. [DOI: 10.1007/978-1-4939-6631-8_63-1] [Reference Citation Analysis]
378 Macgregor-das A, Goggins M. Diagnostic Biomarkers. Pancreatic Cancer 2017. [DOI: 10.1007/978-1-4939-6631-8_56-1] [Reference Citation Analysis]
379 Cotter TG, Burger KN, Devens ME, Simonson JA, Lowrie KL, Heigh RI, Mahoney DW, Johnson DH, Ahlquist DA, Kisiel JB. Long-term Follow-up of Patients Having False-Positive Multitarget Stool DNA Tests after Negative Screening Colonoscopy: The LONG-HAUL Cohort Study. Cancer Epidemiol Biomarkers Prev. 2017;26:614-621. [PMID: 27999144 DOI: 10.1158/1055-9965.epi-16-0800] [Cited by in Crossref: 21] [Cited by in F6Publishing: 21] [Article Influence: 3.0] [Reference Citation Analysis]
380 Zhang Q, Chen S, Zeng L, Chen Y, Lian G, Qian C, Li J, Xie R, Huang KH. New developments in the early diagnosis of pancreatic cancer. Expert Rev Gastroenterol Hepatol 2017;11:149-56. [PMID: 27937041 DOI: 10.1080/17474124.2017.1271323] [Cited by in Crossref: 12] [Cited by in F6Publishing: 15] [Article Influence: 1.7] [Reference Citation Analysis]
381 Rosenthal ET, Evans B, Kidd J, Brown K, Gorringe H, van Orman M, Manley S. Increased Identification of Candidates for High-Risk Breast Cancer Screening Through Expanded Genetic Testing. J Am Coll Radiol 2017;14:561-8. [PMID: 28011157 DOI: 10.1016/j.jacr.2016.10.003] [Cited by in Crossref: 18] [Cited by in F6Publishing: 16] [Article Influence: 2.6] [Reference Citation Analysis]
382 Hidalgo M, Álvarez R, Gallego J, Guillén-Ponce C, Laquente B, Macarulla T, Muñoz A, Salgado M, Vera R, Adeva J, Alés I, Arévalo S, Blázquez J, Calsina A, Carmona A, de Madaria E, Díaz R, Díez L, Fernández T, de Paredes BG, Gallardo ME, González I, Hernando O, Jiménez P, López A, López C, López-Ríos F, Martín E, Martínez J, Martínez A, Montans J, Pazo R, Plaza JC, Peiró I, Reina JJ, Sanjuanbenito A, Yaya R, Carrato A. Consensus guidelines for diagnosis, treatment and follow-up of patients with pancreatic cancer in Spain. Clin Transl Oncol 2017;19:667-81. [PMID: 27995549 DOI: 10.1007/s12094-016-1594-x] [Cited by in Crossref: 21] [Cited by in F6Publishing: 25] [Article Influence: 3.0] [Reference Citation Analysis]
383 Mansfield SA, Pilarski R, Agnese DM. ATM mutations for surgeons. Fam Cancer 2017;16:407-10. [PMID: 27988859 DOI: 10.1007/s10689-016-9959-4] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
384 Frampas E, David A, Regenet N, Touchefeu Y, Meyer J, Morla O. L’adénocarcinome du pancréas : du diagnostic au traitement. Journal de Radiologie Diagnostique et Interventionnelle 2016;97:483-500. [DOI: 10.1016/j.jradio.2016.07.007] [Reference Citation Analysis]
385 Vullierme M, Lagadec M. Predisposing factors for pancreatic adenocarcinoma: What is the role of imaging? Diagnostic and Interventional Imaging 2016;97:1233-40. [DOI: 10.1016/j.diii.2016.08.018] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
386 Frampas E, David A, Regenet N, Touchefeu Y, Meyer J, Morla O. Pancreatic carcinoma: Key-points from diagnosis to treatment. Diagnostic and Interventional Imaging 2016;97:1207-23. [DOI: 10.1016/j.diii.2016.07.008] [Cited by in Crossref: 21] [Cited by in F6Publishing: 21] [Article Influence: 3.0] [Reference Citation Analysis]
387 Vullierme M, Lagadec M. Facteurs prédisposants de l’adénocarcinome pancréatique : quel est le rôle de l’imagerie ? Journal de Radiologie Diagnostique et Interventionnelle 2016;97:509-517. [DOI: 10.1016/j.jradio.2016.10.003] [Reference Citation Analysis]
388 Overbeek KA, Cahen DL, Canto MI, Bruno MJ. Surveillance for neoplasia in the pancreas. Best Pract Res Clin Gastroenterol 2016;30:971-86. [PMID: 27938791 DOI: 10.1016/j.bpg.2016.10.013] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 2.1] [Reference Citation Analysis]
389 Moreira L, Castells A. Surveillance of patients with hereditary gastrointestinal cancer syndromes. Best Pract Res Clin Gastroenterol 2016;30:923-35. [PMID: 27938787 DOI: 10.1016/j.bpg.2016.10.004] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 0.6] [Reference Citation Analysis]
390 Fujita Y, Kitago M, Masugi Y, Itano O, Shinoda M, Abe Y, Hibi T, Yagi H, Fujii-Nishimura Y, Sakamoto M, Kitagawa Y. Two cases of pancreatic ductal adenocarcinoma with intrapancreatic metastasis. World J Gastroenterol 2016; 22(41): 9222-9228 [PMID: 27895409 DOI: 10.3748/wjg.v22.i41.9222] [Cited by in CrossRef: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.9] [Reference Citation Analysis]
391 Sampson JE, Hamman KJ. A current picture of genetic counseling for familial pancreatic cancer. Expert Review of Quality of Life in Cancer Care 2016;1:425-432. [DOI: 10.1080/23809000.2016.1255552] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
392 Midha S, Sreenivas V, Kabra M, Chattopadhyay TK, Joshi YK, Garg PK. Genetically Determined Chronic Pancreatitis but not Alcoholic Pancreatitis Is a Strong Risk Factor for Pancreatic Cancer. Pancreas 2016;45:1478-84. [PMID: 27518468 DOI: 10.1097/MPA.0000000000000684] [Cited by in Crossref: 30] [Cited by in F6Publishing: 26] [Article Influence: 4.3] [Reference Citation Analysis]
393 Graffeo R, Livraghi L, Pagani O, Goldhirsch A, Partridge AH, Garber JE. Time to incorporate germline multigene panel testing into breast and ovarian cancer patient care. Breast Cancer Res Treat 2016;160:393-410. [DOI: 10.1007/s10549-016-4003-9] [Cited by in Crossref: 42] [Cited by in F6Publishing: 48] [Article Influence: 6.0] [Reference Citation Analysis]
394 Pittman ME, Brosens LA, Wood LD. Genetic Syndromes with Pancreatic Manifestations. Surg Pathol Clin. 2016;9:705-715. [PMID: 27926368 DOI: 10.1016/j.path.2016.05.012] [Cited by in Crossref: 13] [Cited by in F6Publishing: 9] [Article Influence: 1.9] [Reference Citation Analysis]
395 de Mestier L, Danset J, Neuzillet C, Rebours V, Cros J, Soufir N, Hammel P. Pancreatic ductal adenocarcinoma in BRCA2 mutation carriers. Endocrine-Related Cancer 2016;23:T57-67. [DOI: 10.1530/erc-16-0269] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 2.0] [Reference Citation Analysis]
396 Petersen GM. Familial pancreatic cancer. Semin Oncol 2016;43:548-53. [PMID: 27899186 DOI: 10.1053/j.seminoncol.2016.09.002] [Cited by in Crossref: 82] [Cited by in F6Publishing: 84] [Article Influence: 11.7] [Reference Citation Analysis]
397 Del Chiaro M, Rangelova E, Segersvärd R, Arnelo U. Are there still indications for total pancreatectomy? Updates Surg 2016;68:257-63. [PMID: 27605208 DOI: 10.1007/s13304-016-0388-6] [Cited by in Crossref: 39] [Cited by in F6Publishing: 42] [Article Influence: 5.6] [Reference Citation Analysis]
398 Stoffel EM. Heritable Gastrointestinal Cancer Syndromes. Gastroenterol Clin North Am 2016;45:509-27. [PMID: 27546846 DOI: 10.1016/j.gtc.2016.04.008] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 1.9] [Reference Citation Analysis]
399 Miller MS, Allen P, Brentnall TA, Goggins M, Hruban RH, Petersen GM, Rao CV, Whitcomb DC, Brand RE, Chari ST, Klein AP, Lubman DM, Rhim AD, Simeone DM, Wolpin BM, Umar A, Srivastava S, Steele VE, Rinaudo JA. Pancreatic Cancer Chemoprevention Translational Workshop: Meeting Report. Pancreas 2016;45:1080-91. [PMID: 27518363 DOI: 10.1097/MPA.0000000000000705] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 2.7] [Reference Citation Analysis]
400 Martinez-Useros J, Garcia-Foncillas J. Can Molecular Biomarkers Change the Paradigm of Pancreatic Cancer Prognosis? Biomed Res Int 2016;2016:4873089. [PMID: 27689078 DOI: 10.1155/2016/4873089] [Cited by in Crossref: 18] [Cited by in F6Publishing: 21] [Article Influence: 2.6] [Reference Citation Analysis]
401 Coronel E, Waxman I. State-of-the-art endoscopic procedures for pancreatic cancer. Future Oncology 2016;12:2037-47. [DOI: 10.2217/fon-2016-0123] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
402 Harinck F, Konings IC, Kluijt I, Poley JW, van Hooft JE, van Dullemen HM, Nio CY, Krak NC, Hermans JJ, Aalfs CM, Wagner A, Sijmons RH, Biermann K, van Eijck CH, Gouma DJ, Dijkgraaf MG, Fockens P, Bruno MJ; Dutch research group on pancreatic cancer surveillance in high-risk individuals. A multicentre comparative prospective blinded analysis of EUS and MRI for screening of pancreatic cancer in high-risk individuals. Gut 2016;65:1505-13. [PMID: 25986944 DOI: 10.1136/gutjnl-2014-308008] [Cited by in Crossref: 109] [Cited by in F6Publishing: 103] [Article Influence: 15.6] [Reference Citation Analysis]
403 Yabar CS, Winter JM. Pancreatic Cancer: A Review. Gastroenterol Clin North Am 2016;45:429-45. [PMID: 27546841 DOI: 10.1016/j.gtc.2016.04.003] [Cited by in Crossref: 63] [Cited by in F6Publishing: 63] [Article Influence: 9.0] [Reference Citation Analysis]
404 Watson J, Hydon K, Adair R. Pancreatic cancer. InnovAiT 2016;9:490-495. [DOI: 10.1177/1755738016655559] [Reference Citation Analysis]
405 Bartsch DK, Slater EP, Carrato A, Ibrahim IS, Guillen-Ponce C, Vasen HF, Matthäi E, Earl J, Jendryschek FS, Figiel J, Steinkamp M, Ramaswamy A, Vázquez-Sequeiros E, Muñoz-Beltran M, Montans J, Mocci E, Bonsing BA, Wasser M, Klöppel G, Langer P, Fendrich V, Gress TM. Refinement of screening for familial pancreatic cancer. Gut 2016;65:1314-21. [PMID: 27222532 DOI: 10.1136/gutjnl-2015-311098] [Cited by in Crossref: 55] [Cited by in F6Publishing: 54] [Article Influence: 7.9] [Reference Citation Analysis]
406 Leoz ML, Sánchez A, Carballal S, Ruano L, Ocaña T, Pellisé M, Castells A, Balaguer F, Moreira L. Hereditary gastric and pancreatic cancer predisposition syndromes. Gastroenterología y Hepatología (English Edition) 2016;39:481-93. [DOI: 10.1016/j.gastre.2016.06.010] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.6] [Reference Citation Analysis]
407 Hur C, Tramontano AC, Dowling EC, Brooks GA, Jeon A, Brugge WR, Gazelle GS, Kong CY, Pandharipande PV. Early Pancreatic Ductal Adenocarcinoma Survival Is Dependent on Size: Positive Implications for Future Targeted Screening. Pancreas 2016;45:1062-6. [PMID: 26692444 DOI: 10.1097/MPA.0000000000000587] [Cited by in Crossref: 25] [Cited by in F6Publishing: 26] [Article Influence: 3.6] [Reference Citation Analysis]
408 Castro M, Vierkoetter K, Prager D, Montgomery S, Sedgwick K. Synchronous Onset of Breast and Pancreatic Cancers: Results of Germline and Somatic Genetic Analysis. Case Rep Oncol 2016;9:387-94. [PMID: 27721756 DOI: 10.1159/000447348] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.9] [Reference Citation Analysis]
409 Peters MLB, Tseng JF, Miksad RA. Genetic Testing in Pancreatic Ductal Adenocarcinoma: Implications for Prevention and Treatment. Clinical Therapeutics 2016;38:1622-35. [DOI: 10.1016/j.clinthera.2016.03.006] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 2.3] [Reference Citation Analysis]
410 Soura E, Eliades PJ, Shannon K, Stratigos AJ, Tsao H. Hereditary melanoma: Update on syndromes and management: Genetics of familial atypical multiple mole melanoma syndrome. J Am Acad Dermatol 2016;74:395-407; quiz 408-10. [PMID: 26892650 DOI: 10.1016/j.jaad.2015.08.038] [Cited by in Crossref: 116] [Cited by in F6Publishing: 75] [Article Influence: 16.6] [Reference Citation Analysis]
411 Ransohoff KJ, Jaju PD, Tang JY, Carbone M, Leachman S, Sarin KY. Familial skin cancer syndromes: Increased melanoma risk. J Am Acad Dermatol 2016;74:423-34; quiz 435-6. [PMID: 26892652 DOI: 10.1016/j.jaad.2015.09.070] [Cited by in Crossref: 39] [Cited by in F6Publishing: 20] [Article Influence: 5.6] [Reference Citation Analysis]
412 Ying H, Dey P, Yao W, Kimmelman AC, Draetta GF, Maitra A, DePinho RA. Genetics and biology of pancreatic ductal adenocarcinoma. Genes Dev. 2016;30:355-385. [PMID: 26883357 DOI: 10.1101/gad.275776.115] [Cited by in Crossref: 301] [Cited by in F6Publishing: 319] [Article Influence: 43.0] [Reference Citation Analysis]
413 Potjer TP, Mertens BJ, Nicolardi S, van der Burgt YE, Bonsing BA, Mesker WE, Tollenaar RA, Vasen HF. Application of a Serum Protein Signature for Pancreatic Cancer to Separate Cases from Controls in a Pancreatic Surveillance Cohort. Transl Oncol 2016;9:242-7. [PMID: 27267843 DOI: 10.1016/j.tranon.2016.03.003] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 1.1] [Reference Citation Analysis]
414 Hackeng WM, Hruban RH, Offerhaus GJ, Brosens LA. Surgical and molecular pathology of pancreatic neoplasms. Diagn Pathol 2016;11:47. [PMID: 27267993 DOI: 10.1186/s13000-016-0497-z] [Cited by in Crossref: 71] [Cited by in F6Publishing: 79] [Article Influence: 10.1] [Reference Citation Analysis]
415 Rahimi E, Batra S, Thosani N, Singh H, Guha S. Increased Incidence of Second Primary Pancreatic Cancer in Patients with Prior Colorectal Cancer: A Population-Based US Study. Dig Dis Sci 2016;61:1652-60. [PMID: 27107866 DOI: 10.1007/s10620-016-4170-x] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.1] [Reference Citation Analysis]
416 Ansari D, Tingstedt B, Andersson B, Holmquist F, Sturesson C, Williamsson C, Sasor A, Borg D, Bauden M, Andersson R. Pancreatic cancer: yesterday, today and tomorrow. Future Oncol. 2016;12:1929-1946. [PMID: 27246628 DOI: 10.2217/fon-2016-0010] [Cited by in Crossref: 185] [Cited by in F6Publishing: 204] [Article Influence: 26.4] [Reference Citation Analysis]
417 Obermair F, Popper U, Romeder F, Rumpold H. Pankreaskarzinom. Wien klin Mag 2016;19:96-106. [DOI: 10.1007/s00740-016-0107-4] [Reference Citation Analysis]
418 Radon TP, Massat NJ, Jones R, Alrawashdeh W, Dumartin L, Ennis D, Duffy SW, Kocher HM, Pereira SP, Guarner posthumous L, Murta-Nascimento C, Real FX, Malats N, Neoptolemos J, Costello E, Greenhalf W, Lemoine NR, Crnogorac-Jurcevic T. Identification of a Three-Biomarker Panel in Urine for Early Detection of Pancreatic Adenocarcinoma. Clin Cancer Res. 2015;21:3512-3521. [PMID: 26240291 DOI: 10.1158/1078-0432.ccr-14-2467] [Cited by in Crossref: 123] [Cited by in F6Publishing: 128] [Article Influence: 17.6] [Reference Citation Analysis]
419 Herreros-Villanueva M, Bujanda L. Non-invasive biomarkers in pancreatic cancer diagnosis: what we need versus what we have. Ann Transl Med. 2016;4:134. [PMID: 27162784 DOI: 10.21037/atm.2016.03.44] [Cited by in Crossref: 61] [Cited by in F6Publishing: 66] [Article Influence: 8.7] [Reference Citation Analysis]
420 Borecka M, Zemankova P, Vocka M, Soucek P, Soukupova J, Kleiblova P, Sevcik J, Kleibl Z, Janatova M. Mutation analysis of the PALB2 gene in unselected pancreatic cancer patients in the Czech Republic. Cancer Genetics 2016;209:199-204. [DOI: 10.1016/j.cancergen.2016.03.003] [Cited by in Crossref: 24] [Cited by in F6Publishing: 25] [Article Influence: 3.4] [Reference Citation Analysis]
421 Vasen H, Ibrahim I, Ponce CG, Slater EP, Matthäi E, Carrato A, Earl J, Robbers K, van Mil AM, Potjer T. Benefit of Surveillance for Pancreatic Cancer in High-Risk Individuals: Outcome of Long-Term Prospective Follow-Up Studies From Three European Expert Centers. J Clin Oncol. 2016;34:2010-2019. [PMID: 27114589 DOI: 10.1200/jco.2015.64.0730] [Cited by in Crossref: 212] [Cited by in F6Publishing: 223] [Article Influence: 30.3] [Reference Citation Analysis]
422 Kleeff J, Korc M, Apte M, La Vecchia C, Johnson CD, Biankin AV, Neale RE, Tempero M, Tuveson DA, Hruban RH, Neoptolemos JP. Pancreatic cancer. Nat Rev Dis Primers. 2016;2:16022. [PMID: 27158978 DOI: 10.1038/nrdp.2016.22] [Cited by in Crossref: 912] [Cited by in F6Publishing: 976] [Article Influence: 130.3] [Reference Citation Analysis]
423 Díez EE, Higueras FÁ, Álvarez FC. Cáncer de la vía biliar y del páncreas. Medicine - Programa de Formación Médica Continuada Acreditado 2016;12:430-441. [DOI: 10.1016/j.med.2016.03.020] [Reference Citation Analysis]
424 Joergensen MT, Gerdes AM, Sorensen J, Schaffalitzky de Muckadell O, Mortensen MB. Is screening for pancreatic cancer in high-risk groups cost-effective? - Experience from a Danish national screening program. Pancreatology 2016;16:584-92. [PMID: 27090585 DOI: 10.1016/j.pan.2016.03.013] [Cited by in Crossref: 37] [Cited by in F6Publishing: 33] [Article Influence: 5.3] [Reference Citation Analysis]
425 Chahla E, Cheesman A, Mahon SM, Garrett RW, Bradenham BP Jr, Schwartz TL, Omran L, Taylor JR, Alkaade S. Frequency and Significance of Abnormal Pancreatic Imaging in Patients with BRCA1 and BRCA2 Genetic Mutations. Scientifica (Cairo) 2016;2016:5619358. [PMID: 27069714 DOI: 10.1155/2016/5619358] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
426 Scarà S, Bottoni P, Scatena R. CA 19-9: Biochemical and Clinical Aspects. Adv Exp Med Biol 2015;867:247-60. [PMID: 26530370 DOI: 10.1007/978-94-017-7215-0_15] [Cited by in Crossref: 144] [Cited by in F6Publishing: 91] [Article Influence: 20.6] [Reference Citation Analysis]
427 Wada K, Takaori K, Traverso LW, Hruban RH, Furukawa T, Brentnall TA, Hatori T, Sano K, Takada T, Majima Y. Clinical importance of Familial Pancreatic Cancer Registry in Japan: a report from kick-off meeting at International Symposium on Pancreas Cancer 2012. J Hepatobiliary Pancreat Sci. 2013;20:557-566. [PMID: 23604538 DOI: 10.1007/s00534-013-0611-5] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 1.6] [Reference Citation Analysis]
428 Le N, Sund M, Vinci A; GEMS collaborating group of Pancreas 2000. Prognostic and predictive markers in pancreatic adenocarcinoma. Dig Liver Dis 2016;48:223-30. [PMID: 26769569 DOI: 10.1016/j.dld.2015.11.001] [Cited by in Crossref: 84] [Cited by in F6Publishing: 89] [Article Influence: 12.0] [Reference Citation Analysis]
429 Serrao EM, Kettunen MI, Rodrigues TB, Dzien P, Wright AJ, Gopinathan A, Gallagher FA, Lewis DY, Frese KK, Almeida J, Howat WJ, Tuveson DA, Brindle KM. MRI with hyperpolarised [1-13C]pyruvate detects advanced pancreatic preneoplasia prior to invasive disease in a mouse model. Gut 2016;65:465-75. [PMID: 26347531 DOI: 10.1136/gutjnl-2015-310114] [Cited by in Crossref: 57] [Cited by in F6Publishing: 57] [Article Influence: 8.1] [Reference Citation Analysis]
430 Eskander MF, Bliss LA, Tseng JF. Pancreatic adenocarcinoma. Current Problems in Surgery 2016;53:107-54. [DOI: 10.1067/j.cpsurg.2016.01.001] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
431 Leoz ML, Sánchez A, Carballal S, Ruano L, Ocaña T, Pellisé M, Castells A, Balaguer F, Moreira L. [Hereditary gastric and pancreatic cancer predisposition syndromes]. Gastroenterol Hepatol 2016;39:481-93. [PMID: 26916701 DOI: 10.1016/j.gastrohep.2015.11.009] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 0.7] [Reference Citation Analysis]
432 Bhutani MS, Koduru P, Joshi V, Saxena P, Suzuki R, Irisawa A, Yamao K. The role of endoscopic ultrasound in pancreatic cancer screening. Endosc Ultrasound. 2016;5:8-16. [PMID: 26879161 DOI: 10.4103/2303-9027.175876] [Cited by in Crossref: 32] [Cited by in F6Publishing: 34] [Article Influence: 4.6] [Reference Citation Analysis]
433 Vasen HF, Bartsch D. Familial Pancreatic Cancer: To Screen or not to Screen? EBioMedicine 2015;2:1858-9. [PMID: 26844259 DOI: 10.1016/j.ebiom.2015.12.014] [Reference Citation Analysis]
434 Chao DT, Shah NH, Zeh HJ 3rd, Bahary N, Whitcomb DC, Brand RE. Increased Serum Insulin Exposure Does Not Affect Age or Stage of Pancreatic Adenocarcinoma Diagnosis in Patients With Diabetes Mellitus. Pancreas 2016;45:228-33. [PMID: 26418902 DOI: 10.1097/MPA.0000000000000439] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
435 Fusaroli P, Serrani M, De Giorgio R, D'Ercole MC, Ceroni L, Lisotti A, Caletti G. Contrast Harmonic-Endoscopic Ultrasound Is Useful to Identify Neoplastic Features of Pancreatic Cysts (With Videos). Pancreas 2016;45:265-8. [PMID: 26474428 DOI: 10.1097/MPA.0000000000000441] [Cited by in Crossref: 49] [Cited by in F6Publishing: 47] [Article Influence: 7.0] [Reference Citation Analysis]
436 Kamisawa T, Wood LD, Itoi T, Takaori K. Pancreatic cancer. Lancet. 2016;388:73-85. [PMID: 26830752 DOI: 10.1016/s0140-6736(16)00141-0] [Cited by in Crossref: 1277] [Cited by in F6Publishing: 1422] [Article Influence: 182.4] [Reference Citation Analysis]
437 Mughetti M, Calculli L, Chiesa AM, Ciccarese F, Rrusho O, Pezzilli R. Implications and issues related to familial pancreatic cancer: a cohort study of hospitalized patients. BMC Gastroenterol 2016;16:6. [PMID: 26767414 DOI: 10.1186/s12876-016-0421-8] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
438 Ibrahim AM, Wang YH. Viro-immune therapy: A new strategy for treatment of pancreatic cancer. World J Gastroenterol 2016; 22(2): 748-763 [PMID: 26811622 DOI: 10.3748/wjg.v22.i2.748] [Cited by in CrossRef: 11] [Cited by in F6Publishing: 12] [Article Influence: 1.6] [Reference Citation Analysis]
439 Grote T, Gress TM. EUS and Its Role in Pancreatic Cancer. Pancreatic Cancer 2016. [DOI: 10.1007/978-1-4939-6631-8_79-1] [Reference Citation Analysis]
440 Pho LN, Champine M, Leachman SA, Kohlmann W. Inherited Gene Mutations in Melanoma. Genetics of Melanoma 2016. [DOI: 10.1007/978-1-4939-3554-3_5] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
441 Amin S, Dimaio CJ. Pancreatic Adenocarcinoma. Pancreatic Masses 2016. [DOI: 10.1007/978-3-319-19677-0_2] [Reference Citation Analysis]
442 Roberts NJ, Klein AP. Familial Pancreatic Cancer. Pancreatic Cancer 2016. [DOI: 10.1007/978-1-4939-6631-8_78-1] [Reference Citation Analysis]
443 Konings ICAW, Cahen DL, Bruno MJ. How to Manage Cystic Tumors of the Pancreas in High-Risk Individuals. Cystic Tumors of the Pancreas 2016. [DOI: 10.1007/978-3-319-31882-0_14] [Reference Citation Analysis]
444 Lachter J. Screening first-degree relatives for gastric cancer prevention. Gastrointest Endosc 2016;83:274. [PMID: 26706309 DOI: 10.1016/j.gie.2015.08.010] [Reference Citation Analysis]
445 Michaelson-cohen R, Beeri R, Golomb E, Levy-lahad E. Inherited Breast Cancer. Molecular Pathology in Clinical Practice 2016. [DOI: 10.1007/978-3-319-19674-9_22] [Reference Citation Analysis]
446 Humphris JL, Biankin AV. Diagnosis and Management of Hereditary Pancreatic Cancer. Recent Results in Cancer Research 2016. [DOI: 10.1007/978-3-319-29998-3_5] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
447 Adán-merino L, Aldeguer-martínez M, Lozano-maya M, Hernández-garcía-gallardo D, Casado-fariñas I. Lights and shadows in the diagnosis and surveillance of a young asymptomatic patient with Peutz-Jeghers syndrome. Revista de Gastroenterología de México (English Edition) 2016;81:59-61. [DOI: 10.1016/j.rgmxen.2015.08.002] [Reference Citation Analysis]
448 Barnes C, Christians KK, Evans DB, Tsai S. Pancreas Adenocarcinoma and Ampullary Cancer. Pancreas and Biliary Disease 2016. [DOI: 10.1007/978-3-319-28089-9_6] [Reference Citation Analysis]
449 Nayor J, Grover S, Syngal S. Evaluation and Surveillance Strategies for Patients at Increased Risk of Pancreatic Cancer. Pancreatic Masses 2016. [DOI: 10.1007/978-3-319-19677-0_15] [Reference Citation Analysis]
450 Petrone MC, Arcidiacono PG. New strategies for the early detection of pancreatic cancer. Expert Rev Gastroenterol Hepatol 2016;10:157-9. [PMID: 26582179 DOI: 10.1586/17474124.2016.1122521] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
451 Roberts NJ, Norris AL, Petersen GM, Bondy ML, Brand R, Gallinger S, Kurtz RC, Olson SH, Rustgi AK, Schwartz AG, Stoffel E, Syngal S, Zogopoulos G, Ali SZ, Axilbund J, Chaffee KG, Chen YC, Cote ML, Childs EJ, Douville C, Goes FS, Herman JM, Iacobuzio-Donahue C, Kramer M, Makohon-Moore A, McCombie RW, McMahon KW, Niknafs N, Parla J, Pirooznia M, Potash JB, Rhim AD, Smith AL, Wang Y, Wolfgang CL, Wood LD, Zandi PP, Goggins M, Karchin R, Eshleman JR, Papadopoulos N, Kinzler KW, Vogelstein B, Hruban RH, Klein AP. Whole Genome Sequencing Defines the Genetic Heterogeneity of Familial Pancreatic Cancer. Cancer Discov. 2016;6:166-175. [PMID: 26658419 DOI: 10.1158/2159-8290.cd-15-0402] [Cited by in Crossref: 217] [Cited by in F6Publishing: 230] [Article Influence: 27.1] [Reference Citation Analysis]
452 Hanada K, Okazaki A, Hirano N, Izumi Y, Minami T, Ikemoto J, Kanemitsu K, Hino F. Effective screening for early diagnosis of pancreatic cancer. Best Pract Res Clin Gastroenterol 2015;29:929-39. [PMID: 26651254 DOI: 10.1016/j.bpg.2015.09.017] [Cited by in Crossref: 37] [Cited by in F6Publishing: 34] [Article Influence: 4.6] [Reference Citation Analysis]
453 Khashab MA, Canto MI. Endoscopic Ultrasonography. Yamada' s Textbook of Gastroenterology 2015. [DOI: 10.1002/9781118512074.ch146] [Reference Citation Analysis]
454 Margalit O, Dubois RN. Neoplasia of the Gastrointestinal Tract. Yamada' s Textbook of Gastroenterology 2015. [DOI: 10.1002/9781118512074.ch31] [Reference Citation Analysis]
455 Pandharipande PV, Jeon A, Heberle CR, Dowling EC, Kong CY, Chung DC, Brugge WR, Hur C. Screening for Pancreatic Adenocarcinoma in BRCA2 Mutation Carriers: Results of a Disease Simulation Model. EBioMedicine 2015;2:1980-6. [PMID: 26844277 DOI: 10.1016/j.ebiom.2015.11.005] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.4] [Reference Citation Analysis]
456 Yu J, Blackford AL, Dal Molin M, Wolfgang CL, Goggins M. Time to progression of pancreatic ductal adenocarcinoma from low-to-high tumour stages. Gut 2015;64:1783-9. [PMID: 25636698 DOI: 10.1136/gutjnl-2014-308653] [Cited by in Crossref: 119] [Cited by in F6Publishing: 110] [Article Influence: 14.9] [Reference Citation Analysis]
457 Shin EJ, Topazian M, Goggins MG, Syngal S, Saltzman JR, Lee JH, Farrell JJ, Canto MI. Linear-array EUS improves detection of pancreatic lesions in high-risk individuals: a randomized tandem study. Gastrointest Endosc 2015;82:812-8. [PMID: 25930097 DOI: 10.1016/j.gie.2015.02.028] [Cited by in Crossref: 37] [Cited by in F6Publishing: 36] [Article Influence: 4.6] [Reference Citation Analysis]
458 Kelly KA, Hollingsworth MA, Brand RE, Liu CH, Singh VK, Srivastava S, Wasan AD, Yadav D, Andersen DK. Advances in Biomedical Imaging, Bioengineering, and Related Technologies for the Development of Biomarkers of Pancreatic Disease: Summary of a National Institute of Diabetes and Digestive and Kidney Diseases and National Institute of Biomedical Imaging and Bioengineering Workshop. Pancreas 2015;44:1185-94. [PMID: 26465948 DOI: 10.1097/MPA.0000000000000552] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 1.9] [Reference Citation Analysis]
459 Flores K, Dinh K, Rouleau E, Whalen G, Wassef W, Lafemina J. Identification of genetic risk for pancreatic adenocarcinoma. Cancer Genetics 2015;208:559-63. [DOI: 10.1016/j.cancergen.2015.09.002] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
460 Gallmeier E, Hernaez R, Gress TM. Controversy on the time to progression of pancreatic ductal adenocarcinoma. Gut 2015;64:1676-7. [PMID: 25731873 DOI: 10.1136/gutjnl-2014-309066] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
461 Ryu JK. The Early Detection of Pancreatic Cancer: Whom and How? Korean J Pancreas Biliary Tract 2015;20:198-203. [DOI: 10.15279/kpba.2015.20.4.198] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
462 Slavin TP, Niell-Swiller M, Solomon I, Nehoray B, Rybak C, Blazer KR, Weitzel JN. Clinical Application of Multigene Panels: Challenges of Next-Generation Counseling and Cancer Risk Management. Front Oncol 2015;5:208. [PMID: 26484312 DOI: 10.3389/fonc.2015.00208] [Cited by in Crossref: 20] [Cited by in F6Publishing: 63] [Article Influence: 2.5] [Reference Citation Analysis]
463 Gironi LC, Colombo E, Farinelli P, Giorgione R, Bozzola C, Ogliara P, Pasini B. Germline CDKN2A mutations in childhood melanoma: a case of melanoma-pancreatic cancer syndrome. Int J Dermatol 2015;54:e553-5. [PMID: 26381259 DOI: 10.1111/ijd.12933] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
464 Griffin JF, Poruk KE, Wolfgang CL. Pancreatic cancer surgery: past, present, and future. Chin J Cancer Res. 2015;27:332-348. [PMID: 26361403 DOI: 10.3978/j.issn.1000-9604.2015.06.07] [Cited by in F6Publishing: 49] [Reference Citation Analysis]
465 Wáng YX, Gong JS, Loffroy R. On pancreatic cancer screening by magnetic resonance imaging with the recent evidence by Del Chiaro and colleagues. Chin J Cancer Res 2015;27:417-22. [PMID: 26361411 DOI: 10.3978/j.issn.1000-9604.2015.06.09] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
466 Hwang IK, Kim H, Lee YS, Kim J, Cho JY, Yoon YS, Han HS, Hwang JH. Presence of pancreatic intraepithelial neoplasia-3 in a background of chronic pancreatitis in pancreatic cancer patients. Cancer Sci 2015;106:1408-13. [PMID: 26183380 DOI: 10.1111/cas.12744] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
467 Kasi PM, Pedersen KS, McWilliams RR. BRCA2-associated pancreatic cancer and current screening guidelines. Cancer 2015;121:3046. [PMID: 26018189 DOI: 10.1002/cncr.29447] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
468 Neuzillet C, Tijeras-Raballand A, Bourget P, Cros J, Couvelard A, Sauvanet A, Vullierme MP, Tournigand C, Hammel P. State of the art and future directions of pancreatic ductal adenocarcinoma therapy. Pharmacol Ther. 2015;155:80-104. [PMID: 26299994 DOI: 10.1016/j.pharmthera.2015.08.006] [Cited by in Crossref: 69] [Cited by in F6Publishing: 75] [Article Influence: 8.6] [Reference Citation Analysis]
469 Brandão C, Lage J. Management of Patients with Hereditary Colorectal Cancer Syndromes. GE Port J Gastroenterol 2015;22:204-12. [PMID: 28868409 DOI: 10.1016/j.jpge.2015.06.003] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
470 Adán-Merino L, Aldeguer-Martínez M, Lozano-Maya M, Hernández-García-Gallardo D, Casado-Fariñas I. Lights and shadows in the diagnosis and surveillance of a young asymptomatic patient with Peutz-Jeghers syndrome. Rev Gastroenterol Mex 2016;81:59-61. [PMID: 26233267 DOI: 10.1016/j.rgmx.2015.06.004] [Reference Citation Analysis]
471 Connor AA, Gallinger S. Hereditary Pancreatic Cancer Syndromes. Surg Oncol Clin N Am. 2015;24:733-764. [PMID: 26363539 DOI: 10.1016/j.soc.2015.06.007] [Cited by in Crossref: 26] [Cited by in F6Publishing: 23] [Article Influence: 3.3] [Reference Citation Analysis]
472 Potjer TP, Bartsch DK, Slater EP, Matthäi E, Bonsing BA, Vasen HF. Limited resection of pancreatic cancer in high-risk patients can result in a second primary. Gut 2015;64:1342-4. [PMID: 25838549 DOI: 10.1136/gutjnl-2015-309568] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
473 Capurso G, Signoretti M, Valente R, Arnelo U, Lohr M, Poley JW, Fave GD, Chiaro MD. Methods and outcomes of screening for pancreatic adenocarcinoma in high-risk individuals. World J Gastrointest Endosc 2015; 7(9): 833-842 [PMID: 26240684 DOI: 10.4253/wjge.v7.i9.833] [Cited by in CrossRef: 26] [Cited by in F6Publishing: 27] [Article Influence: 3.3] [Reference Citation Analysis]
474 Mocci E, Guillen-Ponce C, Earl J, Marquez M, Solera J, Salazar-López MT, Calcedo-Arnáiz C, Vázquez-Sequeiros E, Montans J, Muñoz-Beltrán M, Vicente-Bártulos A, González-Gordaliza C, Sanjuanbenito A, Guerrero C, Mendía E, Lisa E, Lobo E, Martínez JC, Real FX, Malats N, Carrato A. PanGen-Fam: Spanish registry of hereditary pancreatic cancer. Eur J Cancer 2015;51:1911-7. [PMID: 26212471 DOI: 10.1016/j.ejca.2015.07.004] [Cited by in Crossref: 34] [Cited by in F6Publishing: 35] [Article Influence: 4.3] [Reference Citation Analysis]
475 Lin QJ, Yang F, Jin C, Fu DL. Current status and progress of pancreatic cancer in China. World J Gastroenterol 2015; 21(26): 7988-8003 [PMID: 26185370 DOI: 10.3748/wjg.v21.i26.7988] [Cited by in CrossRef: 173] [Cited by in F6Publishing: 190] [Article Influence: 21.6] [Reference Citation Analysis]
476 Gall TM, Wasan H, Jiao LR. Pancreatic cancer: current understanding of molecular and genetic aetiologies. Postgrad Med J 2015;91:594-600. [PMID: 26124188 DOI: 10.1136/postgradmedj-2014-133161] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
477 Cannistrà M, Ruggiero M, Zullo A, Serafini S, Grande R, Nardo B. Metastases of pancreatic adenocarcinoma: A systematic review of literature and a new functional concept. Int J Surg 2015;21 Suppl 1:S15-21. [PMID: 26123383 DOI: 10.1016/j.ijsu.2015.04.093] [Cited by in Crossref: 14] [Cited by in F6Publishing: 9] [Article Influence: 1.8] [Reference Citation Analysis]
478 Wada K, Takaori K, Traverso LW. Screening for Pancreatic Cancer. Surg Clin North Am. 2015;95:1041-1052. [PMID: 26315522 DOI: 10.1016/j.suc.2015.05.010] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 1.6] [Reference Citation Analysis]
479 Falconi M, Crippa S, Chari S, Conlon K, Kim SW, Levy P, Tanaka M, Werner J, Wolfgang CL, Pezzilli R, Castillo CF. Quality assessment of the guidelines on cystic neoplasms of the pancreas. Pancreatology 2015;15:463-9. [PMID: 26100659 DOI: 10.1016/j.pan.2015.05.478] [Cited by in Crossref: 18] [Cited by in F6Publishing: 15] [Article Influence: 2.3] [Reference Citation Analysis]
480 Petersen GM. Familial Pancreatic Adenocarcinoma. Hematol Oncol Clin North Am 2015;29:641-53. [PMID: 26226902 DOI: 10.1016/j.hoc.2015.04.007] [Cited by in Crossref: 35] [Cited by in F6Publishing: 27] [Article Influence: 4.4] [Reference Citation Analysis]
481 Hammel P, Neuzillet C, Bendaoud S, Lekhal C, de Mestier L, Hentic O. Traitement médical du cancer du pancréas : en 10 ans, enfin des progrès. Bulletin du Cancer 2015;102:S62-71. [DOI: 10.1016/s0007-4551(15)31219-4] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
482 Underhill M, Berry D, Dalton E, Schienda J, Syngal S. Patient experiences living with pancreatic cancer risk. Hered Cancer Clin Pract. 2015;13:13. [PMID: 26029287 DOI: 10.1186/s13053 -015-0034-1] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
483 Underhill M, Berry D, Dalton E, Schienda J, Syngal S. Patient experiences living with pancreatic cancer risk. Hered Cancer Clin Pract 2015;13:13. [PMID: 26029287 DOI: 10.1186/s13053-015-0034-1] [Cited by in Crossref: 8] [Cited by in F6Publishing: 11] [Article Influence: 1.0] [Reference Citation Analysis]
484 Jang KM, Kim SH, Kim YK, Song KD, Lee SJ, Choi D. Missed pancreatic ductal adenocarcinoma: Assessment of early imaging findings on prediagnostic magnetic resonance imaging. Eur J Radiol 2015;84:1473-9. [PMID: 26032128 DOI: 10.1016/j.ejrad.2015.05.012] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 2.3] [Reference Citation Analysis]
485 Holter S, Borgida A, Dodd A, Grant R, Semotiuk K, Hedley D, Dhani N, Narod S, Akbari M, Moore M, Gallinger S. Germline BRCA Mutations in a Large Clinic-Based Cohort of Patients With Pancreatic Adenocarcinoma. J Clin Oncol. 2015;33:3124-3129. [PMID: 25940717 DOI: 10.1200/jco.2014.59.7401] [Cited by in Crossref: 246] [Cited by in F6Publishing: 271] [Article Influence: 30.8] [Reference Citation Analysis]
486 Goel G, Sun W. Novel approaches in the management of pancreatic ductal adenocarcinoma: potential promises for the future. J Hematol Oncol. 2015;8:44. [PMID: 25935754 DOI: 10.1186/s13045-015-0141-5] [Cited by in Crossref: 28] [Cited by in F6Publishing: 29] [Article Influence: 3.5] [Reference Citation Analysis]
487 Stoffel EM. Screening in GI Cancers: The Role of Genetics. J Clin Oncol. 2015;33:1721-1728. [PMID: 25918283 DOI: 10.1200/jco.2014.60.6764] [Cited by in Crossref: 21] [Cited by in F6Publishing: 21] [Article Influence: 2.6] [Reference Citation Analysis]
488 Bruenderman E, Martin RC. A cost analysis of a pancreatic cancer screening protocol in high-risk populations. Am J Surg. 2015;210:409-416. [PMID: 26003200 DOI: 10.1016/j.amjsurg.2014.11.017] [Cited by in Crossref: 32] [Cited by in F6Publishing: 32] [Article Influence: 4.0] [Reference Citation Analysis]
489 Szmola R, Farkas G, Hegyi P, Czakó L, Dubravcsik Z, Hritz I, Kelemen D, Lásztity N, Morvay Z, Oláh A, Párniczky A, Rubovszky G, Sahin-Tóth M, Szentkereszti Z, Szücs Á, Takács T, Tiszlavicz L, Pap Á; Magyar Hasnyálmirigy Munkacsoport, Hungarian Pancreatic Study Group. [Pancreatic cancer. Evidence based management guidelines of the Hungarian Pancreatic Study Group]. Orv Hetil 2015;156:326-39. [PMID: 25662149 DOI: 10.1556/OH.2015.30063] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.3] [Reference Citation Analysis]
490 Turpin A, Cattan S, Leclerc J, Wacrenier A, Manouvrier-Hanu S, Buisine MP, Lejeune-Dumoulin S. [Hereditary predisposition to cancers of the digestive tract, breast, gynecological and gonadal: focus on the Peutz-Jeghers]. Bull Cancer 2014;101:813-22. [PMID: 25036236 DOI: 10.1684/bdc.2014.1942] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 1.5] [Reference Citation Analysis]
491 Laitman Y, Keinan Boker L, Liphsitz I, Weissglas-volkov D, Litz-philipsborn S, Schayek H, Friedman E. Cancer risks in Jewish male BRCA1 and BRCA2 mutation carriers. Breast Cancer Res Treat 2015;150:631-5. [DOI: 10.1007/s10549-015-3340-4] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.3] [Reference Citation Analysis]
492 Nicholson JA, Greenhalf W, Jackson R, Cox TF, Butler JV, Hanna T, Harrison S, Grocock CJ, Halloran CM, Howes NR, Raraty MG, Ghaneh P, Johnstone M, Sarkar S, Smart HL, Evans JC, Aithal GP, Sutton R, Neoptolemos JP, Lombard MG. Incidence of post-ERCP pancreatitis from direct pancreatic juice collection in hereditary pancreatitis and familial pancreatic cancer before and after the introduction of prophylactic pancreatic stents and rectal diclofenac. Pancreas 2015;44:260-5. [PMID: 25438071 DOI: 10.1097/MPA.0000000000000246] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
493 Urayama S. Pancreatic cancer early detection: Expanding higher-risk group with clinical and metabolomics parameters. World J Gastroenterol 2015; 21(6): 1707-1717 [PMID: 25684935 DOI: 10.3748/wjg.v21.i6.1707] [Cited by in CrossRef: 22] [Cited by in F6Publishing: 25] [Article Influence: 2.8] [Reference Citation Analysis]
494 Piciucchi M, Capurso G, Valente R, Larghi A, Archibugi L, Signoretti M, Stigliano S, Zerboni G, Barucca V, La Torre M, Cavallini M, Costamagna G, Marchetti P, Ziparo V, Delle Fave G. Early onset pancreatic cancer: risk factors, presentation and outcome. Pancreatology 2015;15:151-5. [PMID: 25708929 DOI: 10.1016/j.pan.2015.01.013] [Cited by in Crossref: 43] [Cited by in F6Publishing: 42] [Article Influence: 5.4] [Reference Citation Analysis]
495 Del Chiaro M, Mucelli RP, Blomberg J, Segersvärd R, Verbeke C. Is intraductal tubulopapillary neoplasia a new entity in the spectrum of familial pancreatic cancer syndrome? Fam Cancer 2014;13:227-9. [PMID: 24317685 DOI: 10.1007/s10689-013-9696-x] [Cited by in F6Publishing: 7] [Reference Citation Analysis]
496 Syngal S, Brand RE, Church JM, Giardiello FM, Hampel HL, Burt RW; American College of Gastroenterology. ACG clinical guideline: Genetic testing and management of hereditary gastrointestinal cancer syndromes. Am J Gastroenterol 2015;110:223-62; quiz 263. [PMID: 25645574 DOI: 10.1038/ajg.2014.435] [Cited by in Crossref: 957] [Cited by in F6Publishing: 948] [Article Influence: 119.6] [Reference Citation Analysis]
497 Mirus JE, Zhang Y, Li CI, Lokshin AE, Prentice RL, Hingorani SR, Lampe PD. Cross-species antibody microarray interrogation identifies a 3-protein panel of plasma biomarkers for early diagnosis of pancreas cancer. Clin Cancer Res. 2015;21:1764-1771. [PMID: 25589628 DOI: 10.1158/1078-0432.ccr-13-3474] [Cited by in Crossref: 38] [Cited by in F6Publishing: 39] [Article Influence: 4.8] [Reference Citation Analysis]
498 Rastegar N, Matteoni-Athayde LG, Eng J, Takahashi N, Tamm EP, Mortele KJ, Syngal S, Margolis D, Lennon AM, Wolfgang CL, Fishman EK, Hruban RH, Goggins M, Canto MI, Kamel IR. Incremental value of secretin-enhanced magnetic resonance cholangiopancreatography in detecting ductal communication in a population with high prevalence of small pancreatic cysts. Eur J Radiol 2015;84:575-80. [PMID: 25619503 DOI: 10.1016/j.ejrad.2014.12.028] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 2.0] [Reference Citation Analysis]
499 Mittal R, Arulampalam THA. Screening and Prevention of Extra Colonic Cancer in Hereditary Non-polyposis Colorectal Cancer. GI Surgery Annual 2015. [DOI: 10.1007/978-981-10-2010-0_3] [Reference Citation Analysis]
500 Chen F, Guo Y, Wang L. The Emerging Genetic Basis and Its Clinical Implication in Pancreatic Cancer. Gastrointest Tumors 2015;2:131-143. [DOI: 10.1159/000435764] [Reference Citation Analysis]
501 Lai Sey MS, Dewitt J, Al-haddad M. EUS in Pancreatic Tumors. ERCP and EUS 2015. [DOI: 10.1007/978-1-4939-2320-5_30] [Reference Citation Analysis]
502 Luz LP, Al-haddad M, Dewitt J. EUS and Pancreatic Tumors. Endosonography. Elsevier; 2015. pp. 187-208. [DOI: 10.1016/b978-0-323-22151-1.00015-3] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
503 Iskandar ME, Wayne MG, Steele JG, Cooperman AM. Familial pancreatic cancer: the case for prophylactic pancreatectomy in lieu of serial screening and shared decision making. Case Rep Oncol Med 2014;2014:737183. [PMID: 25506012 DOI: 10.1155/2014/737183] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
504 Hanada K, Okazaki A, Hirano N, Izumi Y, Teraoka Y, Ikemoto J, Kanemitsu K, Hino F, Fukuda T, Yonehara S. Diagnostic strategies for early pancreatic cancer. J Gastroenterol. 2015;50:147-154. [PMID: 25501287 DOI: 10.1007/s00535-014-1026-z] [Cited by in Crossref: 72] [Cited by in F6Publishing: 56] [Article Influence: 8.0] [Reference Citation Analysis]
505 Maisonneuve P, Lowenfels AB. Risk factors for pancreatic cancer: a summary review of meta-analytical studies. Int J Epidemiol. 2015;44:186-198. [PMID: 25502106 DOI: 10.1093/ije/dyu240] [Cited by in Crossref: 242] [Cited by in F6Publishing: 258] [Article Influence: 26.9] [Reference Citation Analysis]
506 Lavu H, Yeo CJ. Pancreatic ductal adenocarcinoma treatment--the past, present, and future. Semin Oncol. 2015;42:4-7. [PMID: 25726047 DOI: 10.1053/j.seminoncol.2014.12.001] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
507 Lennon AM, Victor D, Zaheer A, Ostovaneh MR, Jeh J, Law JK, Rezaee N, Molin MD, Ahn YJ, Wu W, Khashab MA, Girotra M, Ahuja N, Makary MA, Weiss MJ, Hirose K, Goggins M, Hruban RH, Cameron A, Wolfgang CL, Singh VK, Gurakar A. Liver transplant patients have a risk of progression similar to that of sporadic patients with branch duct intraductal papillary mucinous neoplasms. Liver Transpl 2014;20:1462-7. [PMID: 25155689 DOI: 10.1002/lt.23983] [Cited by in Crossref: 2] [Cited by in F6Publishing: 5] [Article Influence: 0.2] [Reference Citation Analysis]
508 Zhen DB, Rabe KG, Gallinger S, Syngal S, Schwartz AG, Goggins MG, Hruban RH, Cote ML, McWilliams RR, Roberts NJ, Cannon-Albright LA, Li D, Moyes K, Wenstrup RJ, Hartman AR, Seminara D, Klein AP, Petersen GM. BRCA1, BRCA2, PALB2, and CDKN2A mutations in familial pancreatic cancer: a PACGENE study. Genet Med. 2015;17:569-577. [PMID: 25356972 DOI: 10.1038/gim.2014.153] [Cited by in Crossref: 175] [Cited by in F6Publishing: 191] [Article Influence: 19.4] [Reference Citation Analysis]
509 Bergeron JP, Perry KD, Houser PM, Yang J. Endoscopic ultrasound-guided pancreatic fine-needle aspiration: potential pitfalls in one institution's experience of 1212 procedures. Cancer Cytopathol 2015;123:98-107. [PMID: 25410732 DOI: 10.1002/cncy.21497] [Cited by in Crossref: 31] [Cited by in F6Publishing: 36] [Article Influence: 3.4] [Reference Citation Analysis]
510 Avril MF, Bahadoran P, Cabaret O, Caron O, de la Fouchardière A, Demenais F, Desjardins L, Frébourg T, Hammel P, Leccia MT, Lesueur F, Mahé E, Martin L, Maubec E, Remenieras A, Richard S, Robert C, Soufir N, Stoppa-Lyonnet D, Thomas L, Vabres P, Bressac-de Paillerets B. [Recommendations for genetic testing and management of individuals genetically at-risk of cutaneous melanoma]. Ann Dermatol Venereol 2015;142:26-36. [PMID: 25600792 DOI: 10.1016/j.annder.2014.09.606] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 1.3] [Reference Citation Analysis]
511 Sadakari Y, Kanda M, Maitani K, Borges M, Canto MI, Goggins M. Mutant KRAS and GNAS DNA Concentrations in Secretin-Stimulated Pancreatic Fluid Collected from the Pancreatic Duct and the Duodenal Lumen. Clin Transl Gastroenterol 2014;5:e62. [PMID: 25393586 DOI: 10.1038/ctg.2014.14] [Cited by in Crossref: 22] [Cited by in F6Publishing: 26] [Article Influence: 2.4] [Reference Citation Analysis]
512 Pandharipande PV, Heberle C, Dowling EC, Kong CY, Tramontano A, Perzan KE, Brugge W, Hur C. Targeted screening of individuals at high risk for pancreatic cancer: results of a simulation model. Radiology 2015;275:177-87. [PMID: 25393849 DOI: 10.1148/radiol.14141282] [Cited by in Crossref: 24] [Cited by in F6Publishing: 26] [Article Influence: 2.7] [Reference Citation Analysis]
513 Humphris JL, Johns AL, Simpson SH, Cowley MJ, Pajic M, Chang DK, Nagrial AM, Chin VT, Chantrill LA, Pinese M. Clinical and pathologic features of familial pancreatic cancer. Cancer. 2014;120:3669-3675. [PMID: 25313458 DOI: 10.1002/cncr.28863] [Cited by in Crossref: 40] [Cited by in F6Publishing: 43] [Article Influence: 4.4] [Reference Citation Analysis]
514 Bruenderman EH, Martin RC 2nd. High-risk population in sporadic pancreatic adenocarcinoma: guidelines for screening. J Surg Res. 2015;194:212-219. [PMID: 25479908 DOI: 10.1016/j.jss.2014.06.046] [Cited by in Crossref: 18] [Cited by in F6Publishing: 19] [Article Influence: 2.0] [Reference Citation Analysis]
515 Fabbri C, Luigiano C, Maimone A, Tarantino I, Baccarini P, Fornelli A, Liotta R, Polifemo A, Barresi L, Traina M, Virgilio C, Cennamo V. Endoscopic ultrasound-guided fine-needle biopsy of small solid pancreatic lesions using a 22-gauge needle with side fenestration. Surg Endosc. 2015;29:1586-1590. [PMID: 25303907 DOI: 10.1007/s00464-014-3846-6] [Cited by in Crossref: 34] [Cited by in F6Publishing: 36] [Article Influence: 3.8] [Reference Citation Analysis]
516 Singer CF, Rappaport-fuerhauser C, Sopik V, Narod SA. Prostate cancer in a man with a BRCA2 mutation and a personal history of bilateral breast cancer: BRCA 2 and cancer in men. Clin Genet 2015;88:187-9. [DOI: 10.1111/cge.12478] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
517 Mersch J, Jackson MA, Park M, Nebgen D, Peterson SK, Singletary C, Arun BK, Litton JK. Cancers associated with BRCA1 and BRCA2 mutations other than breast and ovarian. Cancer. 2015;121:269-275. [PMID: 25224030 DOI: 10.1002/cncr.29041] [Cited by in Crossref: 303] [Cited by in F6Publishing: 336] [Article Influence: 33.7] [Reference Citation Analysis]
518 Chiaro MD, Segersvärd R, Lohr M, Verbeke C. Early detection and prevention of pancreatic cancer: Is it really possible today? World J Gastroenterol 2014; 20(34): 12118-12131 [PMID: 25232247 DOI: 10.3748/wjg.v20.i34.12118] [Cited by in CrossRef: 91] [Cited by in F6Publishing: 95] [Article Influence: 10.1] [Reference Citation Analysis]
519 Tung N, Battelli C, Allen B, Kaldate R, Bhatnagar S, Bowles K, Timms K, Garber JE, Herold C, Ellisen L. Frequency of mutations in individuals with breast cancer referred for BRCA1 and BRCA2 testing using next-generation sequencing with a 25-gene panel. Cancer. 2015;121:25-33. [PMID: 25186627 DOI: 10.1002/cncr.29010] [Cited by in Crossref: 304] [Cited by in F6Publishing: 326] [Article Influence: 33.8] [Reference Citation Analysis]
520 He XY, Yuan YZ. Advances in pancreatic cancer research: Moving towards early detection. World J Gastroenterol 2014; 20(32): 11241-11248 [PMID: 25170208 DOI: 10.3748/wjg.v20.i32.11241] [Cited by in CrossRef: 49] [Cited by in F6Publishing: 56] [Article Influence: 5.4] [Reference Citation Analysis]
521 Becker AE, Hernandez YG, Frucht H, Lucas AL. Pancreatic ductal adenocarcinoma: Risk factors, screening, and early detection. World J Gastroenterol 2014; 20(32): 11182-11198 [PMID: 25170203 DOI: 10.3748/wjg.v20.i32.11182] [Cited by in CrossRef: 189] [Cited by in F6Publishing: 196] [Article Influence: 21.0] [Reference Citation Analysis]
522 Okano K, Suzuki Y. Strategies for early detection of resectable pancreatic cancer. World J Gastroenterol 2014; 20(32): 11230-11240 [PMID: 25170207 DOI: 10.3748/wjg.v20.i32.11230] [Cited by in CrossRef: 30] [Cited by in F6Publishing: 32] [Article Influence: 3.3] [Reference Citation Analysis]
523 Ghiorzo P. Genetic predisposition to pancreatic cancer. World J Gastroenterol 2014; 20(31): 10778-10789 [PMID: 25152581 DOI: 10.3748/wjg.v20.i31.10778] [Cited by in CrossRef: 56] [Cited by in F6Publishing: 62] [Article Influence: 6.2] [Reference Citation Analysis]
524 Selkirk CG, Vogel KJ, Newlin AC, Weissman SM, Weiss SM, Wang C, Hulick PJ. Cancer genetic testing panels for inherited cancer susceptibility: the clinical experience of a large adult genetics practice. Familial Cancer 2014;13:527-36. [DOI: 10.1007/s10689-014-9741-4] [Cited by in Crossref: 29] [Cited by in F6Publishing: 30] [Article Influence: 3.2] [Reference Citation Analysis]
525 Giardiello FM, Allen JI, Axilbund JE, Boland CR, Burke CA, Burt RW, Church JM, Dominitz JA, Johnson DA, Kaltenbach T, Levin TR, Lieberman DA, Robertson DJ, Syngal S, Rex DK; US Multi-Society Task Force on Colorectal Cancer. Guidelines on genetic evaluation and management of Lynch syndrome: a consensus statement by the US Multi-Society Task Force on colorectal cancer. Gastroenterology 2014;147:502-26. [PMID: 25043945 DOI: 10.1053/j.gastro.2014.04.001] [Cited by in Crossref: 323] [Cited by in F6Publishing: 328] [Article Influence: 35.9] [Reference Citation Analysis]
526 Giardiello FM, Allen JI, Axilbund JE, Boland CR, Burke CA, Burt RW, Church JM, Dominitz JA, Johnson DA, Kaltenbach T, Levin TR, Lieberman DA, Robertson DJ, Syngal S, Rex DK; American Society for Gastrointestinal Endoscopy. Guidelines on genetic evaluation and management of Lynch syndrome: a consensus statement by the U.S. Multi-Society Task Force on Colorectal Cancer. Gastrointest Endosc 2014;80:197-220. [PMID: 25034835 DOI: 10.1016/j.gie.2014.06.006] [Cited by in Crossref: 37] [Cited by in F6Publishing: 33] [Article Influence: 4.1] [Reference Citation Analysis]
527 Giardiello FM, Allen JI, Axilbund JE, Boland CR, Burke CA, Burt RW, Church JM, Dominitz JA, Johnson DA, Kaltenbach T, Levin TR, Lieberman DA, Robertson DJ, Syngal S, Rex DK. Guidelines on genetic evaluation and management of Lynch syndrome: a consensus statement by the US Multi-society Task Force on colorectal cancer. Am J Gastroenterol 2014;109:1159-79. [PMID: 25070057 DOI: 10.1038/ajg.2014.186] [Cited by in Crossref: 308] [Cited by in F6Publishing: 312] [Article Influence: 34.2] [Reference Citation Analysis]
528 Lami G, Biagini MR, Galli A. Endoscopic ultrasonography for surveillance of individuals at high risk for pancreatic cancer. World J Gastrointest Endosc 2014; 6(7): 272-285 [PMID: 25031786 DOI: 10.4253/wjge.v6.i7.272] [Cited by in CrossRef: 15] [Cited by in F6Publishing: 19] [Article Influence: 1.7] [Reference Citation Analysis]
529 Van Loon K, Tempero M. Pancreatic Cancer. Cancer Consult: Expertise for Clinical Practice 2014. [DOI: 10.1002/9781118589199.ch89] [Reference Citation Analysis]
530 Vukobrat-Bijedic Z, Husic-Selimovic A, Bijedic N, Gornjakovic S, Sofic A, Gogov B, Bjelogrlic I, Mehmedovic A, Glavas S. Sensitivity of EUS and ERCP Endoscopic Procedures in the Detection of Pancreatic Cancer During Preoperative Staging Correlated with CT and CT Angiography Imaging Methods. Acta Inform Med 2014;22:160-3. [PMID: 25132706 DOI: 10.5455/aim.2014.22.160-163] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
531 Lennon AM, Wolfgang CL, Canto MI, Klein AP, Herman JM, Goggins M, Fishman EK, Kamel I, Weiss MJ, Diaz LA, Papadopoulos N, Kinzler KW, Vogelstein B, Hruban RH. The Early Detection of Pancreatic Cancer: What Will It Take to Diagnose and Treat Curable Pancreatic Neoplasia? Cancer Res 2014;74:3381-9. [DOI: 10.1158/0008-5472.can-14-0734] [Cited by in Crossref: 157] [Cited by in F6Publishing: 173] [Article Influence: 17.4] [Reference Citation Analysis]
532 Mastoraki A, Chatzimavridou-grigoriadou V, Chatzipetrou V, Mastoraki S, Papanikolaou IS, Danias N, Smyrniotis V, Arkadopoulos N. Familial Pancreatic Cancer: Challenging Diagnostic Approach and Therapeutic Management. J Gastrointest Canc 2014;45:256-61. [DOI: 10.1007/s12029-014-9609-8] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 0.9] [Reference Citation Analysis]
533 Lucas AL, Frado LE, Hwang C, Kumar S, Khanna LG, Levinson EJ, Chabot JA, Chung WK, Frucht H. BRCA1 and BRCA2 germline mutations are frequently demonstrated in both high-risk pancreatic cancer screening and pancreatic cancer cohorts. Cancer. 2014;120:1960-1967. [PMID: 24737347 DOI: 10.1002/cncr.28662] [Cited by in Crossref: 41] [Cited by in F6Publishing: 45] [Article Influence: 4.6] [Reference Citation Analysis]
534 Smith LA, Jamieson NB, McKay CJ. Investigation and management of pancreatic tumours. Frontline Gastroenterol 2014;5:144-52. [PMID: 28839761 DOI: 10.1136/flgastro-2013-100364] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
535 Gabree M, Patel D, Rodgers L. Clinical Applications of Melanoma Genetics. Curr Treat Options in Oncol 2014;15:336-50. [DOI: 10.1007/s11864-014-0282-8] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
536 Chang MC, Wong JM, Chang YT. Screening and early detection of pancreatic cancer in high risk population. World J Gastroenterol 2014; 20(9): 2358-2364 [PMID: 24605033 DOI: 10.3748/wjg.v20.i9.2358] [Cited by in CrossRef: 30] [Cited by in F6Publishing: 34] [Article Influence: 3.3] [Reference Citation Analysis]
537 Reznik R, Hendifar AE, Tuli R. Genetic determinants and potential therapeutic targets for pancreatic adenocarcinoma. Front Physiol. 2014;5:87. [PMID: 24624093 DOI: 10.3389/fphys.2014.00087] [Cited by in Crossref: 16] [Cited by in F6Publishing: 21] [Article Influence: 1.8] [Reference Citation Analysis]
538 Rodrigues CG, Pereira E, Caldeira A, Santos A, Sousa H, Banhudo A. Ecoendoscopia digestiva na prática clínica parte IIa – utilidade na avaliação do pâncreas. GE Jornal Português de Gastrenterologia 2014;21:60-74. [DOI: 10.1016/j.jpg.2013.11.002] [Reference Citation Analysis]
539 Rustgi AK. Familial pancreatic cancer: genetic advances. Genes Dev. 2014;28:1-7. [PMID: 24395243 DOI: 10.1101/gad.228452.113] [Cited by in Crossref: 69] [Cited by in F6Publishing: 73] [Article Influence: 7.7] [Reference Citation Analysis]
540 Carballal S, Leoz ML, Moreira L, Ocaña T, Balaguer F. Hereditary colorectal cancer syndromes. Colorectal Cancer 2014;3:57-76. [DOI: 10.2217/crc.13.80] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
541 Kim H, Saka B, Knight S, Borges M, Childs E, Klein A, Wolfgang C, Herman J, Adsay VN, Hruban RH, Goggins M. Having pancreatic cancer with tumoral loss of ATM and normal TP53 protein expression is associated with a poorer prognosis. Clin Cancer Res 2014;20:1865-72. [PMID: 24486587 DOI: 10.1158/1078-0432.CCR-13-1239] [Cited by in Crossref: 58] [Cited by in F6Publishing: 62] [Article Influence: 6.4] [Reference Citation Analysis]
542 Hodgson SV, Foulkes WD, Eng C, Maher ER. Gastrointestinal System. A Practical Guide to Human Cancer Genetics 2014. [DOI: 10.1007/978-1-4471-2375-0_5] [Reference Citation Analysis]
543 Reynolds RB, Folloder J. Clinical Management of Pancreatic Cancer. J Adv Pract Oncol 2014;5:356-64. [PMID: 26114016] [Reference Citation Analysis]
544 Neesse A, Krug S, Gress TM, Tuveson DA, Michl P. Emerging concepts in pancreatic cancer medicine: targeting the tumor stroma. Onco Targets Ther. 2013;7:33-43. [PMID: 24379681 DOI: 10.2147/ott.s38111] [Cited by in Crossref: 47] [Cited by in F6Publishing: 59] [Article Influence: 4.7] [Reference Citation Analysis]
545 Sipos B, Sperveslage J. [Will molecular diagnostics become established in pancreatic pathology?]. Pathologe 2013;34 Suppl 2:214-20. [PMID: 24196616 DOI: 10.1007/s00292-013-1865-z] [Reference Citation Analysis]
546 Andersen DK, Andren-Sandberg Å, Duell EJ, Goggins M, Korc M, Petersen GM, Smith JP, Whitcomb DC. Pancreatitis-diabetes-pancreatic cancer: summary of an NIDDK-NCI workshop. Pancreas 2013;42:1227-37. [PMID: 24152948 DOI: 10.1097/MPA.0b013e3182a9ad9d] [Cited by in Crossref: 102] [Cited by in F6Publishing: 93] [Article Influence: 10.2] [Reference Citation Analysis]
547 Murtaugh LC. Pathogenesis of pancreatic cancer: lessons from animal models. Toxicol Pathol 2014;42:217-28. [PMID: 24178582 DOI: 10.1177/0192623313508250] [Cited by in Crossref: 27] [Cited by in F6Publishing: 27] [Article Influence: 2.7] [Reference Citation Analysis]
548 Wolfgang CL, Herman JM, Laheru DA, Klein AP, Erdek MA, Fishman EK, Hruban RH. Recent progress in pancreatic cancer. CA Cancer J Clin. 2013;63:318-348. [PMID: 23856911 DOI: 10.3322/caac.21190] [Cited by in Crossref: 553] [Cited by in F6Publishing: 633] [Article Influence: 55.3] [Reference Citation Analysis]
549 Wolfgang CL, Herman JM, Laheru DA, Klein AP, Erdek MA, Fishman EK, Hruban RH. Recent progress in pancreatic cancer. CA Cancer J Clin. 2013;63:318-348. [PMID: 23856911 DOI: 10.1002/caac.21190] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
550 Tang RS. Many roles of endoscopic ultrasound in the evaluation of pancreatic neoplasms: getting to know its strengths and limitations. J Gastroenterol Hepatol 2013;28:1069-70. [PMID: 23782116 DOI: 10.1111/jgh.12232] [Reference Citation Analysis]
551 Isayama H, Nakai Y, Draganov PV. The role of Endoscopic Ultrasound (EUS) in the management of patients with pancreatic cancer: now bigger than ever. J Gastrointest Oncol 2013;4:121-2. [PMID: 23730506 DOI: 10.3978/j.issn.2078-6891.2013.009] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
552 Bhutani MS, Thosani N, Suzuki R, Guha S. Pancreatic cancer screening: what we do and do not know. Clin Gastroenterol Hepatol 2013;11:731-3. [PMID: 23403010 DOI: 10.1016/j.cgh.2013.02.004] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
553 Li A, Yu J, Kim H, Wolfgang CL, Canto MI, Hruban RH, Goggins M. MicroRNA array analysis finds elevated serum miR-1290 accurately distinguishes patients with low-stage pancreatic cancer from healthy and disease controls. Clin Cancer Res. 2013;19:3600-3610. [PMID: 23697990 DOI: 10.1158/1078-0432.ccr-12-3092] [Cited by in Crossref: 205] [Cited by in F6Publishing: 230] [Article Influence: 20.5] [Reference Citation Analysis]
554 Lucas AL, Shakya R, Lipsyc MD, Mitchel EB, Kumar S, Hwang C, Deng L, Devoe C, Chabot JA, Szabolcs M, Ludwig T, Chung WK, Frucht H. High prevalence of BRCA1 and BRCA2 germline mutations with loss of heterozygosity in a series of resected pancreatic adenocarcinoma and other neoplastic lesions. Clin Cancer Res. 2013;19:3396-3403. [PMID: 23658460 DOI: 10.1158/1078-0432.ccr-12-3020] [Cited by in Crossref: 52] [Cited by in F6Publishing: 57] [Article Influence: 5.2] [Reference Citation Analysis]
555 Raymond VM, Stoffel EM. Familial Gastric and Pancreatic Cancers: Diagnosis and Screening. American Society of Clinical Oncology Educational Book 2013. [DOI: 10.14694/edbook_am.2013.33.e44] [Reference Citation Analysis]
556 Wörmann SM, Algül H. Risk Factors and Therapeutic Targets in Pancreatic Cancer. Front Oncol 2013;3. [DOI: 10.3389/fonc.2013.00282] [Cited by in Crossref: 27] [Cited by in F6Publishing: 30] [Article Influence: 2.7] [Reference Citation Analysis]
557 Campbell F, Verbeke CS. Hereditary Exocrine Disorders. Pathology of the Pancreas 2013. [DOI: 10.1007/978-1-4471-2449-8_6] [Reference Citation Analysis]
558 Lucas AL, Chang MM, Lipsyc MD, Frucht H. The prevention and genetics of pancreatic cancer: a programmatic approach. Methods Mol Biol 2013;980:205-14. [PMID: 23359155 DOI: 10.1007/978-1-62703-287-2_10] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]